Autologous Fat Transfer
Melvin A. Shiffman (Ed.)
Autologous Fat Transfer Art, Science, and Clinical Practice
Dr. Melvin A. Shiffman Tustin Hospital and Medical Center Department of Surgery 14662 Newport Avenue Tustin, CA 92680 USA
[email protected]
ISBN: 978-3-642-00472-8
e-ISBN: 978-3-642-00473-5
DOI: 10.1007/978-3-642-00473-5 Springer Heidelberg Dordrecht London New York Library of Congress Control Number: 2009926019 © Springer-Verlag Berlin Heidelberg 2010 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature. Cover design: eStudio Calamar, Figueres/Berlin Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Foreword
It is with great pleasure that I submit a foreword for this new book. Many authors have written in detail about fat transplantation; however, experience and education are never enough on any of the cosmetic fields. The first text on fat transplantation by Charles H. Willi dates back to 1926. This means that someone before us understood the importance of autologous resources that we have. The technique has naturally evolved and has developed in these years. It is of utmost importance for a cosmetic surgeon to know every detail about the techniques: anatomy, metabolism of fat, pharmacology, and eventually the treatment of complications. A simple procedure is not necessarily a procedure that has no complications. All over the world and all over the centuries beauty has been a great spiritual force and has affected the evolution of civilization. Nowadays we are going toward an era in which major cosmetic surgical techniques are not so requested anymore. Patients want to stay young; they do not want to become young again! Fat is a wonderful resource, which can be used for reconstructive purposes or for cosmetic ones. It is important for any surgeon paving the first steps in this field to study and read and learn every time a bit more in order to have the best results with the least problems. I congratulate the author and my friend Mel Shiffman for his precious contributions in everything he does.
Rome, Italy
With great affection Giorgio Fischer
v
Preface
This book is the most up to date text on autologous fat transfer and includes chapters concerning the history of fat transfer and fat transfer survival, principles of fat transfer, adipose cell anatomy and physiology, guidelines for fat transfer and interpretation of results, subcision and fat transfer, fat transfer to a variety of areas of the body for aesthetic purposes and plastic reconstruction, fat autograft to muscle, complications of fat transfer, and medical legal aspects of fat transfer. Included are chapters on fat transfer for nonaesthetic purposes such as for recontouring postradiation defects, treatment of migraine headaches, treatment of sulcus vocalis, transfer around temporomandibular prosthesis, for skull base repair after craniotomy, and for congenital short palate. There are 63 chapters by international experts with the newest techniques explained in detail. Fat transfer is now one of the most common aesthetic procedures performed. Use of fat avoids the complications of other fillers, including solid and injectable, both temporary and permanent. Fat for transfer is available on almost all patients so that there is essentially no cost. Local anesthesia and/or tumescent local anesthesia are most commonly used and this increases the safety of the procedure. The effects of fat transfer are marked, resulting in a younger appearance, completing the three-dimensional correction of the face, and elevating depressions and deficits. Fat transfer may also prevent excessive fibrosis in noncosmetic applications. The techniques have improved allowing better volume retention of fat. Many procedures in fat transfer are discussed and described so that the reader will have a better understanding of the procedure and should be able to perform fat transfer avoiding many of the complications. Much of the improvement in fat transfer to the liposuction technique can be attributed to the contribution of liposuction by Fischer that was first reported in 1975 [1] and the many surgeons who contributed to the advances improving fat retention and safety. The history of fat transfer is replete with attempts to make fat transfer a viable procedure and to improve the techniques to increase the percentage of retention. The improvements of fat transfer have been through the contributions of surgeons in many specialties. We should recognize these international specialists who have spent their efforts in making fat transfer a viable procedure in aesthetic surgery. References 1. Fischer G. Surgical treatment of cellulitis. IIIrd Congress International Acad Cosm Surg, Rome, May 31, 1975 California, USA
Melvin A. Shiffman vii
Contents
Part I History, Principles, Fat Cell Physiology and Metabolism 1
History of Autologous Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
3
2
History of Autologous Fat Transplant Survival . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
5
3
Principles of Autologous Fat Transplantation. . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
11
4
The Adipocyte Anatomy, Physiology, and Metabolism/Nutrition . . . . Mitchell V. Kaminski and Rose M. Lopez de Vaughan
19
5
Fat Cell Biochemistry and Physiology . . . . . . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
29
6
White Adipose Tissue as an Endocrine Organ . . . . . . . . . . . . . . . . . . . Kihwa Kang
37
Part II Preoperative 7
Preoperative Consultation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
43
Part III Techniques for Aesthetic Procedures 8
Guidelines for Autologous Fat Transfer, Evaluation, and Interpretation of Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Sorin Eremia
47
9
Face Rejuvenation with Rice Grain-Size Fat Implants . . . . . . . . . . . . . Giorgio Fischer
53
10
Fat Transfer in the Asian. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Samuel M. Lam
59
ix
x
Contents
11
Subcison with Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
65
12
Autologous Fat Transplantation for Acne Scars . . . . . . . . . . . . . . . . . . Bernard I. Raskin
69
13
The Art of Facial Lipoaugmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . Edward B. Lack
79
14
Use of Platelet-Rich Plasma to Enhance Effectiveness of Autologous Fat Grafting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Robert W. Alexander
87
15
Fat Transfer to the Face . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman and Mitchell V. Kaminski
113
16
Fat Autograft Retention with Albumin . . . . . . . . . . . . . . . . . . . . . . . . . Mitchell V. Kaminski and Rose M. Lopez de Vaughan
123
17
Aesthetic Face-lift Using Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . Anthony Erian and Aqib Hafeez
135
18
Fat Transfer to the Glabella and Forehead . . . . . . . . . . . . . . . . . . . . . . Felix-Rüdiger G. Giebler
147
19
Eyebrow Lift with Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Giorgio Fischer
153
20
Treatment of Sunken Eyelid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dae Hwan Park
155
21
Fat Graft Postvertical Myectomy for Crow’s Feet Wrinkle Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fausto Viterbo
165
Optimizing Midfacial Rejuvenation: The Midface Lift and Autologous Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Allison T. Pontius and Edwin F. Williams III
171
22
23
Autologous Fat Transfer to the Cheeks and Chin. . . . . . . . . . . . . . . . . Steven B. Hopping
179
24
Nasal Augmentation with Autologous Fat Transfer . . . . . . . . . . . . . . . Jongki Lee
185
25
Lipotransfer to the Nasolabial Folds and Marionette Lines . . . . . . . . Robert M. Dryden and Dustin M. Heringer
189
26
Autologous Fat Transplantation to the Lips . . . . . . . . . . . . . . . . . . . . . Steven B. Hopping, Lina I. Naga, and Jeremy B. White
197
Contents
xi
27
Three Dimensional Facelift . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Sid J. Mirrafati
203
28
Complementary Fat Grafting of the Face . . . . . . . . . . . . . . . . . . . . . . . Samuel M. Lam, Mark J. Glasgold, and Robert A. Glasgold
209
29
Fat Transplants in Male and Female Genitals . . . . . . . . . . . . . . . . . . . Enrique Hernández-Pérez, Hassan Abbas Khawaja, José Enrique Hernández-Pérez, and Mauricio Hernández-Pérez
217
30
History of Breast Augmentation with Autologous Fat . . . . . . . . . . . . . Melvin A. Shiffman
223
31
Breast Augmentation with Autologous Fat . . . . . . . . . . . . . . . . . . . . . . Tetsuo Shu
229
32
Fat Transfer and Implant Breast Augmentation. . . . . . . . . . . . . . . . . . Katsuya Takasu and Shizu Takasu
237
33
Fat Transfer with Platelet-Rich Plasma for Breast Augmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Robert W. Alexander
243
Cell-Assisted Lipotransfer for Breast Augmentation: Grafting of Progenitor-Enriched Fat Tissue . . . . . . . . . . . . . . . . . . . . . Kotaro Yoshimura, Katsujiro Sato, and Daisuke Matsumoto
261
34
35
Fat Transfer to the Hand for Rejuvenation . . . . . . . . . . . . . . . . . . . . . . Pierre F. Fournier
36
Correction of Deep Gluteal and Trochanteric Depressions Using a Combination of Liposculpturing with Lipo-Augmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Robert F. Jackson and Todd P. Mangione
37
Buttocks and Legs Fat Transfer: Beautification, Enlargement, and Correction of Deformities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lina Valero de Pedroza
273
281
291
38
Autologous Fat Transfer for Gluteal Augmentation . . . . . . . . . . . . . . . Adrien E. Aiache
297
39
Autologous Fat for Liposuction Defects . . . . . . . . . . . . . . . . . . . . . . . . . Pierre F. Fournier
301
40
Periorbital Fat Transfer with Platelet Growth Factor . . . . . . . . . . . . . Julio A. Ferreira and Gustavo Ferreira
303
41
Cryopreserved Fat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bernard I. Raskin
305
xii
Contents
Part IV Techniques for Non-Aesthetic Procedures 42
Fat Transfer for Non-Aesthetic Procedures. . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman, Enrique Hernández-Pérez, Hassan Abbas Khawaja , José Enrique Hernández-Pérez, and Mauricio Hernández-Pérez
315
43
Fat Transplantation for Mild Pectus Excavatum . . . . . . . . . . . . . . . . . Luiz Haroldo Pereira and Aris Sterodimas
323
44
Correction of Hemifacial Atrophy with Fat Transfer. . . . . . . . . . . . . . Qing Feng Li, Yun Xie, and Danning Zheng
331
45
Recontouring Postradiation Thigh Defect with Autologous Fat Grafting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Richard H. Tholen, Ian T. Jackson, Richard Simman, and Vincent D. DiNick
46
Management of Migraine Headaches with Botulinum Toxin and Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . Devra Becker and Bahman Guyuron
47 Retropharyngeal Fat Transfer for Congenital Short Palate . . . . . . . . P. H. Dejonckere 48
49
Autologous Fat Grafts Placed Around Temporomandibular Joint (TMJ) Total Joint Prostheses to Prevent Heterotopic Bone . . . . . . . . . . . . . . . . . . . . . . . . Larry M. Wolford and Daniel Serra Cassano Autologous Fat Grafts for Skull Base Repair After Craniotomies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Jose E. Barrera, Sam P. Most, and Griffith R. Harsh IV
341
347
357
361
383
Part V Fat Processing and Survival 50
Fat Processing Techniques in Autologous Fat Transfer . . . . . . . . . . . . Nancy Kim and John G. Rose Jr.
391
51
Injection Gun Used as a Precision Device for Fat Transfer . . . . . . . . . Joseph Niamtu
397
52
Tissue Processing Considerations for Autologous Fat Grafting . . . . . Adam J. Katz and Peter B. Arnold
403
53
Fat Grafting Review and Fate of the Subperiostal Fat Graft . . . . . . . Defne Önel, Ufuk Emekli, M. Orhan Çizmeci, Funda Aköz, and Bilge Bilgiç
407
Contents
xiii
Part VI Complications 54
Complications of Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hassan Abbas Khawaja, Melvin A. Shiffman, Enrique Hernandez-Perez, Jose Enrique Hernandez-Perez, and Mauricio Hernandez-Perez
55
Facial Fat Hypertrophy in Patients Who Receive Autologous Fat Tissue Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Giovanni Guaraldi, Pier Luigi Bonucci, and Domenico De Fazio
56
Lid Deformity Secondary to Fat Transfer . . . . . . . . . . . . . . . . . . . . . . . Brian D. Cohen and Jason A. Spector
417
427
433
Part VII Miscellaneous 57
The Viability of Human Adipocytes After Liposuction Harvest . . . . . John K. Jones
58
Autologous Fat Grafting: A Study of Residual Intracellular Adipocyte Lidocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Robert W. Alexander
59
Autologous Fat Transfer National Consensus Survey: Trends in Techniques and Results for Harvest, Preparation, and Application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Matthew R. Kaufman, James P. Bradley, Brian Dickinson, Justin B. Heller, Kristy Wasson, Catherine O’Hara, Catherine Huang, Joubin Gabbay, Kiu Ghadjar, Timothy A. Miller, and Reza Jarrahy
439
445
451
60
Medical Legal Aspects of Autologous Fat Transplantation . . . . . . . . . Melvin A. Shiffman
459
61
Editor’s Commentary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Melvin A. Shiffman
463
Index
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 467
Contributors
Adrien E. Aiache 9884 Little Santa Monica Blvd, Beverly Hills, CA 90212, USA,
[email protected] Funda Aköz Department of Plastic and Reconstructive Surgery, Osmaniye State Hospital, Osmaniye, Turkey,
[email protected] Robert W. Alexander Department of Surgery, University of Texas, Health Science Center at San Antonio, San Antonio, TX, USA Department of Surgery, University of Washington, Seattle, WA, USA 3500 188th St. S.W. Suite 670, Lynnwood, WA 98037, USA
[email protected] Peter B. Arnold University of Virginia, P.O. Box 800376, Charlottesville, VA 22908-0376,
[email protected] Jose E. Barrera Department of Otolaryngology, Division of Facial Plastic and Reconstructive Surgery, Wilford Hall Medical Center, 59 MDW/SGOSO, 2200 Bergquist Drive, Ste 1, Lackland AFB, TX 78236-9908, USA
[email protected] Devra Becker 29017 Cedar Road, Cleveland (Lyndhurst), OH 44124, USA, devra:becker@uhospitals:org Bilge Bilgiç Department of Pathology, Istanbul University, Fevzi Pasa cad. Sarachane Parki Yani Fatih, Istanbul, Turkey,
[email protected] Pier Luigi Bonucci Strada del Diamante 86, 41100 Modena, Italy
[email protected] James P. Bradley Division of Plastic and Reconstructive Surgery, 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Daniel Serra Cassano Rua Vicente Satriana, 316 apt 52, Jardim Sao Jorge, Araraquara, Sao Paulo, Brazil 14807-9878,
[email protected] Brian D. Cohen Combined Divisions of Plastic Surgery, New York-Presbyterian, The University Hospital of Columbia and Cornell, 525 East 68th Street, P.O. Box 115, New York, NY 10065, USA,
[email protected] M. Orhan Çizmeci Department of Pathology, Istanbul University, Fevzi Pasa cad. Sarachane Parki Yani Fatih, Istanbul, Turkey,
[email protected] Domenico De Fazio Strada del Diamante 86, 41100 Modena, Italy,
[email protected] xv
xvi
P. H. Dejonckere The Institute of Phoniatrics, ENT Department, Division of Surgery, University Medical Centre, P.O. Box 85 500, 3508 Utrecht, The Netherlands,
[email protected] Brian Dickinson 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Vincent D. DiNick 135 S.Prospect, Ypsilante, MI 48198, USA,
[email protected] Robert M. Dryden Arizona Centre of Plastic Surgery, Tucson, AZ 85712, USA,
[email protected] Ufuk Emekli Department of Pathology, Istanbul University, Fevzi Pasa cad. Sarachane Parki Yani Fatih, Istanbul, Turkey,
[email protected]@ Sorin Eremia Cosmetic Surgery Unit, Division of Dermatology, UCLA, Brockton Cosmetic Surgery Center, 4440 Brockton, Suite 200, Riverside, CA 92501, USA,
[email protected] Anthony Erian Orwell Grange, 43 Cambridge Road, Wimpole, Cambridge, UK,
[email protected] Gustavo Ferreira Velez Sorsfield 220, 1640 Martinez, Buenos Aires, Argentina,
[email protected] Julio A. Ferreira Santiago Del Estero 102 (1640), Buenos Aires, Argentina,
[email protected] Giorgio Fischer Via della Camiluccia, 643, 00135 Rome, Italy,
[email protected] Pierre F. Fournier 55 Boulevard de Strasbourg, 75 010 Paris, France,
[email protected] Joubin Gabbay 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Kiu Ghadjar 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Felix-Rüdiger G. Giebler Vincemus-Klinik, Brückenstrasse 1a, 25840 Friedrichstadt/Eider, Germany,
[email protected] Mark J. Glasgold Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ, USA 31 River Road, Highland Park, NJ 08904, USA,
[email protected] Robert A. Glasgold Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ, USA,
[email protected] Giovanni Guaraldi Department of Medicine and Medicine Specialities, Infectious Diseases Clinic, University of Modena and Reggio Emilia School of Medicine, Via del Pozzo 71, 41100 Modena, Italy,
[email protected] Bahman Guyuron Department of Plastic Surgery, Case Western Reserve University, Cleveland, OH 44124, USA,
[email protected]
Contributors
Contributors
xvii
Griffith R. Harsh IV Department of Neurosurgery, Stanford University, School of Medicine, Stanford, CA, USA 875 Blake Wilbur Drive CC2222, Stanford, CA 94305, USA,
[email protected] Justin B. Heller 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Dustin M. Heringer Arizona Centre of Plastic Surgery, Tucson, AZ 85712, USA,
[email protected] Enrique Hernandez-Pérez 7801 NW 37th St., Club VIP, Suite 369, Miami, FL 33166-6503, USA,
[email protected] José Enrique Hernández-Pérez Center for Dermatology and Cosmetic Surgery, Pje. Dr. Roberto Orellana Valdé #137, Col. Médica, San Salvador CP 0-804, El Salvador,
[email protected] Mauricio Hernández-Pérez Center for Dermatology and Cosmetic Surgery, Pje. Dr. Roberto Orellana Valdé #137, Col. Médica, San Salvador CP 0-804, El Salvador,
[email protected] Steven B. Hopping George Washington University, Washington, DC, USA The Center for Cosmetic Surgery, 2440 M Street, NW, Suite 205, Washington, DC 20037, USA,
[email protected] Catherine Huang 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Ian T. Jackson Gretchen Hofman, Craniofacial Institute, 16001 West Nine Mile Road, Third Floor Fisher Center, Southfield, MI 48075, USA,
[email protected] Robert F. Jackson 330 North Wabash Avenue, Suite 450, Marion IN 46952, USA,
[email protected] Reza Jarrahy Division of Plastic Surgery, 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] John K. Jones 6818 Austin Center Blvd, Suite 204, Austin, TX 78731-3100, USA,
[email protected] Mitchell V. Kaminski Finch University of Health Sciences, Chicago Medical School, 230 Center Drive, Vernon Hill, Chicago, IL 60061-1584, USA,
[email protected] Kihwa Kang Department of Genetics and Complex Diseases, Harvard School of Public Health, 665 Huntington Avenue, Bldg2, Rm 129, Boston, MA 02115, USA,
[email protected] Adam J. Katz Department of Plastic and Maxillofacial Surgery, University of Virginia, P.O. Box 800376, Charlottesville, VA 22908-0376, USA,
[email protected] Matthew R. Kaufman Drexel College of Medicine, Shrewsbury, NJ, USA Plastic Surgery Center, 535 Sycamore Avenue, Apt. 732, Shrewsbury, NJ 07702-4224, USA,
[email protected] Hassan Abbas Khawaja Cosmetic Surgery and Skin Center, 53A, Block B II, Gulberg III, 53660 Lahore, Pakistan,
[email protected]
xviii
Nancy Kim Oculoplastics Service, Department of Ophthalmology, University of Wisconsin Hospitals and Clinics, 600 Highland Avenue, F3-332, Madison, WI 53703, USA,
[email protected] Edward B. Lack 2350 Ravine Way, Ste 400, Glenview, IL 60025, USA,
[email protected] Samuel M. Lam Willow Bend Wellness Center, Lam Facial Plastic Surgery Center and Hair Restoration Institute, 6101 Chapel Hill Boulevard, Suite 101, Plano, TX 75093, USA,
[email protected] Jongki Lee In & In Apt. 101-Dong 903-Ho, 834 Jijok-Dong Yooseong-Gu Daejeon-City, Korea 305-330,
[email protected] Qing Feng Li Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizhaoju Road, Shanghai, PR China, 200011,
[email protected] Rose M. Lopez de Vaughan Successful Longevity Clinic, 381 W. Northwest Highway, Palatine, IL 60067, USA,
[email protected] Todd P. Mangione Pasco Surgical Associates, 37840 Medical Arts Court, Zephyrhills, FL 33541-4325, USA,
[email protected] Daisuke Matsumoto Department of Plastic Surgery, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan,
[email protected] Timothy A. Miller 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Sid J. Mirrafati 3140 Redhill Avenue, Costa Mesa, CA 92626, USA,
[email protected] Sam P. Most Departments of Otolaryngology and Surgery (Plastic Surgery), Division of Facial Plastic and Reconstructive Surgery, Stanford University, School of Medicine, 801 Welch Rd, Stanford, CA 94305, USA,
[email protected] Lina I. Naga The Center for Cosmetic Surgery, 2440 M Street, NW, Suite 205, Washington, DC 20037, USA,
[email protected] Joseph Niamtu 11319 Polo Pl., Midlothian, VA 23113-1434, USA,
[email protected] Catherine O’Hara 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Defne Önel Plastic and Reconstructive Surgery Department, Medical Park Hospital, Fevzi Pasa cad. Sarachane Parkı Yani Fatih, Istanbul, Turkey,
[email protected] Dae Hwan Park Department of Plastic and Reconstructive Surgery, College of Medicine, Catholic University of Daegu, 3056-6 Daemyung 4-dong Namgu, Daegu, 705-718, Korea,
[email protected] Luiz Haroldo Pereira Luiz Haroldo Clinic, Rua Xavier da Silveira 45/206, 22061-010, Rio de Janeiro, Brazil,
[email protected]
Contributors
Contributors
xix
Allison T. Pontius The Williams’ Center for Plastic Surgery, 1072 Troy Schenectady Road, Latham, NY 12110, USA,
[email protected] Bernard I. Raskin Department of Medicine, Division of Dermatology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA,
[email protected] John G. Rose Jr. Davis Duehr Dean and The Aesthetic Surgery Center, Dean Health Systems, 1025 Regent Street, Madison, WI 53715, USA,
[email protected] Katsujiro Sato Cellport Clinic Yokohama, Yokohama Excellent III Building 2F, 3-35, Minami-nakadori, Naka-ku, Yokohama, Japan,
[email protected] Melvin A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA 92780-2302, USA,
[email protected] Tetsuo Shu Daikanyama Clinic, 4F, 1-10-2 Ebisu-Minami, Shibuya-ku, Tokyo, Japan 150-0022 Richard Simman 2130 Leiter Road, Suite 205, Miamisburg, OH 45342, USA,
[email protected] Jason A. Spector Division of Plastic Surgery, Weill Medical College of Cornell University, 525 East 68th Street, Payson 709, New York, NY 10065, USA,
[email protected] Aris Sterodimas Department of Plastic Surgery, Ivo Pitanguy Institute, Pontifical Catholic University of Rio de Janeiro, Rua Dona Mariana 65, 22280-020, Rio de Janeiro, Brazil,
[email protected] Katsuya Takasu Takasu Clinic, 2-14-27 Akasaka, Kokusai-Shin-Akasaka Building, Higashi-kan 2F, Minato-ku, Tokyo 107-0052, Japan,
[email protected] Richard H. Tholen Minneapolis Plastic Surgery, Ltd., 4825 Olsen Memorial Highway, Suite 200, Minneapolis, MN 55422, USA,
[email protected] Lina Valero de Pedroza Carrera 16 No 82-95-Cons: 301, Bogotá DC, Colombia,
[email protected] Fausto Viterbo Rua Domingos Minicucci Filho, 587, Botucatu – SP 18607-255, Brazil,
[email protected] Kristy Wasson 200 UCLA Medical Plaza, Suite 465, Los Angeles, CA 90095, USA,
[email protected] Jeremy B. White Division of Otolaryngology Head and Neck Surgery, George Washington University Washington, DC, USA 2440 Virginia Avenue, Apt. D710, Washington, DC 20037, USA,
[email protected] Edwin F. Williams III Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Albany Medical Center, Albany, NY 12208, USA The Williams’ Center for Plastic Surgery, 1072 Troy Schenectady Road, Latham, NY 12110, USA,
[email protected] Larry M. Wolford 3409 Worth Street, Suite 400, Dallas, TX 75246, USA,
[email protected]
xx
Yun Xie Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, 639 Zhizhaoju Road, Shanghai, PR China, 200011,
[email protected] Kotaro Yoshimura Department of Plastic Surgery, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan,
[email protected] Danning Zheng Department of Plastic and Reconstructive Surgery, Shanghai Ninth People’s Hospital, 639 Zhizhaoju Road, Shanghai, PR China, 200011, adizdn@@gmail.com
Contributors
Part History, Principles, Fat Cell Physiology and Metabolism
I
1
History of Autologous Fat Transfer1 Melvin A. Shiffman
1.1 Introduction The history of autologous fat augmentation gives an insight into the development of fat transfer for both cosmetic and non-cosmetic problems. Transplantation of pieces of fat and occasionally diced pieces of fat advanced to the removal of small segments of fat by liposuction after the development of the technique by Fischer and Fischer, reported in 1975.
1.2 History Neuber (1) reported the use of small pieces of fat from the upper arm to reconstruct a depressed area of the face resulting from tuberculosis osteitis. He concluded that small pieces of fat, of bean or almond size, appeared to have a good chance of survival. Czerny (2) used a large lipoma to fill a defect in the breast following resection of a benign mass. The transplanted breast, however, appeared darker in color and smaller in volume than the opposite breast. Verderame (4) observed that fat transplants solved the problem of shrinkage at the transplant site. Lexer (3) reported personal experience with fat transplants and found that larger pieces of fat gave better results. Bruning (5) used fat grafts to fill a post-rhinoplasty deformity by placing fat in a syringe and injecting the tissue through a needle. 1
Reprinted with permission of Lippincott Williams & Wilkins.
M. A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA, 92780-2302, USA e-mail:
[email protected]
Tuffier (6) inserted fat into the extrapleural space to treat pulmonary conditions. Biopsy of the fat 4 months post transplant showed that most of the fat was resorbed and replaced by fibrous tissue. Straatsma and Peer (7) used free fat grafts to repair postauricular fistulas and depressions or fistulas resulting from frontal sinus operations. Cotton (8) used a technique of broad undercutting and insertion of finely cut fat that was molded to fill defects. Peer (9) noted that grafts the size of a walnut appear to lose less bulk after transplanting than do smaller multiple grafts. He also found that free fat grafts lose about 45% of their weight and volume 1 year or more following the transplantation because of the failure of some fat cells to survive the trauma of grafting as well as the new environment. Fat grafts are affected by trauma, exposure, infection, and excessive pressure from dressings (10). Peer (11) stated that microscopically, grafts appear like normal adipose tissue 8 months after trans plantation. Liposuction was conceived by Fischer and Fischer in 1974 (12) and put into practice in 1975 (13). Fischer (14) first reported removal of fat by means of 5 mm incisions using a “rotating, alternating instrument electrically and air powered.” This allowed aspiration of fat through a cannula. Through a separate incision, saline solution was injected to dilute the fat. In 1977 (15), they reviewed 245 cases of liposuction with the “planotome” for treatment of cellulite in the lateral trochanteric areas. There was a 4.9% incidence of seromas despite wound suction catheters and compression dressings. Pseudocyst formation, which required removal of the capsule through a wider incision and the use of the planotome, occurred in 2% of cases. The advent of liposuction spurred a move toward using the liposuctioned fat for reinjecting areas of the body for filling defects or augmentation. Bircoll (16)
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_1, © Springer-Verlag Berlin Heidelberg 2010
3
4
first reported the use of autologous fat from liposuction for contouring and filling defects. Illouz (17) claimed that in 1983, he began to inject aspirated fat. Johnson (18) stated that in 1983, he began to use auto logous fat injection for contouring defects of the buttocks, anterior tibial area, lateral thighs, coccyx area, breasts, and face. Bircoll (19) presented the method of injecting fat that had been removed by liposuction. Krulig (20) asserted that he began to use fat grafts by means of a needle and syringe. He called the procedure “lipoinjection.” He began to use a disposable fat trap to facilitate the collection process and to ensure the fat’s sterility. Newman (21) stated that he began reinjecting fat in 1985. The idea of utilizing the aspirated fat, which was otherwise wasted, was an attractive idea and other surgeons began to make use of the aspirate to augment defects and other abnormalities. The American Society of Plastic and Reconstructive Surgery (ASPRS) Ad-Hoc Committee on New Proce dures produced a report on 30 September 1987, regarding autologous fat transplantation (22). The conclusions were: 1. Autologous fat injection has a historical and scientific basis. 2. It is still an experimental procedure. 3. Fat injection has achieved varied results, and longterm, controlled clinical studies are needed before firm conclusions can be made regarding its validity. 4. Fat transplant for breast augmentation can inhibit early detection of breast carcinoma and is hazardous to public health. Coleman and Saboeiro (23) reported success in fat transfer to the breast and concluded that it should be considered as an alternative to breast augmentation and reconstruction procedures. Two of 17 patients had breast cancer diagnosed by mammography, one 12 months and the other 92 months after fat transfer to the breast. Now fat transfer to the breast area is being used outside the breast itself, into the pectoralis major muscle and behind and in front of the muscle. The fat is also being used to augment tissues around the breast following treatment for breast cancer. Although most of the fat transfer procedures are for augmentation of tissues, there has been a surge of the use of fat for non-cosmetic procedures.
M. A. Shiffman
References 1. Neuber F. Fettransplantation. Chir Kongr Verhandl Deutsche Gesellsch Chir 1893;22:66. 2. Czerny V. Plastischer ersatz der brustdruse durch ein lipoma. Chi Kong Verhandl 1895;2:126. 3. Lexer E. Freie fettransplantation. Deutsch Med Wochenschr 1910;36:640. 4. Verderame P. Ueber fettransplantation bei adharenten knochennarben am orbitalrand. Klin Monatsbl fur Augenh 1909; 47:433–442. 5. Bruning P. Cited by Broeckaert, TJ, Steinhaus, J. Contribution e l’etude des greffes adipueses. Bull Acad Roy Med Belgique 1914;28:440. 6. Tuffier T. Abces gangreneux du pouman ouvert dans les bronches: Hemoptysies repetee operation par decollement pleuro-parietal; guerison. Bull et Mem Soc de Chir de Paris 1911;37:134. 7. Straatsma CR, Peer LA. Repair of postauricular fistula by means of a free fat graft. Arch Otolaryngol 1932;15:620–621. 8. Cotton FJ. Contribution to technique of fat grafts. N Engl JMed 1934;211:1051–1053. 9. Peer LA. The neglected free fat graft. Plast Reconstr Surg 1956;18(4):233–250. 10. Peer LA. Loss of weight and volume in human fat grafts. Plast Reconstr Surg 1950;5:217–230. 11. Peer LA. Transplantation of Tissues, Transplantation of Fat. Baltimore, Williams & Wilkins, 1959. 12. Fischer G. The evolution of liposculpture. Am J Cosm Surg 1997;14(3):231–239. 13. Fischer G. Surgical treatment of cellulitis. Third Congress of the International Academy of Cosmetic Surgery, Rome, 31 May 1975. 14. Fischer G. First surgical treatment for modeling body’s cellulite with three 5 mm incisions. Bull Int Acad Cosm Surg 1976;2:35–37. 15. Fischer A, Fischer G. Revised technique for cellulitis fat reduction in riding breeches deformity. Bull Int Acad Cosm Surg 1977;2(4):40–43. 16. Bircoll M. Autologous fat transplantation. The Asian Congress of Plastic Surgery, February 1982. 17. Illouz YG. The fat cell “graft”: A new technique to fill depressions. PlastReconstrSurg 1986;78(1):122–123. 18. Johnson GW. Body contouring by macroinjection of autologous fat. Am J Cosm Surg 1987;4(2):103–109. 19. Bircoll MJ. New frontiers in suction lipectomy. Second Asian Congress of Plastic Surgery, Pattiyua, Thailand, February 1984. 20. Krulig E. Lipo-injection. Am J Cosm Surg 1987;4(2):123–129. 21. Newman J, Levin J. Facial lipo-transplant surgery. Am J Cosm Surg 1987;4(2):131–140. 22. American Society of Plastic and Reconstructive Surgery Committee on New Procedures. Report in autologous fat transplantation September 30,1987. Plast Surg Nurs 1987; Winter:140–141. 23. Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: Safety and efficacy. Plast Reconstr Surg 2007;119(3): 775–785.
2
History of Autologous Fat Transplant Survival1 Melvin A. Shiffman
2.1 Introduction The survival of free fat used as an autograft is operator dependent and requires delicate handling of the graft tissue, careful washing of the fat to minimize extraneous blood cells, and installation into a site with adequate vascularity. There is evidence that fat cells will survive and that filling of defects is not from the residual collagen following cell destruction. There is some loss of fat after transplant, and most surgeons tend to overfill the recipient site.
2.2 Historical Review Verderame (1) reported that autogenous fat grafts in ocular surgery became reduced in size and advised the use of a larger transplant than that seemed necessary to fill the defect. Lexer (2) claimed that manipulation and tearing of the graft at the time of transfer would cause a great degree of graft shrinkage. Kanavel (3) felt that graft survival was improved by not using suture to secure the graft, careful hemostasis, and aseptic technique. He transplanted sheets of fat varying from 0.25 to 1 in. in thickness to prevent adhesions and contractures and lessen deformity of tendons, nerves, blood vessels, and joints. He felt that fat can be transplanted into any Reprinted with permission of Lippincott Williams & Wilkins.
1
M. A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA 92780-2302, USA e-mail:
[email protected]
ordinary field with the assurance that it will not act as a foreign body. Clinically it appears to live, become a part of the structure in which it is placed, and persists for many months and probably years. Davis (4) concluded that omentum, transplanted freely beneath the skin in a mass, 1 in. in diameter, maintains the greater part of its bulk. Lexer (5) reported excellent clinical results with very large fat grafts but stated that up to 66% of the fat autografts were absorbed and significant overcorrection should be used. He stated that multiple small grafts would turn to scar, while larger grafts would remain fatty tissue. Mann (6) performed free transplant of omentum fat and stated that it remained seemingly viable for as long as 1 year and retained a small percentage of its fat. Neuhof (7) examined available experimental and clinical evidence and concluded that: 1. Transplanted autologous fat undergoes practically some changes as transplanted bone. 2. The transplant dies and is replaced either by fibrous tissue or by newly formed fat. 3. Newly formed fat occurs through the activity of a large wandering histocyte-like cell, which takes on fat and becomes a fat cell. Guerney (8) noted that autogenous fat grafts should be transplanted in larger bulk than required since only 25–50% of the graft survives 1 year after transplantation. He studied transplanted, 1.7 mm3 (average size), fat grafts over a period of 12 months in rats and concluded that: 1. Liberation of fat by contiguous cells probably gives rise to fatty cysts. 2. Phagocytosis of liberated fat was assisted by polymorphonuclear leucocytes. 3. The percentage of normal fat in any surviving graft gradually increased throughout the year.
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_2, © Springer-Verlag Berlin Heidelberg 2010
5
6
4. A certain portion of the transplanted tissue gained an adequate blood supply early and continued to survive, while the remainder of the graft degenerated and was gradually eliminated from the site of the implant without evidence of gross scar. 5. Crushed grafts eventually disappeared attesting to the devastating effect of trauma on the vitality of a graft. 6. Single pieces of fat remain viable for at least 1 year, while grafts of a similar size cut into smaller pieces may last as long as 6 months, but the majority disappear by the third month. 7. Absolute hemostasis is essential since even a slight hemorrhage jeopardizes the viability of the graft. 8. Although slight infection results in only a small loss of tissue, gross infection leads to a loss of the whole graft. 9. Phagocyte cells do not use their fat to form new fat cells during the first year after transplantation. Hilse (9) showed histologically that free fat transplants regenerate fatty tissue without any exception. He referred to the histocyte filled with fat as a “lipoblast.” Green (10) used fat and fat-fascia autografts in the treatment of osseous defects secondary to osteomyelitis. He presumed that transplanted fat would become connective tissue and then bone, closing the defect. Wertheimer and Shapiro (11) studied fat physiology and determined that fat develops from primitive adipose cells the structure of which is like that of the fibroblasts of connective tissue. Peer (12) implanted autogenous fat (single piece compared to a piece cut into 20 segments) into the rectus muscle. Grafts were removed at intervals from 3 to 14 months. Grossly all grafts were surrounded by a connective-tissue capsule and, upon sectioning, the bulk of the graft contained fatty tissue. Single grafts (the size of a walnut) lost 45% of their weight while multigrafts lost 79% of their weight. He concluded that the fat grafts appeared like normal fat tissue 1 year or more after transplantation. Bames (13) noted that circulation in grafts is established in about 4 days after transplantation by anastomosis between the host and graft blood vessels. Traumatized fat grafts lose much more weight and volume than gently handled transplants (50% loss after 1 year). Normal appearing adipose cells were present in all the transplants. Dermal-fat grafts provide a readily available transplantation material for establishing normal contour in small breasts instead of foreign implants.
M. A. Shiffman
Hansberger (14) proposed that histocytes phagocytose the lipid and do not replace graft fat. After the graft of mature autotransplanted fat goes through initial ischemia, fat cells either necrose or dedifferentiate into immature cells. Under suitable conditions, the immature fat cells revert to mature adipocytes. Schorcher (15) reported using autogenous free fat transplantation to treat hypomastia. He noted that the connective elements remained intact with fat shrinkage to 25% of the original size by 6–9 months. He believed that if the graft was in several pieces, it would receive better nourishment from the recipient site. Van and Roncari (16, 17) demonstrated conversion of adipocyte precursors into adult adipocytes, both in vitro and in vivo, in rats. Saunders et al. (18) studied fat autograft survival and observed initial adipose tissue breakdown followed by revascularization. There is early breakdown of fat cells with formation of cyst like lipid deposits and infiltration by host histocytes. Illouz (19) opined that the human body is an excellent culture medium and that the fat cells apparently survive by intercellular lipolysis and osmosis until they are revascularized. The area to be augmented should be over corrected by 30% because approximately 30% necrosis of fat cells results when using the wet technique. Illouz (20) reported that fat transplantation in one patient biopsied 9 and 16 months later, showed normal fat cells. Asken (21) found that 90% of fat extracted by liposuction appears viable, assuming it is not traumatized either by handling or by high suction pressure. Damage incurred by the adipocytes is inversely related to the diameter of the instrument used for harvesting and injection. Campbell et al. (22) noted, both morphologically and biochemically, that adipocyte integrity and metabolism remain intact when subjected to liposuction. Johnson (23) examined liposuctioned fat and noted that 90% or more of the fat cells remained viable. He found that there was 75–85% of original fat present 3 months after transplantation. Agris (24) claimed that trauma and desiccation injured transplanted fat cells. Bircoll (25) stated that the ASPRS report (26) of 30% survival and Peer’s report (27) of 50% survival of autologous fat transplantation were based on the older technique of bulk fat transfer. Biopsies show 80% survival of fat after 1 year and an additional bulk of 10–20% of fibrous tissue. Fat transplants must be placed into the fatty subcutaneous tissue. Billings and May (28) analyzed the histology of free fat grafts and noted the following:
2 History of Autologous Fat Transplant Survival
7
Time (days)
Histology
First 4 days
Cellular infiltrate: polymorphonuclear cells, plasma cells, lymphocytes, eosinophils With vessels of graft: red blood cells were clumped together, white blood cells were in the process of diapedesis (passage of blood cells through intact vessel walls) No degeneration of graft endothelial cells and fibroblasts of the stroma
Fourth day
Engorgement and dilatation of smaller stromal vessels with abundant red blood cells and diapedetic white blood cells (anastomoses between smaller graft vessels and host red blood supply). Increased number of eosinophils in cellular infiltrate. Foreign-body type giant cells often seen
10 days
Areas of necrotic adipose tissue. Regenerative proliferation of original fat cells mostly at periphery of lobules – includes proliferating adipose cells of the graft and host round “histocyte-like” cells that took up lipid and enlarged 14–21 days. Further adipose cell breakdown. Increasing number of large host histocytes that appear to be picking up lipid with formation of droplets within their cytoplasm
30–60 days
Increasing numbers of large histocytes which peak at 2 months. Coalescing of fat globules in the cytoplasm.
Markman (29) has suggested that the number of fat cells may increase, through differentiation of existing preadipocytes, when fat cells reach a “critical size.” Illouz (30) reported that fibroblast-like precursor cells are able to multiply and give rise to fibroblasts or cells that resemble fibroblasts. When these cells are stimulated to absorb fat vacuoles with insulin or dexamethasone, they do not because adipocytes. He noted that adipocytes are very fragile and have a short life span outside the body. The cells live longer if mixed with normal saline and kept at a moderate temperature. They do not tolerate excessive manipulation, refrigeration, or major trauma such as grinding. Hudson et al. (31) demonstrated a greater cell size and lipogenic activity (using measurement of activity of lipogenic enzyme adipose tissue lipoprotein lipase [ATLPL]) in the gluteal – femoral area compared to the abdomen. Facial fat was found to have small cells with almost no ATLPL activity. This may have implications for donor site suitability. Nguyen et al. (32) compared suctioned fat, aspirated fat, and excised fat 9 months after implantation. Suctioned fat was obtained by using 1 atm negative pressure and on microscopy, only 10% of the fat cells were found with intact cell membrane. In all the grafts, fat was replaced with fibrosis, and only a small number of surviving adipocytes were still present. Kononas et al. (33) compared the loss of fat following transplant between surgically excised fat cut into small pieces and suctioned fat which was centrifuged. Weight loss was 59% for excised fat and 67% for suctioned fat. Ersek (34) used a wire whisk to agitate harvested fat and then strained it. He reported disappointing results even with repeated injection
and concluded that little, if any, autologous fat survives in its new site. Courtiss et al. (35) reported marginal success in fat grafting of two patients with postliposuction depressions. Asaadi (36) reported 5-year successful retention of fat transplanted to a right trochanteric post-traumatic depressed scar. Samdal et al. (37) measured blood flow and the amount of surviving fat following needle abrasion of the recipient site in rats. Abrasion was performed by a criss-cross pattern with 20 strokes using an 18 gauge needle in the subcutaneous tissue prior to transplant and compared this to controls without abrasion. They found that the mean weight of the fat transplant had shrunk to 44.6% of the original weight in the abraded group and 33.5% in the control group. The mean blood flow in fat was 0.165 mL/min/g in normal fat, 0.120 mL/min/g in the controls, and 0.187 mL/min/g in the abraded group. Microscopic examination of the transplanted fat varied from oil cysts, connective tissue, and inflammatory cells in some specimens and completely normal fatty tissue in others. Fat survival varied from 0–90%. They concluded that fat transplant survival was unpredictable. Eppley et al. (38) reported that the addition of basic fibroblast growth factor delivered by dextran beads to fat grafts results in a larger weight maintenance of fat at 1 year than controls. Group A Group B Group C
Group D
Fat alone Fat with dextran beads Fat with dextran beads soaked with cytochrome C (nonmitogenic control solution) Fat with dextran beads soaked with basic fibroblast growth factor
8
M. A. Shiffman
Group
Weight retention after 12 months (%)
A B C D
48.8 79.6 75.2 93.8
Histologically, he noted extensive interlacing collagen formation between the adiposites that provide support for the known effects of basic fibroblast growth factor on mesenchymal cell lines. There was an increased uniformity in adipocyte size seen in 1 year grafts compared to 1 month grafts which may indicate a possible maturation of these more “immature” cells. Whether this represents repair of damaged adipocytes, preadipocyte differentiation, conversion of infiltrating macrophages or fibroblasts, or entrapped lipid material is speculative. Carpaneda and Ribeiro (39) examined fat 2 months after transplantation and noted viable tissue only in the peripheral zone of 3.5 mm diameter cylindrical grafts. There was 60% loss of grafted tissue which occurred closer to the center. They reported, in 1994 (40), that graft viability depends on the thickness and geometric shape and is inversely proportional to the graft diameter if the diameter is greater than 3 mm. The maximum percentage of viability is 40% when the graft is no greater than 3.0 mm thick. Niechajev and Sevchuk (41) reported 50% fat survival over 3.5 years after single fat transplantation with 50% overcorrection. They found that fat obtained under maximum negative pressure (−0.95 atm) results in partial breakage and vaporization of the fatty tissue. About two-thirds of the fat withstood the trauma of aspiration. Low pressure (−0.5 atm) resulted in smaller cell size (29% smaller than with aspiration at −0.95 atm) and they assumed that high pressure causes mechanical distention of the adipocytes which increases the risk of and sometimes causes cell breakage. Courtiss (42) stated that fat grafting remains controversial and poorly understood and that “some surgeons have some impressive results, but most of us have many disappointing results.” Fagrell et al. (43) examined fat 6 months after implantation in the ears of rabbits. The fat implanted was obtained by: 1. Fat cylinder retrieved with 4.5 mm internal diameter syringe pushed into the fat and pulling the piston back. 2. Excised fat, 1 mg in weight. 3. Aspirated fat using 2 mm (14 gauge) cannula and syringe.
The tissue was examined by light microscopy and computer-assisted image analysis. There was no difference between the weight of the 6 month excised specimen (no weight loss) between the fat cylinder and excised fat, but there was a 59% loss of weight of the aspirated fat. The conclusion was that fat aspiration is traumatic and breaks up the cells. However, there was histologic evidence of viable fat cells in all transplants. Jones and Lyles (44) harvested fat with a 60 mL syringe, 3.0 mm pyramid cannula, and locked the plunger at 35 mL. The harvested fat was washed three times with normal saline and gently agitated. Cell cultures were prepared and maintained for 1 day to 2 months. Microscopy disclosed maintenance of mature adipose cells without dedifferentiation into a precursor phenotype. There was very little evidence of cellular damage or debris. Using photographs over a 6 year period of time, Coleman (45) demonstrated long-term survival of liposuctioned fat transplanted into the nasolabial fold. He stated that fat can migrate as the pressure of excess tissue forces the transplanted fat to shift and that fat can die from inadequate nutrition and oxygen from competition with other transplanted parcels of fatty tissue. Placement of fat into multiple tunnels allows closer location to nutrition. He concluded that fat survival is technique dependent and the primary reason for failure of long-term correction of the nasolabial fold is initial inadequate correction. Sattler and Sommer (46) found that autologous fat, dried over sterile swabs and frozen at −20°C (lower temperatures down to −70°C are preferable) up to 2 years and then thawed at room temperature, contains only fat cells and no fibrous debris. Ullmann et al. (47) added Cariel, a modified serum-free cell culture medium (MCDB 153), to aspirated human fat prior to reinjection into mice. Cariel contains essential and nonessential amino acids, vitamins, inorganic salts, trace elements, buffers, thyroxin, growth hormone, insulin, and sodium selenite. There was 46% of the weight of the fat remaining after 15 weeks in the group with Cariel compared to 29% in the control without Cariel. They concluded that the addition of nutrients enriched with anabolic hormones enabled the survival and take of more adipose cell in the graft. United States Patent (Lindenbaum) Composition and methods for enhancing wound healing. Patent No. 5461030. Date of patient: 24 October 1995.
2 History of Autologous Fat Transplant Survival
References 1. Verderame P. Ueber fettransplantation bei adharenten knochennarben am orbitalran. Klin Montsbl f Augenh 1909; 7:433. 2. Lexer E. Ueber freie fettransplantation. Klin Therap Wehnschr 1911;18:53. 3. Kanavel AR. The transplantation of free flaps of fat. Surg Gynecol Obstet 1916;23:163–176. 4. Davis CB. Free transplantation of the omentum, subcutaneously and within the abdomen. J Am Med Assoc 1917;68: 705–706. 5. Lexer E. Fatty tissue transplantation. In: Die Transplantation, Part I. Stuttgart, Ferdinand Enke, 1919, pp. 265–302. 6. Mann FC. The transplantation of fat in the peritoneal cavity. Surg Clin N Am 1921;1:1465–1471. 7. Neuhof H. The Transplantation of Tissues. New York, D. Appleton, 1923, p. 74. 8. Guerney CE. Experimental study of the behavior of free fat transplants. Surgery 1938;3:679–692. 9. Hilse A. Histologische ergebuisse der experimentellen freien fettgewebstronsplantation. Beitr 2 Path Anal U Z Allg Path 1928;79:592–624. 10. Green JR. Repairing bone defects in cranium and tibia. South Med J 1947;40:289. 11. Wertheimer E, Shapiro B. The physiology of adipose tissue. Physiol Rev 1948;28:451. 12. Peer LA. Loss of weight and volume in human fat grafts: With postulation of a “cell survival theory.” Plast Reconstr Surg 1950;5:217–230. 13. Bames HO. Augmentation mammoplasty by lipotransplant. Plast Reconstr Surg 1953;11(5):404–412. 14. Hansberger FX. Quantitative studies on the development of autotransplants of immature adipose tissue of rats. Anat Rec 1995;122:507. 15. Schorcher F. Fettgewebsver pflanzung bei zu kneiner brust. Munchen Med Wochenschr. 1957;99(14):489. 16. Van RL, Roncari DA. Complete differentiation of adipocyte precursors: A culture system for studying the cellular nature of adipose tissue. Cell Tiss Res 1978;195(2):317–329. 17. Van RL, Roncari DA. Complete differentiation in vivo of implanted cultured adipocyte precursors from adult rats. Cell Tiss Res 1982;225(3):557–566. 18. Saunders MC, Keller JT, Dunsker SB, Mayfield FH. Survival of autologous fat grafts in humans and mice. Connect Tiss Res 1981;8(2):85–95. 19. Illouz YG: New applications of liposuction. In Illouz YG (ed), Liposuction: The Franco-American Experience. Beverly Hills, CA, Medical Aesthetics, 1985, pp. 365–414. 20. Illouz YG. The fat cell “graft”: A new technique to fill depressions. Plast Reconstr Surg 1986;78(1):122–123. 21. Asken S. Autologous fat transplantation: Micro and macro techniques. Am J Cosm Surg 1987;4:111–121. 22. Campbell GL, Laudenslager N, Newman J. The effect of mechanical stress on adipocyte morphology and metabolism. Am J Cosm Surg 1987;4:89–94. 23. Johnson GW. Body contouring by macroinjection of autogenous fat. Am J Cosm Surg 1987;4(2):103–109. 24. Agris J. Autologous fat transplantation: A 3-year study. Am J Cosm Surg 1987;4(2):95–102.
9 25. Bircoll M. Autologous fat transplantation: An evaluation of microcalcification and fat cell survivability following (AFT) cosmetic breast augmentation. Am J Cosm Surg 1988;5(4) 283–288. 26. ASPRS Ad-Hoc Committee on new Procedures: Report on Autologous fat transplantation. Plast Surg Nurs 1987 Winter; 7(4):140–141. 27. Peer LA. The neglected free fat graft. Plast Reconstr Surg 1956;18(4):233–250. 28. Billings E Jr, May JW. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 1989;83(2):368–381. 29. Markman B. Anatomy and physiology of adipose tissue. Clin Plast Surg 1989;16(2):235–244. 30. Illouz YG. Fat injection: A four year clinical trial. In Hetter GP (ed), Lipoplasty: The Theory and Practice of Blunt Suction Lipectomy, Second Edition, Boston, Little Brown, 1990, pp. 239–246. 31. Hudson DA, Lambert EV, Block CE. Site selection for fat autotransplantation: Some observations. Aesthetic Plast Surg 1990;14(3):195–197. 32. Nguyen A, Pasyk KA, Bouvier TN, Hassett CA, Argernt LC. Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg 1990;85(3):378–386. 33. Kononas TC, Bucky LP, Hurley C, May JW Jr. The fate of suctioned and surgically removed fat after reimplantation for soft-tissue augmentation. A volume and histologic study in the rabbit. Plast Reconstr Surg 1993;91(5):763–768. 34. Ersek RA. Transplantation of purified autologous fat: A 3-year follow-up is disappointing. Plast Reconstr Surg 1991;87(2):219–227. 35. Courtiss EH, Choucair RJ, Donelan MB. Large-volume suction lipectomy: An analysis of 108 patients. Plast Reconstr Surg 1992;89(6):1068–1079. 36. Asaadi M, Haramis HT. Successful autologous fat injection at 5-year follow-up. Plast Reconstr Surg 1993;91(4): 755–756. 37. Samdal F, Skolleborg KC, Berthelsen N. The effect of preoperative needle abrasion of the recipient on survival of autologous free fat grafts in rats. Scand J Reconstr hand Surg 1992;26(1):33–36. 38. Eppley BL, Sidner RA, Plastis JM, Sadove AM. Bioactivation of free-fat transfers: A potential new approach to improving graft survival. Plast Reconstr Surg 1992;90(6):1022–1030. 39. Carpaneda CA, Ribeiro MT. Study of the histologic alterations and viability of the adipose graft in humans. Aesthetic Plast Surg 1993;17(1):43–47. 40. Carpaneda CA, Ribeiro MT. Percentage of graft viability versus injected volume in adipose autotransplants. Aesthetic Plast Surg 1994;18(1):17–19. 41. Niechajev I, Sevchuk O. Long-term results of fat transplantation: Clinical and histologic studies. Plast Reconstr Surg 1994;94(3):496–506. 42. Courtiss EH. Surgical correction of postliposuction contour irregularities. Plast Reconstr Surg 1994;94:137–138; discussion 137–138. 43. Fagrell D, Eneström S, Berggren A, Kniola B. Fat cylinder transplantation: An experimental comparative study of three different kinds of fat transplants. Plast Reconstr Surg 1996; 98(1):90–96.
10 44. Jones JK, Lyles ME. The viability of human adipocytes after closed-syringe liposuction harvest. Am J Cosm Surg 1997; 14:275–279. 45. Coleman SR. Long-term survival of fat transplants: Con trolled demonstrations. Aesthetic Plast Surg 1995;19(5): 421–425.
M. A. Shiffman 46. Sattler G, Sommer B. Liporecycling: Immediate and delayed. Am J Cosm Surg 1997;14:311–316. 47. Ullmann Y, Hyams M, Ramon Y, Beach D, Peled IJ, Linderbaum ES. Enhancing the survival of aspirated human fat injected into mice. Plast Reconstr Surg 1998; 101(7): 1940–1944.
Principles of Autologous Fat Transplantation Melvin A. Shiffman
3.1 Introduction The introduction of liposuction for fat reduction and body contouring has developed into transplantation of the extracted fat for augmentation of defects or for cosmetic purposes. There has been a controversy concerning the manner of collecting, injecting, and cleansing the fat and the effectiveness of the fat transfer. Some physicians have been disappointed with the long-term results of fat transplantation. The process of fat transplantation has not yet been standardized, and there is a need to analyze some of the methods and results.
3.2 Fat Transplant Survival Vitamin E is a necessary factor in the maintenance of fat tissue (1) while insulin increases the metabolic activity of fat cells (2) and retards lipolysis (3–7). Hiragun et al. (8) theorized that insulin may induce fibroblasts to pick up lipid lost from lipolysis and become adipocytes. Skouge (3) felt that fat cells from an area of relatively poor vascularity will be more hardy, have decreased metabolic needs, and increase survival. Asken (9), however, stated that the more fibrous areas, such as upper abdomen, are not ideal for donor sites. Fat characteristics may be helpful in determining which area of fat is more likely to be retained. The adipocytes with alpha 2 receptors are antilipolytic with poor response to diet and appear more likely to survive with
M. A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA 92780-2302, USA e-mail:
[email protected]
little change from weight loss or weight gain in comparison with adipocytes with beta 1 receptors (Table 3.1). Survival of adipocytes depends on the instrumentation used for harvesting and injecting the fat. Damage is inversely related to the diameter of the instrument to extract and inject fat (10). The pressure generated in injecting fat increases as a function of decreasing needle diameter (from 16 to 22 gauge) (11). There is some decrease in the metabolic activity of fragments that are passed through 20-gauge needles or smaller (Table 3.2). However, the size of the extracted particles is not de scribed. If the extraction of fat is with a cannula that is 20 gauge, it is doubtful that the 20-gauge needle would cause damage to the adipocytes. The presence of blood in the fat injected stimulates macrophage activity to remove the cells. Washing the cells in a physiologic solution prior to injection will solve the problem (12–14). Skouge (3) raised the question of whether washing decreases the viability of fragile adipocytes. Campbell et al. (11) concluded that adipocyte integrity and metabolism of fat fragments subjected to mechanical manipulation by liposuction using wall suction remain intact. Illouz (12) biopsied the areas of fat injection and found normal fat cells. McCurdy (15) analyzed fat cell survival and concluded that the technical factors to accomplish the goal of 40–50% transplanted adipocyte survival include: 1. Low vascularity of donor site 2. High vascularity for recipient site 3. Low pressure technique of aspiration of fat 4. Filtering and washing harvested adipocytes 5. Use of ³2 mm cannula for injection to minimize adipocyte injury 6. Multilayered deposition of fat 7. Overcorrection of the recipient site
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_3, © Springer-Verlag Berlin Heidelberg 2010
11
3
12
M. A. Shiffman
Table 3.1 Fat characteristics (8) Lipolysis Response to diet Region of fat
Alpha 2 receptors
Beta 1 receptors
Antilypolytic Poor Abdominal, trochanteric (genetic fat)
Lipolytic Good Facial, arms, upper torso
Berdeguer (23): Clinical indications for fat trans plantation
Table 3.2 Needle size and cell survival (11) Needle gauge Pad integrity Cell morphology Nuclear morphology Fat globule
16
18
20
22
+ + + +
o + + +
− o o +
− − +
+ = 75% or more without cell damage o = 25–75% cell damage − = >75% cell damage
Because of the problem of resorption of fat with fat transplantation, 30–50% overinjection is ordinarily used (16–21). Asadi and Haramis (16) determined that subdermal injection is important for long-term results.
3.3 Indications for Fat Transplantation There have been two papers that relate to the indications for autologous fat transplantation. Skouge (22): Indications for fat transplantation • Facial −− Aging changes −− Melolabial grooves −− Central cheek depressions −− Subcommissural depressions −− Flattened upper lip −− Glabella −− Diffuse age-related lipoatrophy • Cosmetic −− Lip augmentation −− Chin augmentation −− Malar augmentation • Scars −− Traumatic −− Lipoatrophy, acne −− Idiopathic lipodystrophy −− Facial hemiatrophy
• Nonfacial −− Rejuvenation of the hands −− Body contour defects −− Depressions, liposuction induced −− Breast enlargement −− Traumatic scars
(a) Depressed scars – face and body 1. Postsurgical 2. Posttraumatic (b) Aging skin with loss of supportive tissue 1. Glabellar furrows 2. Upper lip 3. Melolabial folds 4. Hollow cheeks 5. Dorsal hands (c) Aesthetic enhancement 1. Cheek augmentation 2. Chin augmentation 3. Breast augmentation 4. Leg contour surgery (d) Congenital defects 1. Hemifacial atrophy 2. Soft-tissue defects of the body In analyzing these lists, a simpler and more useful classification can be devised: Indications (Shiffman) 1. Fill defects (a) Congenital (b) Traumatic (c) Disease (acne) (d) Iatrogenic 2. Cosmetic (a) Furrows (wrinkles) (b) Refill Lost Supportive Tissue (aging) (c) Enhancement 3. Non cosmetic (a) Migraine headaches, clival chordoma surgery, congenital short palate, vocal cord paralysis, lumbar laminectomy, sulcus vocalis, vocal cord scar, hemifacial atrophy, myringoplasty, eye socket reconstruction, frontal sinus fracture, temporomandibular joint reconstruction). Some of these procedures need fat transfer to prevent scarring.
3 Principles of Autologous Fat Transplantation
3.4 Complications of Fat Transplantation Injection of small globules will prevent cyst formation. Johnson (24) showed that one, three, and five cc injections resulted in small cysts, but 10 cc injection had macroscopic cyst formation. Oil cysts develop through the confluence of necrotic fat cells having a lining of macrophages, and resorption may take years, thus giving a false impression of a successful transplantation (25). Sterility of fat retrieval and injection must be maintained. Infection has not been reported (22). Bruising, temporary swelling, and tenderness may result from fat transplantation (22). Teimourian (26) reported that a patient upon injection of fat into the glabellar frown lines complained of pain and loss of vision in one eye. There was central retinal artery thrombosis, probably secondary to fat particle embolism. Calcifications have only been reported in fat transplantation to the breast for augmentation. This does not appear to be a significant risk since the timing of the appearance, the position, and the character of the calcifications will indicate the etiology. The most important problem encountered is fat resorption. Trauma to the cells, desiccation during transfer, and the presence of blood are contributing factors. At least an 18-gauge needle should be used to reinject fat. Ersek (27) reported that very little autologous fat survives but his use of a whisk in the cleansing process probably destroyed most of the fat cells.
3.5 Technique of Autologous Fat Transplantation The lack of standardization of fat collection and transplantation allows a wide range of methods with varied results. Following are methods utilized by certain cosmetic surgeons, which the author obtained by personal commu nication: Billie (28) “I do have patients whose cases go back to over 10 years, at this point. I have had good fortune over all
13
with non-smokers and actually a moderate amount of success among smokers. I have found that the younger the patients are, the better they seem to do. We placed it at multiple sites, including defects in legs from traumatic events such as automobile accidents or recluse spider bites, the nasal labial furrows in aging patients. Over the years, I have washed the fat, sometimes not washed the fat, added insulin, sometimes not added insulin, tried everything and currently even utilizing a 4-mm cannula to remove the fat, catching it in the sterile in-line trap, not washing it and reapplying it utilizing a 16-gauge fat grafting needle with a 10-mL syringe apparatus.” Fragen (29) “I have found that autologous fat transplantation is a very effective part of my facial rejuvenation surgery, provided I give the patients a detailed explanation of the limited nature of the procedure and the fact that it is always somewhat temporary. Depending on the patient and the location to where the fat is transferred, the fat survives for a variable period. I have found that transferring fat under skin grafts, scars, and on top of semirigid or rigid surfaces improves the viability of the fat transfer. For example, if one transfers fat under the skin post mastectomy, it seems to stay there and offers some padding. Putting it under burn scars will help increase the padding of the burn scar and make the skin grafts over it more pliable and flexible. If fat is transferred to a lip, it seems to survive there the least, because of the active nature of the lip. My method of transfer is very simple. I like to call it a closed system. Essentially what is done is the area for fat harvesting is prepped and draped and infiltrated with a Klein solution. The fat is then harvested with a 14-gauge blunt cannula on a 10-cc syringe. If there appears to be excess saline, the excess saline is decanted. If there is excess bloody tissue, then the specimen is washed in saline and again decanted. If, as is usual, essentially pure fat is removed from the donor site, then it is maintained within the syringe with the blunt 14-gauge cannula. A small stab incision is made near the site for fat transfer, and the blunt cannula is then placed into the donor area. Several tunnels are made with the blunt cannula so that the fat is not squeezed into the area, but rather easily injected into the donor site. Then, the fat is transferred to the donor site. Both sites are prepared sterilely. If the patient is under general anesthesia then usually no anesthesia is used for the recipient site. If
14
this is done under local anesthesia, a small amount of 1% Xylocaine with adrenaline is infiltrated into either the lips or the glabella or whatever site we are transferring the fat to. I usually over-fill the graft site by approximately 50%, and I tell patients that the swelling will last 3–5 days. I routinely do fat transferring on face lift patients. I do somewhere around ten or more face lifts per month, and I would guess that 80% of those have a fat transfer associated with it. Untoward effects include bruising, short-term swelling, occasional lumpiness, and stimulation of fever blisters. The lumping has never been a problem, in that the fat can easily be compressed, even months later. Once a patient had a small fat cyst that was easily removed. It is my feeling that fat injected into the lower portion of the nasolabial fold, the lips, and the droll lines has a relatively short life span, with the ideal results being reached in approximately 2 weeks and slow disappearance over 2–4 months. In the glabella, I believe the fat will last six to more months and, in many cases, over a year. I think the area nearer the nose in the nasolabial fold will retain fat a little better. In that area also the fat will last 6–8 months. Fat injected under graft sites, scars, and over other hard prominences I think lasts for many months and I have several cases where the fat has lasted several years. The primary advantage of fat transfer is that it can very effectively camouflage cosmetic defects (such as thin upper lips with wrinkling, glabellar frown lines, drool line, etc) which are difficult to correct without other extensive procedures. In Palm Springs, we find many people who do not want to restrict their outdoor activities, such as tennis and golf. These patients accept the safe, though temporary, correction by fat transfer. Their biggest complaint is that the wonderful result they get is short-lived, but, until we find a safe, nonresorbable filler which the FDA will approve, we do not have a better alternative.” Tobin (30) “About 10 years ago, when liposuction surgery was first introduced, we began hearing recommendations for re-injection of fat. My initial experience with this procedure was to attempt to refine breast reconstruction cases by injecting small amounts of fat adjacent to implants or in patients on whom other surgeons had carried out flap reconstructions. We initially harvested the fat with a syringe and reinjected it using an old, mechanical injector that was designed initially to inject
M. A. Shiffman
Teflon into the vocal cords. In essence, we were injecting it through an 18-gauge needle with a very precise ratchet mechanism. The results were discouraging with rapid re-absorption. We felt that perhaps this was related to the fact that we were injecting into a scarred area. At about the same time, we began injecting fat into the face. My first experience with this procedure was to attempt to correct grooving in the cheeks that was caused by facial liposuction. We did not understand the risks that were involved when liposuction was carried out in this area. Many of us ended up with patients who had irregularities or waviness. Again, we used the same technique – namely aspiration with a syringe and re-injection through the Teflon gun. Again, the results were discouraging. Because of these failures, we essentially abandoned the technique. Sometime later, we heard about successes with injection of fat into the back of the hand and we attempted a few cases. By this time, we had stopped using the Teflon gun and were simply aspirating the fat with the syringe and transferring it to smaller syringes through a small transfer tube after which the fat was injected into the back of the hand. Our technique included aspiration of fat with a syringe, rinsing and straining with saline and then re-injection. Again, both we and our patients were disappointed with the results. About 3 years ago, after hearing of successes with the injection of separated fat, we were tempted to try again. Several surgeons had various techniques of morselizing the fat and injecting the fibrous portion. Often, this material was called autologous collagen, although I am not aware of any confirmation that the material was in any way similar to the bovine collagen that had become so popular under the trade name Zyderm. We utilized the technique recommended by Hilton Becker of Palm Beach. Kits were available which included syringes for transferring the material through a progressively smaller orifice. This resulted in the morselization of the material. Following this, the material was centrifuged and the collagenous component was obtained to be used for re-injection. The material was supposedly capable of being preserved by freezing and we attempted this as well. We probably treated about 25 patients with this process, carrying out multiple injections over a period of several months. As far as I can remember, we did not have even a single patient who was really pleased with the results and we have since then abandoned it.
3 Principles of Autologous Fat Transplantation
At present, our use of injectable fat is uncommon. When patients request for it, we explain the fact that the previous experiences have not been very positive, but we do offer it as an option. Occasionally, patients request it but once again, I have not seen any convincing evidence that there is any permanent augmentation. Obviously, I am perplexed by the reports and the literature by reputable surgeons who claim they see permanent results. Until I see a series of consecutive cases presented over a relatively long period of time, I will remain unconvinced but will attempt to be open minded.”
3.6 Insulin Some physicians have added insulin to the fat in preparation for transplantation (12, 31, 32). The theory is that insulin inhibits lipolysis. Sidman (33) found that insulin decreases lipolysis. Hiragun et al. (34) stated that theoretically insulin may induce fibroblasts to pick up the lipid lost and become adipocytes. Chajchir et al. (35) found that the use of insulin did not show any positive effect on adipocyte survival during transplantation compared to fat not prepared with insulin.
3.7 Centrifugation Some physicians centrifuge the adipose tissue to remove blood products and free lipids to improve the quality of the fat to be injected (31, 36, 37). Asken (9) stated that his “method of reducing the material to be injected to practically pure fat is to place the fat-filled syringe with a rubber cap (the plunger having been previously removed and kept in a sterile environment) into a centrifuge. The syringe is then spun for a few seconds at the desired rpm and the serum, blood, and liquefied fat collects in the dependent part of the syringe…” Toledo (36) reported that “for facial injection we spin the full syringes for 1 min… in a manual centrifuge (about 2,000 rpm), eject the unwanted solution, and transfer the fat…”
15
Uebel (38) centrifuged autologous fat at 10,000 rpm for 10 min in order to obtain a “fat-collagen graft.” The centrifuged material on histologic examination showed cell residues, collagen fibers, and 5% intact fat cells. The material is absorbed at a slow rate and maintains the contour and volume for 18–24 months. A new graft procedure is always performed to achieve a more permanent result. Chajchir et al. (35) centrifuged 1 cc of bladder fat pad from mince (both at 1,000 rpm for 5 min and 5,000 rpm for 5 min) and injected it into the malar area subdermis. Microscopically, after 1–2 months there were macrophages filled with lipid droplets, giant cells, focal necrosis of adipocytes, and cyst like cavities of irregular size and shapes. After 112 months following injection no recognized adipocytes could be found. Total cellular damage was present in both groups. Brandow and Newman (39) found that centrifugation of harvested fat did not alter the microscopic structured integrity of cells. Spun and unspun samples were examined and were similar. Fulton et al. (40) found that centrifuged fat, 3 min at 3,400 rpm, works well for small volume transfers, but not for large volume transfers into breasts, biceps, or buttocks.
3.8 Ratchet Gun for Injection Neuman and Levin (41) designed a lipo-injector with gear driven plunger to inject fat tissue evenly into desired sites. Fat injected with excessive pressure in the barrel of a syringe can cause sudden injections of undesired quantities of fat which will pour into recipient sites. Agris (42) stated that a ratchet-type gun allows controlled accurate deposition of autologous fat. Each time the trigger is pulled, 0.1 cc is deposited. Neichajev (43) used a ratchet gun for free transplantation of fat harvested at −0.5 atm. pressure. EH noted only partial resorption of the fat but with significant improvement of the contour. Asadi and Haramis (44) described the use of a gun with disposable 10 mL syringe for fat injection. Niechajev and Sevc´uk (45) utilized a special pistol and a blunt typed cannula, with 2.3 mm internal diameter, to inject the fat. Berdeguer (23) used a lipotransplant gun to inject fat into areas to be enhanced.
16
Fulton et al. (40) stated that it is beneficial for a beginning surgeon i.e., a fresher to use a ratcheted pistol for injection as this gives a more uniform injection volume.
3.9 Severing Tethering Bands Several surgeons have suggested severing of tethering bands, usually with a needle, paddle shaped, or V shaped (“pickle-fork”) typed instrument, to allow the skin to lift more easily with injection of fat (36, 46–48). Recurrence of depressions was thought to be less likely.
3.10 Machine Liposuction “Liposuction harvesting of fat is traumatic and results in a graft composed of intact cells combined with cellular debris and free lipid” (49). Liposuction removal of autologous fat by −1 atm. suction was reported by Nguyen et al. (50) as showing microscopically 90% elongated, irregularly shaped, and ruptured adipocytes and only 10% unchanged, normal-appearing adipocytes. With the use of a 10-ml syringe for aspiration of fat, they found 95% unchanged adipocytes. May (51), in commenting of Nguyen’s study stated that “…one would have thought that aspiration could produce nearly the same degree of suction (1 atm.) as formal suctioning. If the degrees of negative pressure produced by these two techniques are similar, and if the cannulas are similar then the degree of cell damage should have been similar.” Niechajev (43) obtained fat for grafting using a vacuum pump with –0.5 atm. pressure. Using a ratchet gun for injection into the cheek, he noted only partial resorption of the fat over 1½–4 years (mean 3 years). Niechajev and Sevc´uk (45) reported 50% fat survival over 3.5 years after single fat transplantation with 50% overcorrection. They found that fat obtained under maximum negative pressure (–0.95 atm.) results in partial breakage and vaporization of the fatty tissue. About two-thirds of the fat withstood the trauma of aspiration. Low pressure (–0.5 atm.) results in smaller cell size (29% smaller than with aspiration at –0.95% atm.) and assumed that high pressure causes mechanical distention of the adipocytes which increases the risk of and sometimes causes cell breakage.
M. A. Shiffman
Elam et al. (52) noted more effective fat removal by lowering the negative suction pressure during liposuction. Negative pressures varied from 15 in. of mercury (–375 mm mercury) to 30 in. (–750 mm) (–760 mm = 1 atm.). Above 25 in. of mercury (–625 mm) an obvious amount of blood appears in the aspiration along with air bubbles. At maximum vacuum (–750 mm) the aspirate is a blood-tinged mixture of fatty globules with significant amounts of dark venous blood. The ideal liposuction vacuum pressure at sea level was felt to be a negative 20 in. of mercury (–500 mm).
3.11 Specific Principles Regional block is better than local anesthesia to prevent destruction of injected fat cells by local anesthetic in the region of the fat transfer. If local anesthesia is used, compress the area for 15 min to reduce swelling and distortion of the area prior to injection. Injection should be on withdrawing the needle to prevent accidental injection into vessels and over injection into an area that is fibrous causing resistance to the cannula insertion. Sharp needles should not be used to inject fat into the recipient site. Recently, small cannulas have been devised with relatively blunt tips that can be used for reinjection without the problem of bleeding in the recipient area. Blood in the donor fat should be removed by decanting with physiologic solution. Blood, as is infection, is the enemy of fat and will result in a major loss of the transferred fat.
References 1. Meschik Z. Vitamin E and adipose tissue. Edinburgh Med J 1944;51:486. 2. Katoes AS Jr, et al. Perfused fat cells: effects of lipolytic agents. J Biol Chem 1933;248:5089. 3. Skouge J.W. Autologous fat transplantation in facial surgery. Presented at American Academy of Cosmetic Surgery: Controversies in Breast and Facial Augmentation, Phila delphia, PA, 7–9 Aug 1992. 4. Sidman RL. The direct effect of insulin on organ cultures of brown fat. Anal Rec 1956;124(4):723–739. 5. Smith U. Human adipose tissue in culture studies on the metabolic effect of insulin. Diabetologia 1976;12(2):137–143. 6. Solomon SS. Comparative studies of the antilipolytic effect of insulin and adenosine in the perfused fat cell. Horm Metab Res 1980;12(11):601–604.
3 Principles of Autologous Fat Transplantation 7. Solomon SS, Duckworth WC. Effect of antecedent hormone administration on lipolysis in the perfused isolated fat cell. J Lab Clin Med 1976;88(6):984–994. 8. Hiragun A, Sato M, Mitsui H. Establishment of a clonal cell line that differentiates into adipose cells in vitro. In Vitro 1980;16(8):685–693. 9. Asken S. Autologous fat transplantation: Micro and macro techniques. Am J Cosmet Surg 1987;4(2):111–121. 10. Dolsky RL. Adipocyte survival. Presented at the Third Annual Scientific Meeting of the American Academy of Cosmetic Surgery and The American Society of LipoSuction Surgery, Los Angeles, February 1987. 11. Campbell GL, Laudenslager N, Newman J. The effect of mechanical stress on adipocyte morphology and metabolism. Am J Cosmet Surg 1987; 4(2):89–94. 12. Illouz YG. The fat cell “graft”: A new technique to fill depressions. Plast Reconstr Surg 1986;78(1):122–123. 13. Krulig E. Lipo-injection. Am J Cosmet Surg 1987;4(2): 123–129. 14. Lewis CM. Correction of deep gluteal depression by autologous fat grafting. Aesthetic Plast Surg 1992;16(3):247–250. 15. McCurdy JA, Jr. Five years of experience using fat for leg contouring (Commentary). Am J Cosmet Surg 1995;12(3):228. 16. Asadi M, Haramis HT. Successful autologous fat injection at 5-year follow-up. Plast Reconstr Surg 1993;91(4): 755–756. 17. Chajchir A, Benzaquen I. Liposuction fat grafts in face wrinkles and hemifacial atrophy. Aesthetic Plast Surg 1986;10(2): 115–117. 18. Chajchir A, Benzaquen I. Fat-grafting injection for soft tissue augmentation. Plast Reconstr Surg 1989;84(6):921–934.. 19. Chiu DT, Edgerton BW. Repair and grafting of dermis, fat, and fascia. In: McCarthy, J (ed), Plastic Surgery. Philadelphia, W.B. Saunders, 1990, p. 515. 20. Illouz YG. De l’utilization de la graisse aspiree pour combler les defects cutanes. Rev Chir Esthet Langue Fr 1985; 10(40):13. 21. Matsudo PK, Toledo LS. Experience of injected fat grafting. Aesthetic Plast Surg 1988;12(1):35–38. 22. Skouge J. The effectiveness and long term survival of transplanted fat. Presented at American Academy of Cosmetic Surgery, Philadelphia, 7–9 Aug 1992. 23. Berdeguer P. Five years of experience using fat for leg contouring. Am J Cosmet Surg 1995;12(3):221–229. 24. Johnson GW. Body contouring by macroinjection of autogenous fat. Am J Cosmet Surg 1987;4(2):103–109. 25. Smahel J. Fat cylinder transplantation: An experimental study of three different kinds of fat transplants. Plast Reconstr Surg 1996;98(1):97–98. 26. Teimourian B. Blindness following fat injections. Plast Reconstr Surg 1988;82(2):361. 27. Ersek RA. Transplantation of purified autologous fat: A 3-year follow-up is disappointing. Plast Reconstr Surg 1991; 87(2):219–227. 28. Billie JD. Autologous fat transplantation. Personal Commu nication 3/6/96. 29. Fragen R. Autologous fat transplantation. Personal communication 3/19/96. 30. Tobin H. Fat transfer. Personal communication 3//5/96.
17 31. Ellenbogen R. Free autogenous pearl fat grafts in the face – A preliminary report of a rediscovered technique. Ann Plast Surg 1986;16(3):179–194. 32. Newman J. Preliminary report on “fat recycling” – Liposuction fat transfer for facial defects. Am J Cosmet Surg 1986;3: 67–69. 33. Sidman RL. The direct effect of insulin on organ cultures of brown fat. Anat Rec 1956;124(4):723–739. 34. Hiragun A, Sato M, Mitsui H. Establishment of a clonal line that differentiated into adipose cells in vitro. In Vitro 1980;16(8):685–693. 35. Chajchir A, Benzaquen I, Moretti E. Comparative experimental study of autologous adipose tissue processed by different techniques. Aesthetic Plast Surg 1993;17(2):113–115. 36. Toledo LS. Syringe liposculpture: A two-year experience. Aesthetic Plast Surg 1991;15(4):321–326. 37. Zocchi M. Produccion y utilizacion de Colegeno Autologo para el remodelaje facial. II Congreso Chileno de Cirugia Plastica, 1991. 38. Uebel CO. Facial sculpture with centrifuged fat-collagen. In: Hinderer VT (ed), Plastic Surgery, Vol. II. Amsterdam, Excerpta Medica, 1992, pp. 749–752. 39. Brandow K, Newman J. Facial multilayered micro lipo- augmentation. Int J Aesth Restor Surg 1996;4(2):95–110. 40. Fulton JE, Suarez M, Silverton K, Barnes T. Small volume fat transfer. Dermatol Surg 1998;24(8):857–865. 41. Newman J, Levin J. Facial lipo-transplant surgery. Am J Cosmet Surg 1987;4(2):131–140. 42. Agris J. Autologous fat transplantation: A 3-year study. Am J Cosmet Surg 1987;4(2):95–102. 43. Niechajev I. Autologous transplantation of fat (lipo-filling) for the improvement of the cheek contour, long-term results. In: Hinderer VT (ed), Plastic Surgery, Vol. II. Amsterdam, Excerpta Medica, 1992, pp. 747–748. 44. Asaadi M, Haramis HT. Successful autologous fat injection at 5-year follow-up. Plast Reconstr Surg 1993;91(4):755–756. 45. Niechajev I, Sevc´uk O. Long term results of fat transplantation: Clinical and histologic studies. Plast Reconstr Surg 1994;94(3):496–506. 46. Fournier PF. Liposculpture: The Syringe Technique. Paris, Arnette, 1991. 47. Gasparotti M. Superficial liposuction: a new application of the technique for aged and flaccid skin. Aesthetic Plast Surg 1992;16(2):141–153. 48. Grazer FM. Cellulite lysing. Aesth Surg 1991;11:11. 49. Eppley BL, Sidner RA, Platis JM, Sadove AM. Bioactivation of free-fat transfers: A potential new approach to improving graft survival. Plast Reconstr Surg 1992;90(6):1022–1030. 50. Nguyen A, Pasyk KA, Bouvier TN, Hassett CA, Argenta LC. Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast Reconstr Surg 1990;85(3):378–386. 51. May JW Jr. Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques (Discussion). Plast Reconstr Surg 1990;85(3):387–389. 52. Elam MV, Packer D, Schwab J. Reduced negative pressure liposuction (RNPL): Could less be more? Int J Aesth Restor Surg 1997;5:101–104.
4
The Adipocyte Anatomy, Physiology, and Metabolism/Nutrition Mitchell V. Kaminski and Rose M. Lopez de Vaughan
4.1 Introduction With an understanding of the subcutaneous fat anatomy, physiology, and metabolism/nutrition, the surgeon can gain familiarity with the interrelationship between these three aspects of subcutaneous fat as they relate to adipocyte mass, appearance, and liposculpture. With this knowledge, the surgeon should gain a deeper understanding of the impact of the surgical procedure that may lead to improved results following fat transfer. An appreciation of the importance of interstitial soluble protein is crucial because Klein’s solution dramatically dilutes its content and predictably, causes a temporarily pseudo-leaky membrane in that region. Using excess Klein’s solution can produce symptoms of acute congestive heart failure. When administered properly, Klein’s solution is safe in which the total body’s soluble protein reserve will re-equilibrate over a relatively short period of time. Until recently, the study of the lowly lipocyte was considered boring and therefore limited. Fat was viewed as an adynamic tissue that stored energy, improved insulation, and functioned as a shock absorber. The differences in fat distribution between the sexes are well recognized and have been the subject of discussion as well as artful renderings. Removal of fat by liposuction was thought the end of the line, producing a localized permanent reduction in number; however, nothing could be further from the truth. Adult stem cells are abundant within the fat mass, and in the face of excess calorie consumption, these stem cells
M. V. Kaminski () Finch University of Health Sciences, Chicago Medical School, 230 Center Drive, Vernon Hill, Chicago, IL 60061-1584, USA e-mail:
[email protected]
are recruited to form new lipocytes as necessary. It is clear that fat is also an endocrine and exocrine organ. It reacts to and is the source of pro-inflammatory cytokines and has a role in immunity, as well as a dynamic role in metabolic activity and response to injury. As will be detailed at the end of this chapter, fat represents one of the most exciting tissues of the body.
4.2 Histology Fibroblast appearing preadipocytes are noted in the embryo as well as in adult subcutaneous fat tissue. The ultimate shape of a fat-laden mature adipocyte is that of a cygnet ring as the central lipid accumulation pushes the nucleolus to the periphery (Fig. 4.1). The fibroblast appearing preadipocyte is pluripotential. During calorie deprivation fat cells can also dedifferentiate back into the fibroblast appearance. The adult stem cell within the fat tissue has been stimulated to form muscle and bone.
Fig. 4.1 A spread preparation using Fankels combined orcein connective tissue stain that reveals rich microvasculature and adipocytes packed against each other. Ad adipocyte; C collagen; E elastin
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_4, © Springer-Verlag Berlin Heidelberg 2010
19
20
Every lipocyte is surrounded by or touching a capillary (Fig. 4.1). These capillaries are highly sensitive to epinephrine that causes vasoconstriction. This is a phenomenon associated with Klein’s tumescent anesthesia that has made office-based liposuction a relatively nonbloody procedure, and safe outside of the hospital setting. No other additive in Klein’s formula is as important. This surgeon uses 2 mg of epinephrine per 1,000 mL of crystalloid rather than the recommended 1 mg. Total amount of tumescent solution with 2 mg of epinephrine per liter should be limited to 3 L or less per procedure.
4.3 The Interstitium The connective tissue of the interstitium is host to myriad cell types, including fibroblasts, adipocytes, macrophages (histiocytes), neutrophils, eosinophils, lymphocytes, plasma cells, mast cells, monocytes, and undifferentiated mesenchymal cells. These cells, either fixed or transient, interact with each other and the extracellular matrix components (i.e., collagen, elastic fibers, adhesion glycoproteins) and as mentioned a substantial amounts of soluble protein (1, 2). Within this integrated gel-sol assemblage are the vital components of the vasculature, initial lymphatics, and nervous system (lightly myelinated fibers to free nerve endings, myelinated fibers to encapsulated neural structures). The importance of the vasculature and lymphatics in maintaining homeostasis of protein and fluid concentration of the blood and interstitium is well documented and cannot be overstated. The neural components at a single anatomic site, although perhaps not vital, provide for the general sense of well-being. The presence of the above constituents within the interstitium, however, cannot be overlooked and may represent the seed medium for the growth of normal adipose tissue. Considering the cell biology of the anatomic site, liposuction procedures are traumatic, albeit transient, events. Even with the most careful technique, the architecture and physiology are altered dramatically, which sets in motion a cascade of systemic and cytokinemediated cellular responses. Providing a unified concept on the restructuring of this anatomic site after traumatic events is a challenge that needs to be met. The inventory of the components of the interstitium and how they interact is far from complete. Current techniques yield a heterogeneous material composed of liberated fat, locules of adipose cells, collagen fibers and septa, vessels and nerves, clots, ruptured
M. V. Kaminski and R. M. Lopez de Vaughan
cells, hemoglobin, inflammatory proteins, proteases, lipogenic enzymes, and electrolytes including calcium (3). Weber et al. (4) developed a concept of extracellular homeostasis. This concept is one of self-regulation of cellular composition and structure based on fibroblastderived angiotensin that regulates the elaboration of transforming growth factor-1. This is a fibrogenic cyto kine responsible for connective tissue formation at normal and pathologic sites. Biologic responses are found in various connective tissues, including adipose tissue. Given that the three-dimensional architecture is altered profoundly, it is astonishing that it can be reconstituted to normalcy in a relatively short period of time. Lipocytes are not islands unto themselves. They are surrounded by a sea of supportive cells, proteins, growth factors and electrolytes.
4.4 Physiology For the most part, the adipocytes are not rounded, bloated spheres. They have one or more flattened sides and are better described as polygonal and appear packed between the vasculature. This is because they are compressed by colloid osmotic pressure, which is generated by soluble protein in the interstitial space. Under these conditions, the cells are like peanuts sealed by vacuum in a bag. The interstitial proteins that surround cells create −7 mmHg pressure (5). Interstitial protein is reported as total protein (TP) when measured by a laboratory. Its three components are albumin, globulin, and fibrinogen. Albumin is the principle soluble protein and makes up at least 60% of TP (6). Because albumin is the smallest molecule that cannot pass easily through the semi permeable membrane of the capillary, it contributes most of the oncotic force, squeezing cells together. The number of particles in solution on one side of a semi permeable membrane, not their size, creates an oncotic force. To be specific, albumin is 69,000 Daltons (Da), whereas globulin is 150,000 Da, and fibrinogen is 400,000 Da. Thus, one gram of albumin has twice as many molecules as 1gram of globulin, and eight times that of 1 g of fibrinogen. To understand that this is oncotic pressure and not osmotic pressure, one should recall that if the particle in solution can pass back and forth across the semi permeable membrane, it cannot create an oncotic force. For example, if a glass funnel is covered with a semi permeable membrane whose pore size allows water, sodium,
4 The Adipocyte Anatomy, Physiology, and Metabolism/Nutrition
and chloride to pass but not sucrose, and if that funnel is then partially filled with a sugar and salt water solution and placed upside down in a beaker of fresh water, after a period of time the sugar molecules on the funnel side of the membrane are responsible for drawing fluid into it. Because sodium and chloride easily traverse the membrane, they cannot create an oncotic force and will distribute equally on both sides of the membrane. In vivo, soluble proteins that surround adipocytes are dynamic. Even if it be slow, albumin molecules make a circuit from the heart across the capillary membrane through the interstitial space and return to the heart by way of lymphatic flow within 24–48 h.
4.5 Gross Anatomy There are three layer of subcutaneous fat: the apical, the mantle, and deep layers.
4.5.1 Apical Layer This layer, just beneath the reticular dermis (Fig. 4.2) is also called thecal or periadnexal layer in that it surrounds sweat glands and hair follicles.
21
Slightly deeper, the apical layer also surrounds vascular and lymphatic channels. Depending on the quantity and depth of color of fruits and veggies in the diet this layer is rich in carotenoids and tends to be yellow in appearance. Because of the neural, vascular and lym phatic potential for damage this layer should be avoided during liposuction. Extensive disruption of these anatomical elements can lead to seroma, erythema, hyperpigmentation and even full thickness dermal necrosis. This was more of a problem in the past when larger diameter 8 and 10 mm cannulas were directed at the deep fat layer, but these complications have become rare in this era of 2 and 3 mm cannulas.
4.5.2 Mantle Layer Just beneath the adipocytes’ investing dermal structures is another anatomically organized layer of fat cells that is part of the superficial fat layer. It is called the mantle layer and is composed of more columnar shaped lipocytes. It is separated from the deep layer of fat by a fascia-like layer of fibrous tissue. The mantle is absent from the eyelids, nail beds, bridge of the nose and penis. This layer significantly contributes to the skin’s ability to resist trauma. It causes external pressure to be distributed across a larger field; much like a box spring mattress absorbs sitting pressure.
4.5.3 Deep Layer
Fig. 4.2 The general lipocyte distribution from the dermis to the muscular fascia. The apical and mantle layers represent the “no man’s zone” of liposuction. Damage to these layers may compromise the blood supply to the skin and predispose to postoperative complication such as seroma or dermal necrosis
This layer extends from the undersurface of the mantle layer to the muscle fascia below. Its shape and thickness depends on the sex, genes, and diet of the individual. This is the layer best suited for liposculpture. Here fat cells are arranged in pearls and pearls gathered into globules. These globules are then packaged like eggs in an egg crate between fibrous septa and then arranged between tangential and oblique fibrous planes. Histologically tangential planes are thicker and run parallel to the underlying muscle fascia, but they are of little consequence when performing liposuction. Oblique planes are thinner and interconnect the tangential fibrous layers. They hold fat globules in their
22
Fig. 4.3 Submantle fat is amenable to standard liposuction technique using very small canuulas. Removal of the buccal fat requires an intra-oral incision just lateral to the second molar
M. V. Kaminski and R. M. Lopez de Vaughan
tooth. Removal of the intra-digastric fat also requires an incision but is usually not advised unless excessive. However, a partial removal may be indicated (after Pitman (7))
relative positions. Though thinner, they are of a cosmetic consequence because the vertical arrangement of subcutaneous fat from skin to muscle fascia is the cause of cellulite.
4.6 Deep Fat of the Neck A wattle is produce by accumulation of excess of fat between platysma and the superficial layer of the deep cervical fascia and is superficial to the anterior bellies of the digastric muscles (Fig. 4.3). The fat immediately beneath the platysma is amenable to liposuction. How ever, the fat between the digastric muscles and beneath the superficial layer of the deep, or the investing fascia of the neck should not be removed. Doing so may result in a permanent depression. The buccal fat pad accounts for the chipmunk fascial features noted in some families. It extends anterior to the mandibular ramus into the cheek, deep into the subcutaneous musculoaponeurotic system (SMAS) buccinators. The buccal branch of C7 courses over and just lateral to the buccal fat pad.
Fig. 4.4 The majority of upper arm liposuction (alone) procedures are performed in younger patients with good skin contractility. For older patient or patients with excess skin due to recent weight loss, a brachioplasty is usually indicated as a combined one or two stage procedure (after Pitman (7))
brachioplasty. Loose skin of the posterior arm shrinks poorly. The patient who chooses liposuction without resection should understand that an excision may be required later. A middle aged to older individual who complains of loose skin following weight loss or due to senile laxity, will always require an excision of the redundant tissue. Preoperative notes should make clear the fact that these considerations were discussed in detail with the patient.
4.8 Abdomen 4.7 Upper Arm Fat Liposuction without brachioplasty is suitable for younger patients with minimal to moderate fat excess, who exhibit taut skin. It is generally limited to the posterior flap. This flap in layman’s terms produces a “kimono arm” deformity (Fig. 4.4). For the patient who is middle aged and has loose skin, liposuction may have to be accompanied by a
The subcutaneous fat of the abdominal wall is divided by two easily identifiable fascial layers: The superficial Campers fascia and the deeper Scarpas fascia. These layers are most easily observed in the lower abdomen. The deep fascia overlays the musculoaponeurosis and is continuous with the fascia lata of the thigh. It also covers the small arteries and veins along the surface of the anterior rectus sheath. Liposuction using small cannulas of 2–3.7 mm in diameter can be artfully performed
4 The Adipocyte Anatomy, Physiology, and Metabolism/Nutrition
23
adherence in women is more inferior, thus localizing the deep fat over the iliac crest. This difference is largely responsible for the android vs. gynoid appearance of the hip region. Popular Western culture appreciates the visible iliac bones in the female. Following liposuction women like to feel and see these anatomic features.
Fig. 4.5 The relationship of Camper’s fascia to Scarpa’s fascia. Scarpa’s fascia in the membranous layer of the subcutaneous tissue of the abdomen
between these fascial layers in the abdomen with impunity. However, care must be taken not to injure the vascular and lymphatic complexes within the mantle layer of fat just beneath the skin (Fig. 4.5).
4.9 Hips and Flanks
4.10 Thighs and Buttocks The muscle mass of the hamstrings largely determines the contour of the upper posterior thigh. Laterally the zones of adherence represent an area that should not be violated with a liposuction cannula. The gluteal crease represents another zone of adherence (Fig. 4.7). Note that anteriorly, the quad underlies the bulk of the upper anterior thigh.
4.11 Lower Leg
In the area of the hips and flanks the subcutaneous fat is divided into two well-defined layers: the superficial and the deep. The superficial fascial system (SFS) encases the superficial fat. This fat is light yellow and dense, whereas the deeper fat is usually darker and less well structured. Zones of adherence are formed where the SFS connects to the underlying muscle fascia. The zones of adherence differ between men and women (Fig 4.6). In men, the attachment runs along the iliac crest, it confines the deep fat to the mid abdomen. The zone of
A subtle tapering from the thighs to the ankle is considered attractive. Thus, although a degree of fullness at the knee is normal it is usually identified as an area to be reduced during liposuction of the legs. The lateral knee should never be liposuctioned. It is also an area of insertion of thigh musculature (Fig. 4.8). No major arteries or nerves run within the subcutaneous fat. Rather, they run along or beneath the investing fascia of the superficial fat of the legs.
Fig. 4.6 The hip and flank region are distinctly male or female, specifically, the zones of adherence differ. Care should be taken to preserve these attachments during liposuction (after Pitman (7))
Fig. 4.7 The fat anatomy in the hip and buttock region is to be conceptualized as a three dimensional wrap around regarding the gluteal zone of adherence. Note the distribution of the superficial and deep fat above and below the zone of adherence (after Pitman (7))
24
M. V. Kaminski and R. M. Lopez de Vaughan
Fig. 4.8 The deep fat does not extend into the lower leg. Note the zone of adherence located at the lateral knee which has essential not fat (after Pitman (7))
4.12 Nutrition and Metabolism More often than not a patient will present with unwanted fatty deposits that are secondary to the over consumption of food. Stored fat is mobilized during calorie restriction through the activation of triglyceride lipase. Triglyceride lipase is a cyclic AMP dependant mobilizing enzyme. The hormonal signal to activate triglyceride lipase is glucagon and to some extent epinephrine. When the insulin glucagon ratio is in favor of insulin, fat cannot be mobilized. Insulin is secreted in response to circulating glucose levels. Thus, a meal that raises glucose will cause insulin secretion, the magnitude of which depends on the carbohydrate load and the refined vs. complex composition of the food consumed (Fig 4.9). Eating either fat or protein will not raise insulin. All fruits and veggies are predominantly carbohydrates. Fruits and veggies are complex carbohydrates which require more time to digest and absorb Compared to flour and sugar products which are refined carbohydrates. Regarding complex carbohydrates, the tighter the carbohydrates are configured the slower the digestion, absorption and the lower the maximum post parandial glucose will be. On the other hand, all refined carbohydrates such as sugar and flour products will dramatically elevate
Fig. 4.9 Stored calories are in two forms: (1) Dextrose forms a large starch molecule called glycogen. (2) As triglycerides. Triglycerides are composed of even numbered carbon atom fatty acids attached to a glycerol base. Both respond to insulin and glucagon. Insulin promotes uptake of dextrose and fatty acids while glucagon stimulates mobilization. Both moieties enter the Kreb’s cycle to generate ATP
blood glucose and insulin. It is therefore conceivable that someone who eats what he/she believes is a calorie restricted diet will never catabolize stored fat over a 24-h period. Such a diet might be a bagel and coffee for breakfast, a sweet roll at 10 a.m. on coffee break, a can of pop, a cheese sandwich for lunch, a pasta dinner, a soda pop with cake for dessert and fat free cookies while watching television. Even if small portions are chosen, the refined carbohydrate consumed will guarantee an elevated insulin throughout the day. The average soft drink contains more than nine packs of table sugar per can. Patients on this diet are perplexed by their inability to lose weight. When a physician tries to get refined carbohydates out of their diet it is not unusual for the patient to vigorously object because they claim that they suffer from hypoglycemia. They report that unless they are frequently treating themselves with refined carbohydrates they become severely symptomatic. They will complain of brain fog, tremor,
4 The Adipocyte Anatomy, Physiology, and Metabolism/Nutrition
Blood glucose mg %
Pseudohypoglycemia 300
200 Symptomatic 115
Normal 75
Time
Fig. 4.10 The yo-yo hyperglycemia experienced by refined carb carboholics. It is the downward slope of the hyperglycemia curve that initiated the symptoms described as hypoglycemia by the patient. Note the blood sugar is never normal
and severe hunger pains which are quickly ameliorated by consumption of another form of a refined carbohydrate. Thus they are convinced that they are hypoglycemic or refined carbs would not treat their symptoms. The fact is that their blood sugar rapidly rises and then within 90–120 min begins to decline secondary to the insulin response. It is the downward slope of the serum glucose that triggers what they call a hypoglycemic episode. In fact their blood sugar remained above normal at all times (Fig. 4.10) (8). The potential for any given complex carbohydrate or refined carbohydrate to raise blood glucose in comparison to a 50-g dextrose meal is called the glycemic index (GI). All vegetables and fruits are complex carbohydrates but some have a higher GI then others. Keeping the GI below 55 for any given meal is recommended. The GI of anything made from flour or sugar is near 90 thus all baked goods and pasta should be avoided. Geletinization is a process that occurs during boiling where a complex carbohydrate vegetable with a low GI can be converted to a high GI food. During boiling gaps appear in the tight molecular structure that is quickly filled by a water molecule. This new configuration reduces the time of digestion increasing the rate of absorption and therefore increasing the GI. Over heating, especially over boiling is another consideration to be avoided in food preparation. Glycosolation refers to the combination of glucose and protein. This occurs naturally by simple contact. Neither heat nor an enzyme is necessary to create this
25
new molecule. Glycosolation irreparably damages the protein just as oxygen changes iron into rust. When the damaged glycosolated protein is replaced during a healing process as it floats free it is called a advanced glycosolation end (AGE) product. An AGE is recognized by the immune system as a foreign micro. The AGE binds to a receptor on white blood cells called receptors for advanced glycosolation end (RAGE) product which unregulated the immune response. This up regulation increases free radical production. Free radicals then promote all AGE-related disease processes. Inflammation is now known to be a major faction in Alzheimer, osteo and rheumation arthritis, coronary artery and renal disease, etc. Understanding this deepens the reason for advising obese patients who consume refined carbohydrate-carboholism, who present themselves for liposuction to get refined carbs out of their diet. Details of these nutritional concepts and other lifestyle guidance have recently been summarized by the author/surgeon (8). For almost two decades leptin was pursued as the holy grail in the control of obesity. It was considered the adipostat mediator. A specific adipostat may never be found because there are many factors that contribute to energy homeostasis. Since the introduction of fat free and low fat food the average American’s weight for any given age has increased 10 pounds. Adipocyte number is not as stagnant as previously thought. Decrease occurs via a process called apoptosis of both preadipocytes and adipocytes. Adipocytes may also dedifferentiate into preadipocytes. Adipocyte differentiation is the in vitro process by which differentiated fat cells revert morphologically and functionally to less differentiated cells (9, 10). The process has been observed in vitro. These adipocytes lost their cytoplasmic liquid and acquired a fibroblast morphology (11, 12). These dedifferentiated cells also display the gene expression patterns of preadipocytes (13). This is intriguing behavior in that preadipocytes exhibit stem cell-like qualities. Zuk (14) reported isolation of a population of stem cells from human adipocyte tissue. The cells were obtained from liposuction aspirate, and were determined to be mesodermal and mesenchymal in origin. In vitro these cells could differentiate into adipogenic, chondrogenic, osteogenic, and myogenic cells in the presence of proper induction factors (Table 4.1). Researchers from Duke University Medical Center have enthusiastically reported that adipocytes can
26
M. V. Kaminski and R. M. Lopez de Vaughan
Table 4.1 Representative factors secreted by adipocytes and their presumed functions (16) Secreted molecules and their targets Energy homeostasis Agouti Leptin Lipoprotein lipase Insulin like growth factor IGF binding protein Acylation stimulating Protein TNF-a apM-1 Cardiovascular Angiotensinogen ApoE Cholesterol ester transfer protein (CETP) Plaminogen activator inhibitor-1 (PEI-1) Adiponectin Complement factors Adipsin Adipo Q/Acrp30 Complement factor B Other VEGF angiogenesis IL-6 Preadipocyte factor1 (pref 1) Colony stimulating factor
Adipocyte specific
Ref.
No Yes No No No No No Yes
(1) (2) (3) (4) (5) (6) (7) (8)
No No No
(9) (10) (11)
No
(12, 13)
Yes
(14)
Yes Yes
(15) (16) (17)
No No No No
(18) (19) (20) (21)
become true stem cells (15). Their research exposed cells taken from human liposuction procedures to different cocktails of nutrients and vitamins, and, successfully reprogrammed 62% of them to grow into bone, cartilage, fat or nerve cells. Since nerve tissue is ectodermal, and not mesodermal in embryonic origin, these experiments confirm true stem cell potential. Since the publication of this pioneering study, other researchers have continued to use Adipose-derived stromal (stem) cells (ASC) that have been shown to be of great therapeutic use in preclinical studies in diverse fields, but a standard expansion method has not been established (15).
4.13 Fat’s Future The traditional concept of the adipocyte as simply a calorie storage cell has been shattered over the past few years. Fat is an exocrine, endocrine and apocrine organ and plays a role in immunity.
4.14 Conclusions Both the microscopic and gross anatomy of the fat mass should be appreciated by the liposuction surgeon. With this appreciation, a better result can be expected, especially in understanding the caveat not injury to the dermis during a procedure. The physiology keys are an appreciation for colloid osmotic pressure that is significantly reduced by Klein’s tumescent solution. This wash down of interstitial protein would enhance flow of the solution into the vascular space if it were not for the effect of epinephrine. Nevertheless using massive amount of tumescent solution can over-whelm the right heart and cause congestive heart failure. Current research emphasizes the fact that the fat mass is dynamic and that adipocytes can differentiate and dedifferentiate, is exciting in its application to redifferentiation into other cell types. Stem cells from lipo-aspirate make more sense than bone marrow or embryonic sources.
References 1. Fawcett OW. A Textbook of Histology. New York: Chapman and Hall, 1994. 2. Kessel RG. Basic Medical Histology. New York: Oxford University Press, 1998. 3. Lalikos JF, Li YQ, Roth TP, Doyle JW, Matory WE, Lawrence WT. Biochemical assessment of cellular damage after adipocyte harvest. J Surg Res 1997;70(1):95–100. 4. Weber KT, Swamynathan SK, Guntaka RV, Sun Y. Angiotensis II and extracellular matrix homeostasis. Int J Biochem Cell Biol 1999;31(3–4):395–403. 5. Guyton AC. Capillary dynamics and exchange of fluid between the blood and the interstitial fluid. In: Guyton AC (ed), Text Book of Medical Physiology, 7th ed. Philadel phia: WB Saunders, 1986, p. 348. 6. Kaminski MV, Haase T. Albumin and colloid pressure: Implications for fluid resuscitation. Crit Care Clin 1992;8(2): 311–322. 7. Pitman GH. Liposuction & Aesthetic Surgery. Quality Medical Publishing: St. Louis, 1993. 8. Kaminski MV, Lopez de Vaughan R. The Key to Successful Longevity: Book One Nutrition. July 2004. 9. Sugihara H, Yonemitsu N, Miyabara S, Yum K. Primary cultures of unilocular fat cells: characteristics of growth factors. Int J Obes 1994;31:42–49. 10. Cheng AY, Deitel M, Roncari DA. The biochemistry and molecular biology of human adipocyte reversion. Int J Obes 1994;18(Suppl. 2):112.
4 The Adipocyte Anatomy, Physiology, and Metabolism/Nutrition 11. Van RL, Roncari DA. Complete differentiation of adipocyte precursors. Cell Tissue Res 1978;195(2):317–329. 12. Van RL, Bayliss CE, Roncari DA. Cytological and enzymological characterization of adult human adipocyte precursors in culture. J Clin Invest 1976;58(3):699–704. 13. Hauner H. Prevention of adipose tissue growth. Int J Obes 1994;18(Suppl. 2):147. 14. Zuk PA, Zhu M, Mizuno H, Huang J B.S., Futrell W, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells
27
from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211–228. 15. Lott KE, Awad HA, Gimble JM, Guilak F. Clonal Analysis of Multipotent Differentiation of Human Adipose-Derived Adult Stme Cells. DukeMedNews 2004 Mar 8 News Release Available from: URL: http://www.dukemednews.org/news/ article.php?id = 7452.
5
Fat Cell Biochemistry and Physiology Melvin A. Shiffman
5.1 Introduction Fat cell biochemistry and physiology should be understood better by those surgeons doing liposuction and fat transfer. The fat cell is not just another item for us to remove or replace. The fat cell is a functioning hormonal unit of the body and affects other parts of the body as well as is affected by biochemical actions in the surrounding tissues and other parts of the body. We have not answered some questions regarding fat tissue when we do liposuction and transfer fat. For instance, what happens to the physiology of the body when a very large amount of fat is liposuctioned? What biochemical pathways may we disrupt when we lipo suction? A survey of the literature is presented in order to perhaps understand better what will be affected while doing autologous fat transfer.
5.2 Fat Cells It has been presumed that new adipose cells are not formed in adult adipose tissue (1–6). However, primitive reticular cells can differentiate into fat cells (7, 8). The preadipocytes (mesenchymal adipose cells), present in the connective network of the fat lobule, are destined to become mature adipose cells (7, 9, 10). The adipocyte is a metabolically active cell that functions to store energy for times of energy deprivation
M. A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA 92780-2302, USA e-mail:
[email protected]
or enhanced need (11). Atanassova (12) reported that preadipocytes in the subcutaneous tissues that were at different stages of differentiation were positive for S-100 protein. S-100 protein is expressed from the beginning of lipidogenesis and possibly acts as a factor regulating storage of lipids and formation of body fat. Ailhaud et al. (13) found that differentiation of adipose precursor cells can be divided into early and late events. Growth arrest at the G1/S boundary triggers the activation of early genes (pOb24 and lipoprotein lipase). The expression of both genes is primarily regulated at a transcriptional level. The expression of late markers, which leads to terminal differentiation and accumulation of neutral lipids, takes place after a limited number of mitoses of early-marker-expressing cells. Only terminal differentiation requires the presence of growth hormone and triiodothyronine as obligatory hormones and insulin as a modulating hormone, and results in the formation of triacylglycerol-filled nondividing cells. The terminal differentiation involves the cyclic AMP pathway, the diacylglycerol pathway, and a third pathway triggered by an insulin-like growth factor-1 (IGF-1) and insulin. It is proposed that a combination of mitogenic-adipogenic signals is required to trigger terminal differentiation of preadipose cells. There is a possible role of local and/or systemic growth factors in the differentiation of preadipocytes into mature adipocytes (12, 14–22). Li et al. (23) showed that adipocyte differentiation factor (ADF) in vivo may act as a cytokine paracrine agent to regulate the differentiation (adipogenic conversion) of preadipocytes. ADF causes a fourfold increase in triacylglycerol (triglyceride) content and a ninefold increase in glycerol-3-phospharte dehydrogenase (GPDH) activity, a marker of the late phase of differentiation of preadipocytes. According to Catalioto et al. (22) prostacyclin and PGF2 alpha (synthesized and secreted by
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_5, © Springer-Verlag Berlin Heidelberg 2010
29
30
preadipocytes) appear to be autocrine mediators in the process of adipose conversion. Yokota et al. (24) noted that adiponectin, an adipocytederived hormone, is found in subcutaneous and bone marrow fat cells and has an inhibitory effect on adipocyte differentiation. Adiponectin can negatively and selectively influence lymphopoiesis. Adipocytes can contribute to the regulation of blood cell formation. Kawada et al. (16) reported that in 3T3-L1 cells, vitamin C markedly increased the growth rate of preadipocytes at over 50 mM. Vitamin K3 slowed down the growth rate at over 0.1 mM. Vitamin B6 group and vitamin C significantly stimulated the differentiation and consequently increased the glycerophosphate dehydrogenase activity and triglyceride accumulation, to a concentration of over 10 mM. Vitamin A group, including beta-carotene, the vitamin D group, vitamin E, and the vitamin K group strongly inhibited the adipose conversion of 3T3-L1 cells at mM level. Carraro et al. (18) noted that a culture of adherent mature adipocytes contain rapidly proliferating fibroblast-like cells that are a substantially uniform subpopulation of adipocyte-precursor cells highly committed to differentiation. Between 36 and 48 h, such cells begin to accumulate lipid droplets, and by 150 h, they assume the morphology of small mature adipocytes (diameter 20–35 mm). Raclot (25) showed that the preferential hydrolysis of a substrate fraction enriched in the most polar triacylglycerols (TAGs) reflects the pattern of selective fatty acid mobilization and may be one of the regulating factors. Kajimoto et al. (26) claimed that there is an essential role of citrate export from the mitochondrial matrix to the cytosol at the early differentiation stage of 3T3-1 cells for their effective differentiation into fat cells. Vikman et al. (19) reported that GH-R mRNAs are present in rat adipose tissue from different fat depots. GH-R transcripts of the same estimated size were detected in isolated adipocytes and adipocyte precursor cells. There is a rapid and GH-dependent regulation of GH-R mRNA levels in adipose tissue. Ailhaud (27) noted that lipoprotein lipase (LPL) of adipose cells is present only in membrane compartments, mainly in the Golgi apparatus. LPL is a typical secretory protein which appears to be active as a homodimer. LPL is synthesized in the endoplasmic reticulum as an inactive monomer of Mr 51,000. A high-mannose, inactive mono mer of Mr 55,500 is then formed. An active homodi mer form, bearing two complex oligosaccharide chains
M. A. Shiffman
per monomer of Mr 58,000, forms in the Golgi apparatus. This mature form, present in secretory vesicles, can be secreted constitutively or after exposure to heparin. It is proposed that LPL is present in secretory vesicles in a potentially active, condensed, or “polymerized” form. This explains the activation of LPL. Peterfy et al. (28, 29) reported that two isoforms of lipin, lipin-alpha and lipin-beta, have distinct, but com plementary, functions in adipogenesis, with lipin-alpha playing a primary role in differentiation and lipin-beta being predominantly involved in lipogenesis. Variations in lipin levels alone are sufficient to induce extreme states of adiposity and may represent a mechanism by which adipose tissue and skeletal muscle modulate fat mass and energy balance. Benito et al. (20) showed that mammalian 3T3-L1 cells differentiate into adipocytes after continuous expo sure to pharmacological doses of insulin or physiologic doses of IGF-1. Expression of transfected ras oncogenes led to the differentiation of these cells into adipocytes in the absence of externally added insulin of IGF-1. Ras proteins participate in signal transduction pathways initiated by insulin and IGF-1 in these cells.
5.3 Lipolysis There are many substances that may regulate lipolysis, the decomposition or splitting up of fat. Natriuretic peptides (NP) that are known for regulation of blood pressure via membrane guanylyl cyclase (GC) receptors, are lipolytic in human adipose tissue (30). NP stimulate lipolysis and contribute to the regulation of lipid mobilization in humans. Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) stimulate lipolysis in human isolated fat cells (31). The action of ANP is mediated by activation of the adipocyte plasma membrane type A GC receptor (NPR-A), increase in intracellular guanosine 3'5'-cyclic monophosphate (cyclic GMP) levels, and activation of hormone sensitive lipase. ANMP plays a role in conjunction with catecholamines in the control of exercise induced lipid mobilization. Lafontan et al. (32) stated that the control of fat cell lipolysis by the catecholamines involves at least four different adrenoceptor (AR) subtypes: beta 1-, beta 2-, and beta 3-ARs and alpha 2A-adrenoceptors (alpha 2-AR). The physiological amines operate through differential
5 Fat Cell Biochemistry and Physiology
recruitment of these sites on the basis of their relative affinities. Beta 1-AR is always activated at the lowest norepinephrine levels. Van Harmelen et al. (33) showed that acylationstimulating protein (ASP) and insulin inhibited basal and norepinephrine-induced free fatty acid (FFA) release by stimulating fractional FFA re-esterification and by inhibiting FFA produced during lipolysis. This is mediated by phosphodiesterase 3 (PDE3) and for ASP PDE4 might also be involved. Ryden et al. (34) noted that tumor necrosis factoralpha (TNF-a) is a pleiotropic cytokine with a proposed role in obesity-related insulin resistance. This could be mediated by increased lipolysis in adipose tissue resulting in elevated FFA levels. Lipolysis was completely inhibited by blockers specific for p44/42 (PD98059) and JNK (dimetylaminopurine). These appear to be involved in the regulation of lipolysis. TNF-a induces apoptosis of human adipose cells (35) and prevents differentiation of human adipose precursor cells causing delipidation of newly developed fat cells (36). A common Gbeta (3) gene polymorphism (C825T) influences G protein receptor-mediated signal transduction and influences lipolysis (37). Large et al. (38) showed that hormone-sensitive lipase (HSL) catalyzes the rate-limiting step in adipocyte lipolysis. HSL is a major determinant of the maximum, lipolytic capacity of human fat cells. HSL protein expression is, at least in part, caused by HSL mRNA expression. Decreased expression of HSL in the subcutaneous fat cells, which in turn causes decreased enzyme function and impaired lipolytic capacity of adipocytes, is present in obesity. Impaired expression of the HSL gene might explain the enzyme defect (39). Nonconventional partial beta 3-AR agonist, SR 12,177, was shown by Galitzky et al. (40) to activate lipolysis in fat cells through the interaction with beta 4-AR in human fat cells. Portillo et al. (41) reported that the presence of beta1- and beta2-ARs has been clearly established in human fat cells.
5.4 Multilineage Cells in Fat There are primitive cells in accumulations of fat that are fibroblast-like that have the potential to have multilineage potential to form a variety of cells. Zuk et al. (42)
31 Table 5.1 Lineage-specific differentiation induced by media supplementation (51) Medium
Supplementation
Adipogenic
0.5 mM isobutyl-methylxanthine (IBMX), 1 mM dexamethasone, 10 mM insulin, 200 mM indomethacin, 1% antibiotic/ antimycotic 0.1 mM dexamethasone, 50 mM ascorbate2-phosphate, 10 mM b-glycophosphate, 1% antibiotic/antimycotic 6.25 mg/mL insulin, 10 ng/mL transforming growth factor-b1 (TGF-b1), 50 nM ascorbate-2-phosphate, 1% antibiotic/ antimycotic 0.1 mM dexamethasone, 50 mM hydrocortisone, 1% antibiotic/antimycotic
Osteogenic
Chondrogenic
Myogenic
took human adipose tissue, obtained by suction-assisted lipectomy, and this was processed to obtain a fibroblastlike population of cells or a processed lipoaspirate (PLA). PLA cells are of mesodermal or mesenchymal origin with low levels of contaminated pericytes, endothelial cells, and smooth muscle cells. Disruption of the blood supply during liposuction may result in the rele ase of pericytes, known to possess multilineage poten tial both in vivo and in vitro (43–45). PLA cells differentiate into adipogenic, chondrogenic, myogenic, and osteogenic cells in the presence of lineage-specific induction factors (Table 5.1). The multilineage differentiation observed in PLA may be, in part, due to the presence of pericytes. Adipose tissue is a source of adult multipotential stem cells that can differentiate along mesenchymal lineage. Cells tightly attached to mature fat cells can generate two fibroblastic cell populations with multiple but distinct potential of differentiation into adipocytes, osteoblasts, and chondrocytes (46).
5.5 Obesity Pausova (47) found that the presence of large rather than small adipocytes is associated with functional and structural abnormalities of the adipose tissue. These include increased production of bioactive molecules such as leptin, angiotensinogen, proinflammatory cytokines, and reactive oxygen species; insufficient capacity to accommodate excess energy-intake leading to ectopic fat storage in tissues and in turn insulin resistance and hyperinsulinemia; and augmented macrophage infil tration enhancing the production of pro-inflammatory
32
cytokines and reactive oxygen species. Such a “dysfunctional” adipose tissue may, in turn, induce activation of the sympathetic nervous system and renin-angiotensin-aldosterone system and oxidative stress and hence, promote the development of obesity-associated hypertension. Enlarged fat cells from obese subjects are characterized by insulin resistance and abnormal adrenergic regulation of lipolysis (48). Weight reduction decreased fat cell volume and basal and adrenergic-regulated lipolysis rates that were 20–40% lower than those in control women despite the fact that the percentage of body fat was almost identical in the two groups. Insulin-induced antilipolysis and lipogenesis were completely normalized after weight reduction. The adipocyte has long been suggested to be directly involved in the regulation of the body’s homeostasis. Human fat is a highly active endocrine tissue. EhrhartBornstein et al. (49) found that ecretory products from isolated human adipocytes strongly stimulate adrenocortical aldosterone secretion with a predominant effect on mineralocorticoid secretion. This may be responsible for obesity-related hypertension. Gottschling-Zeller et al. (50) reported that elevated levels of plasminogen activator factor inhibitor-1 (PAI-1) are characteristic of the obese state. Human fat cells release a substantial amount of PAI-1 in a depot-specific manner and transforming growth factor b1 (TGF-b1) particularly contributes to the regulation of PAI-1 secretion.
5.6 Diabetes In individuals who develop type 2 diabetes, fat cells tend to enlarge. DeFronzo (51) found that enlarged fat cells are resistant to the antilipolytic effects of insulin, leading to day-long elevated plasma free acid (FFA) levels. Chronically increased plasma FFA stimulates gluconeogenesis, induces hepatic and muscle insulin resistance, and impairs insulin secretion in genetically predisposed in-induced disturbances that are referred to as lipotoxicity. Enlarged fat cells have a diminished capacity to store fat. When adipocyte storage capacity is exceeded, lipid “overflows” into the muscle and liver, and possibly betacells of the pancreas, exacerbating insulin resistance and further impairing insulin secretion. Dysfunctional fat cells produce excessive amounts of insulin resistance
M. A. Shiffman
inducing inflammatory and atherosclerosis-provoking cytokines, and fail to secrete normal amounts of insulin-sensitizing cytokines. The adipocyte hormone adiponectin is negatively correlated with obesity and insulin resistance (52). Adiponectin acts as a regulator of adipocyte secretory function. The globular domain of adiponectin is gAcrp30. At least eight different cytokines were diminished in res ponse to gAcrp30. Lafontan (53) reported that several molecules secreted from adipocytes are involved in fat cell signaling to other tissues. Adipocyte products could initiate antagonistic effects on target tissues. Fat cells produce peptides that can elicit insulin resistance, such as leptin and adiponectin. Secretion of complement proteins, proinflammatory cytokines, procoagulant, and acute phase reactant proteins have been observed in adipocytes. The membrane receptor FAT/CD36 was found by Noushmehr et al. (54) to facilitate the major fraction of long-chain fatty acid (FA) uptake by muscle and adipose tissues. CD36 mediates a modulatory effect on insulin secretion. Sweeney et al. (55) stated that insulin stimulates glucose uptake into muscle and fat cells by translocating glucose transporter 4 (GLUT4) to the cell surface, with input from phosphatidylinositol (PI) 3-kinase and its downstream effector Akt/protein kinase B. Input at the level of PI 3-kinase suffices for GLUT4 translocation but is insufficient to stimulate glucose transport. Insulin-dependent glucose influx in the skeletal muscle and adipocytes is believed to rely largely on GLUT4, but this has not been confirmed directly (56). Buren et al. (57) noted that chronic hyperglycemia promotes the development of insulin resistance. Insu lin resistance in fat cells from type 2 diabetes patients is fully reversible following incubation at physiological glucose concentrations. Cellular insulin resistance appears to be secondary to the hyperglycemic state. Hoffstedt et al. reported that deletion/insertion polymorphism in the calpain-10 gene (SNP-19) is associated with reduced beta (3)-AR function in obesity, which is also linked to type 2 diabetes, insulin resistance, and decreased thermogenesis. A common G to A polymorphism (UCSNP-43) in the Calpain 10 gene was found to be associated with type II (non-insulindependent) diabetes mellitus and variations in post absorptive and insulin stimulated glucose metabolism
5 Fat Cell Biochemistry and Physiology
in vivo (58). It is possible the Calpain 10 gene predisposes to diabetes by influencing the glucose metab olism. Impaired cellular expression of the docking pro tein, IRS 1, and downstream signaling events in fat cells in response to insulin are associated with insulin resistance and Syndrome X (59). Bastelica et al. reported that elevated plasma plasminogen activator inhibitor (PAI) observed during insulin resistance has been connected with an excessive PAI-1 adipose tissue secretion mainly by visceral fat. PAI-1 production is mainly due to stromal cells, which are more numerous in the visceral than in the subcutaneous depot.
5.7 Hypertension The fat cell hormone leptin is implicated in the pathogenesis of hypertension and cardiovascular disease. Angiotensin (Ang II) and its metabolites stimulate leptin production in human adipocytes that is mediated through an extracellular-signal-regulated kinases 1 and 2-dependent pathway and includes the angiotensin II type 1 receptor subtype (60). The relationship between noradrenaline sensitivity and systolic blood pressure may be of importance in the early development of hypertension in humans (61).
5.8 Hematopoiesis Adipocytes are responsible for neuropilin-1 (NRP-1) expression suggesting that they may play a role in hematopoiesis by producing NRP-1 or that NRP-1 may regulate adipocyte activity (62).
5.9 Inflammatory Response Standard isolation procedures for isolating primary adipose cells from mouse adipose tissue triggers induction of many genes encoding inflammatory mediators including TNF-a, interleukin (IL)-1a, IL-6, multiple chemokines, cell adhesion molecules, acutephase proteins, type 1 IL-1 receptor, and multiple
33
transcriptions factors implicated in the cellular inflammatory response (63).
5.10 Traumatic Lipomas There is a genetic origin of lipomas with breakpoints in benign lipomas that may be at 12q13 or 12q14 (64). Lipomas are made up of clusters of rounded multilobulated masses of adipose tissue with a thin fibrous capsule. Various mesenchymal elements can be associated to form variants such as fibrolipomas, myolipomas, angiolipomas, and myxolipoma. Lipomas are multiple in 5% of patients (65, 66). Malignant transformation is unusual but liposarcoma and fibrosarcoma have been reported (67). There have been multiple reports of post traumatic formation of lipomas (67–75). Post traumatic lipomas arise more often in the female (12:1) arising 2–12 months following blunt trauma usually to the lower lumbar, gluteal, and trochanteric regions. The etiology of the lipomas was originally thought to be the result of herniation or relocation of deep adipose tissue secondary to fascial injury (68). Signorini and Campiglio (76) suggested other possible etiologic factors that include local or systemic factors, local inflammation, or products of degradation of hematomas inducing adipocyte proliferation. They also recommended liposuction as treatment for the lipomas. There is some evidence that the inflammatory processes capable of promoting lipomas formation in tendon sheaths and in synovial membranes following trauma (77) could also induce similar growth in the subcutaneous tissues after acute trauma (76).
5.11 Multiple Symmetrical Lipomatosis Multiple symmetric lipomatosis is an inherited disorder in which enlarging unencapsulated lipomas symmetrically develop in the subcutaneous tissues of the neck, shoulders, mammary, and truncal regions. In some cases it is associated with mitochondrial DNA abnormalities. Nisoli et al. (77) showed that the Beta(3)-adrenergic receptor is the functionally relevant adrenergic receptor subtype in brown adipocytes and its stimulation by
34
noradrenaline (NA) modulates the expression of genes such as uncoupling protein (UCP)-1 and inducible nitric oxide synthase (iNOS), involved in fat cell proliferation and differentiation. Trp64Arg mutation of the beta(3)-AR has been implicated in lower NA activity in adipose tissues. No association was found between beta(3)-AR gene polymorphism and noradrenergic signaling in defects in MSL with or without mitochondrial DNA mutations (75).
5.12 Discussion There is a wide range of fat cell biochemistry and physiology that clinically involves medical problems such as diabetes, obesity, hypertension, and lipoma and lipomatosis. The physician who removes or decreases large amounts of fat in a patient through liposuction or other means (bariatric surgery or weight loss regimens) may affect, positively or negatively, some of the body fat functions. Understanding the potential problems may affect the way we surgically and medically approach the patient with body contouring problems.
References 1. Knittle, J.L., Hirsch, J. Effect of early nutrition on the development of rat epididymal fat pads: cellularity and metabolism. J Clin Invest 1968;47(9):2091–2098. 2. Hirsch, J., Han, P.W. Cellularity of rat adipose tissue: effects of growth, starvation and obesity. J Lipid Res 1969;10(1):77–82. 3. Hirsch, J., Knittle, J.L. Cellularity of obese and nonobese human adipose tissue. Fed Proc 1970;29(4):1516–1521. 4. Salans, L.B., Cushman, S.W., Weismann, R.E. Studies of human adipose tissue: adipose cell size and number of nonobese and obese patients. J Clin Invest 1973;52(4):929–941. 5. Bjorntorp, P. Effects of age, sex and clinical conditions on adipose tissue cellularity in man. Metabolism 1974;23(11): 1091–1102. 6. Green, H., Meuth, M. An established pre-adipose cell line and its differentiation in culture. Cell 1974;3(2):127–133. 7. Smahel, J. Adipose tissue in plastic surgery. Ann Plast Surg 1986;16(5):444–453. 8. Herberg, L., Doppen, W., Major, E., Gries, F.A. Dietaryinduced hypertrophic-hyperplastic obesity in mice. J Lipid Res 1974;15(6):580–585. 9. Wassermann, F. Die fettorgane des menschen: entwicklung, bau und systematische stellung des sogenannten fettgewebes. Z Zellforsch Mikr Anat 1925;3:235.
M. A. Shiffman 10. Hausberger, F.X. Quantitative studies on the development of autotransplants of immature adipose tissue of rats. Anat Rec 1955;122(4):507–515. 11. Ramsay, T.G. Fat cells. Endocrinol Metab Clin North Am 1996;25(4):847–870. 12. Atanassova, P. Immunohistochemical expression of S-100 protein in human embryonal fat cells. Cells Tissues Organ 2001;169(4):355–360. 13. Ailhaud, G., Amri, E., Bardon, S., Barcellini-Couget, S., Bertrand, B., Catalioto, R.M., Dani, C., Dijan, P., Doglio, A., Forest, C., et al. The adipocyte: relationships between proliferation and adipose cell differentiation. Am Rev Respir Dis 1990;142(6 Pt):S57–S59. 14. Lau, D.C., Shillabeer, G., Wong, K.L., Tough, S.C., Russell, J.C. Influence of paracrine factors on preadipocyte replication and differentiation. Int J Obes 1990;14(Suppl 3):193–201. 15. Uchida, E., Shimokawa, S., Nishida, Y, Takasu, H., Ikehara, N., Tomita, K., Tanaka, A., Morikawa, N. An active site of growth hormone for eliciting the differentiation of preadipose 3T3-F442A cells to adipose cells. Biochem Biophys Res Commun 1990;172(1):357–363. 16. Kawada, T., Aoki, N., Kamei, Y., Maeshige, K., Nishiu, S., Sugimoto, E. Comparative investigation of vitamins and their analogs on terminal differentiation from preadipocytes to adipocytes of 3T3-LI cells. Comp Biochem Physiol A 1990;96(2):323–326. 17. Gregoire, F., Genart, C., Hauser, N., Remacle, C. Gluco corticoids induce a drastic inhibition of proliferation and stimulate differentiation of adult rat fat cells precursors. Exp Cell Res 1991;196(2):270–278. 18. Carraro, R., Li, Z.H., Johnson, J.F., Jr., Gregerman, R.I. Islets of preadipocytes highly committed to differentiation in cultures of adherent rat adipocytes: light and electron-microscope observations. Cell Tissue Res 1991;264(2):243–251. 19. Vikman, K., Carlsson, B., Billig, H., Eden, S. Expression and regulation of growth hormone (GH) receptor messenger ribonucleic (mRNA) acid in rat adipose tissue, adipocytes and adipocyte precursor cells. Endocrinology 1991;129(3): 1155–1161. 20. Benito, M., Porras, A., Nebreda, A., Santos, E. Differentiation of 3T3-LI fibroblasts to adipocytes induced by transfection of ras oncogenes. Science 1991;253(5019):565–568. 21. Serrero, G., Mills, D. Decrease in transforming growth factor beta-1 binding during differentiation of rat adipocyte precur sors in primary culture. Cell Growth Differ 1991;2(3):173–178. 22. Catalioto, R.M., Gaillard, D., Maclouf, J., Ailhaud, G., Negrel, R. Autocrine control of adipose cell differentiation by prostacyclin and PGF2-alpha. Biochim Biophys Acta 1991;1091(3):364–369. 23. Li, Z.H., Carraro, R., Gregerman, R.I., Lau, D.C. Adipocyte differentiation factor (ADF): a protein secreted by mature fat cells that induces predipocyte differentiation in culture. Cell Biol Int 1998;22(4):253–270. 24. Yokota, T., Meka, C.S. Kouro, T., Medina, K.L., Igarashi, H., Takahashi, M., Oritani,K., Funahashi, T., Tomiyama, Y., Matsuzawa, Y., Kincade, P.W. Adiponectin: a fat cell product, influences the earliest lymphocyte precursors in bone marrow culture by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 2003;171(10): 5091–5099.
5 Fat Cell Biochemistry and Physiology 25. Raclot, T. Selective mobilization of fatty acids from white fat cells: evidence for a relationship to the polarity of triacylglycerols. Biochem J 1997;322(Pt 2):483–489. 26. Kajimoto, K., Terada, H., Baba, Y., Shinohara, Y. Essential role of citrate export from mitochondria at early differentiation stage of 3T3-L1 cells for their effective differentiation into fat cells, as revealed by studies using specific inhibitors of mitochondrial di- and tricarboxylate carriers. Mol Genet Metab 2005;85(1):46–53. 27. Ailhaud, G. Cellular and secreted lipoprotein lipase revisited. Clin Biochem 1990;23(5):343–347. 28. Peterfy, M., Phan, J., Reue, K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem 2005: 280(38):32883–32889. 29. Phan, J., Peterfly, M., Reue, K. Biphasic expression of lipin suggests dual roles in adipocyte development. Drug News Perspect 2005;18(1):5–11. 30. Sengenes, C., Zakaroff-Girard, A., Moulin, A., Berlan, M., Bouloumie, A., Lafontan, M., Galitzky, J. Natriuretic peptidedependent lipolysis is a primate specificity. Am J Physiol Regul Intgr Comp Physiol 2002;283(1):R257–R265. 31. Sengenes, C., Moro, C., Galitzky, J., Merlan, M., Lafontan, M. Natriuretic peptides: a new lipolytic pathway in human fat cells. Med Sci (Paris) 2005;21(1):61–65. 32. Lafontan, M., Bousquet-Melon, A., Galitzky, J., Barbe, P., Carpene, C., Langin, D., Berlan, M., Valet, P., Castan, I., Bouloumie, A., et al. Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation. Obes Res 1995;3(Suppl 4):507S–514S. 33. Van Harmelen, V., Reynisdottir, S., Cianflone, K., Degerman, E., Hofstedt, J., Nilsell, K., Sniderman, A., Arner, P. Mecha nisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem 1999;274(26):18243–18251. 34. Ryden, M., Dicker, A., van Harmelen, V., Hauner, H., Brunnberg, M., Perbeck, L., Lonnqvist, F., Arner, P. Mapping of early signaling events in tumor necrosis factor-alphamediated lipolysis in human fat cells. J Biol Chem 2002; 277(2):1085–1091. 35. Prins, J.B., Niesler, C.M., Winterford, C.M., Bright, N.A., Siddle, K., O’Rahilly, S., Walker, N.I., Cameron, D.P. Tumor necrosis factor-a induses apoptosis of human adipose cells. Diabetes 1997;46:1939–1944. 36. Petruschke, T., Hauner, H. Tumor necrosis factor-a prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 1993;76(3):742–747. 37. Ryden, M., Faulds, G., Hoffstedt, J., Wennlund, A., Arner, P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002; 51(5):1601–1608. 38. Large, V., Arner, P., Reynisdottir, S., Grober, J., van Harmelen, V., Holm, C., Langin, D. Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. Lipid Res 1998;39(80):1688–1695. 39. Large, V., Reynisdottir, S., Langin, D., Fredby, K., Klannemark, M., Holm, C., Arner, P. Decreased expres sion and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 1999; 40(11):2059–2066.
35 40. Galitzky, J., Langin, D., Verwaerde, P., Montastrue, J.L., Lafontan, M., Berlan, M. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor. Br J Pharmacol 1997;122(6):1244–1250. 41. Portillo, M.P., Rocandio, A.M., Garcia-Calonge, M.A., Diaz, E., Campo, E., Martinez-Blazquez, C. Errasti, J., del Barrio, A.S. Lipolytic effects of beta1, beta2, and beta3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues. Rev Esp Fisiol 1995;51(4):193–200. 42. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., Hedrick, M.H. Multi lineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211–228. 43. Schor, A.M., Allen, T.D., Canfield, A.E., Sloan, P., Schor, S.L. Pericyte derived from the retinal microvasculature undergo calcification in vitro. J Cell Sci 1990;97(Pt 3):449–461. 44. Doherty, M.J., Ashton, B.A., Walsh, S., Beresford, J.N., Grant, M.E., Canfield, A.E. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998;13(5):828–838. 45. Diefenderfer, D.L., Brighton, C.T. Microvascular pericytes express aggrecan message which is regulated by BMP2. Biochem Biophys Res Commun 2000;269(1):172–178. 46. Miyazaki, T., Kitagawa, Y., Toriyama, K., Kobori, M., Torii, S. Isolation of two human fibroblastic cell populations with multiple but distinct potential of mesenchymal differentiation by ceiling culture of mature fat cells from subcutaneous adipose tissue. Differentiation 2005;73(2–3):69–78. 47. Pausova, Z. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension. Curr Opin Nephrol Hypertens 2006;15(2):173–178. 48. Lofgren, P., Hoffstedt, J., Naslund, E., Wiren, M., Arner, P. Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction. Diabetologia 2005;48(11):2234–2242. 49. Ehrhart-Bornstein, M., Arakelyan, K., Krug, A.W., Scher baum, W.A., Bornstein, S.R. Fat cells may be the obesityhypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 2004;30(4):865–870. 50. Gottschling-Zeller, H., Birgel, M., Rohrig, K., Hauner, H. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture. Metabolism 2000;49(5):666–671. 51. DeFronzo, R.A. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 2004;(143):9–21. 52. Dietze-Schroeder, D., Sell, H., Uhlig, M., Koenen, M., Eckel, J. Autocrine action of adiponectin on human fat cells prevents the release of insulin-inducing factors. Diabetes 2005;54(7):2003–2011. 53. Lafontan, M. Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 2005;45:119–146. 54. Noushmehr, H., D’Amico, E., Farilla, L., Hui, H., Wawrowsky, K.A., Miynarski, W., Doria, A., Abumrad, N.A., Perfetti, R. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human beta-cells and mediates fatty acid effects on insulin secretion. Diabetes 2005;54 (2):472–481.
36 55. Sweeney, G., Garg, R.R., Ceddia, R.B., Li, D., Ishiki, M., Somwar, R., Foster, L.J., Neilsen, P.O., Prestwich, G.D., Rudich, A., Klip, A. Intracellular delivery of phosphatidylinositol (3,4,5)-triphosphate causes incorporation of glucose transporter 4 into plasma membrane of muscle and fat cells without increasing glucose uptake. J Biol Chem 2004;279(31):32233–32242. 56. Rudich, A., Konrad, D., Torok, D., Ben-Romano, R., Huang, C., Niu, W., Garg, R.R., Wijesekara, N., Germinario, R.J., Bilan, P.J., Klip, A. Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues. Diabetologia 2003;46(5):649–658. 57. Buren, J., Lindmark, S., Renstrom, F., Eriksson, J.W. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism 2003; 52(2):239–245. 58. Hoffstedt, J., Ryden, M., Lofgren, P., Orho-Melander, M., Groop, L., Arner, P. Polymorphism in the Calpain 10 gene influences metabolism in human fat cells. Diabetologia 2002;45(2):278–282. 59. Smith U., Axelsen, M., Carvalho, E., Eliasson, B., Jansson, P.A., Wesslau, C. Insulin signaling and action in fat cells: association with insulin resistance and type 2 diabetes. Ann N Y Acad Sci 1999;892:119–126. 60. Skurk, T., van Harmelen, V., Blum, W.F., Hauner, H. Angio tensin II promotes leptin production in cultured human fat cells by an ERK1/2dependent pathway. Obes Res 2005;13(6): 969–973. 61. Hoffstedt, J., Reynisdottir, S., Lonnqvist, F. Systolic blood pressure is related to catecholamine sensitivity in subcutaneous abdominal fat cells. Obes Res 1996;4(1):21–26. 62. Belaid, Z., Hubint, F., Humblet, C., Boniver, J., Nusgens, B., Defresne, M.P. Differential expression of vascular endothelial growth factor and its receptors in hematopoietic and fatty bone marrow: evidence that neuropilin-1 is produced by fat cells. Haematologica 2005;90(3):400–401. 63. Ruan, H., Zarnowski, M.J., Cushman, S.W., Lodish, H.F. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and
M. A. Shiffman down-regulates adipocyte genes. J Biol Chem 2003;278(48): 47585–47593. 64. Turc-Carel, C., Dal Cin, P., Boghosian, L., Leong, S.P., Sandberg, A.A. Breakpoints in benign lipomas may be at 12q13 or 12q14. Cancer Genet Cytogenet 1988;36(1):131–135. 65. Grandi, E., Trisolini, M.P. Tumors of the adipose tissue during 10 years of diagnostic activities (1979–1988). Pathologica 1990;82(1079):217–256. 66. Enzinger, F., Weiss, S. Soft Tissue Tumors. St. Louis, Mosby, 1983. 67. David, L.R., De Franzo, A., Marks, M., Argenta, L.C. Post traumatic pseudolipoma. J Trauma 1996;40(3):396–400. 68. Brooke, R.I., MacGregor, A.J. Traumatic pseudolipoma of the buccal mucosa. Oral Surg Oral Med Oral Pathol 1969; 28(2):223–225. 69. Meggitt, B.F., Wilson, J.N. The battered buttock syndromefat fractures. Br J Surg 1972;59(3):165–169. 70. Herbert, D.C., DeGeus, J. Post-traumatic lipomas of the abdominal wall. Br J Plast Surg 1975;28(4):303–306. 71. Rozner, I., Isaacs, G.W. The traumatic pseudolipoma. Austr N Z J Surg 1977;47(6):779–782. 72. Penoff, J.H. Traumatic lipomas/pseudolipomas. J Trauma 1982;22(1):63–65. 73. Dodenhoff, T.T. Trauma induced saddle bag: case report. Lipoplasty Newslett 1988;5:55. 74. Elsahy, N.I. Posttraumatic fatty deformities. Eur J Plast Surg 1989;12:208. 75. Cormenzana Olaso, P.S., Martinez Florez, A.E., Cecilia Gomez, J.A. Lipodistrofia post-traumatica. Cir Plast IberoLatinoamer 1992;18:47. 76. Signorini, M., Campiglio, G.L. Posttraumatic lipomas: where do they really come from? Plast Reconstr Surg 1998; 101(3):699–705. 77. Armstrong, S.J., Watt, I. Lipoma arborescens of the knee. Br J Radiol 1989;62(734):178–180. 78. Nisoli, E., Regianini, L., Bulbarelli, A., Busetto, L., Coin, A., Enzi, G., Carruba, M.O. Multiple symmetrical lipomatosis (MSL) may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells. J Pathol 2002;198(3):378–387.
6
White Adipose Tissue as an Endocrine Organ Kihwa Kang
6.1 Introduction White adipose tissue (WAT) is the main site of energy storage in mammals and provides the body’s thermal and mechanical insulation. Adipocytes store dietary sugar or fatty acids as a form of triglyceride in lipid droplets. When the body needs energy, as for fasting, these triglycerides are hydrolyzed and released into the blood stream to supply energy to other tissues. For a long time, WAT has been recognized only for energy storage until the discovery of leptin production by adipocytes (1). Since this finding, the perspective on the physiological role of WAT has begun to change and endocrine function of adipose tissue has begun to emerge. Following studies revealed that adipocytes can produce large numbers of peptide hormones and cytokines, called adipokines. These molecules affect energy metabolism in other tissues such as liver and muscle, as well as behaviors related to feeding through effects on neuroendocrine pathways. Some adipokines exhibit proinflammatory activities. For example, TNF-a and IL-6 are shown to cause insulin resistance. These findings indicate that WAT might be the main organ that plays an important role in obesity and obesity-induced metabolic disorders including type 2 diabetes.
K. Kang Department of Genetics and Complex Diseases, Harvard School of Public Health, 665 Huntington Avenue, Bldg 2, Rm 129, Boston, MA 02115, USA email:
[email protected]
6.2 Role of White Adipose Tissue in Metabolism Adipose tissue is composed of mature adipocytes, fibroblasts, endothelial cells, preadipocytes, and immune cells. Different from other cell types, adipocytes can store lipids without compromising their cellular function. Lipoprotein lipase (LPL) and glucose transporters (GLUTs) are the major proteins responsible for the uptake of circulating energy sources in addition to de novo fatty acid synthesis in the cells. LPL breaks down triglyceride in circulating lipoprotein particles generating fatty acids, and GLUTs help in the uptake blood glucose. Inside the cells, fatty acids and glucose are either stored in a highly condensed form such as triglycerides, or are metabolized to generate cellular ATP. Among GLUTS, GLUT1 is responsible for basal glucose uptake and GLUT4 for insulin-stimulated glucose entry into cells. The expression of GLUT4 is highly correlated with insulin sensitivity (2). WAT is also important in endocrine function. In addition to release of fatty acids during fasting, adipocytes secrete multiple protein signals and factors called adipokines into the blood stream. The production of adipokines is regulated by the status of adipose tissue expansion and other physiological environment. Obese humans and animals have bigger adipocytes, increased adipose tissue mass, and a different method of producing adipokines. For example, proinflammatory cytokine TNF-a and satiety hormone leptin production are increased (3), while adiponectin level is decreased in obesity (4).
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_6, © Springer-Verlag Berlin Heidelberg 2010
37
38
K. Kang
a
sensitive to feeding and fasting statuses. For example, plasma level of leptin is increased after meals or in obesity. Circulating leptin binds to the leptin receptor at the hypothalamus in the brain, and subsequently activates the neuron for satiety (pro-opiomelanocortin (POMC)) and energy expenditure pathway, whereas it suppresses the neuron for appetite (neuropeptide-Y (NP-Y)) and energy conservation pathway. In support of this theory, mice lacking leptin (ob/ob) or leptin receptors (db/db) are severely obese due to loss of appetite regulation and energy control (1).
b
6.4 Adiponectin on Liver and Muscle
Fig. 6.1 Macropahges infiltrated into WAT. C57/B7 mice were fed normal chow diet (a) or high fat diet (b). Macrophages are accumulated around adipocytes and make crown like structure. Obesity increases macrophage content in WAT, which results in insulin resistance
Obesity not only increases proinflammatory adipokine production in adipocytes, but also induces macrophages infiltration into the tissue (5) (Fig. 6.1). This is one of the main causes of peripheral and systemic insulin resistance and metabolic syndrome. Although the mechanisms underlying accumulation of macrophages in adipose tissue in obesity are not clear, it is hypothesized that the removal of dead adipocytes caused by hypertrophy leads to this phenomenon.
6.3 Leptin on Brain Although leptin, a satiety hormone, is primarily produced by adipocytes, it exhibits its activity in the brain and peripheral organs. Its production and release are
Adiponectin, one of the most extensively characterized adipokines, is exclusively secreted by the adipose tissues. There are several forms of adiponectin including oligomers and multimers; the multimer forms of adiponectin are the major active hormones (6). Serum adiponectin binds to its receptor in the liver and muscle, and then activates cellular downstream proteins such as AMP-activated protein kinase (AMPK) and peroxi some proliferators-activated receptor a (PPARa). The main biological effect of adiponectin is the regulation of glucose and lipid metabolism in the liver and skeletal muscle. Many studies in humans and animals show that a lower adiponectin level is well correlated with obesity, insulin resistance, and diabetes (7). Further more, a lower adiponectin level is associated with higher blood pressure, proinflammatory state, and coronary artery disease (8).
6.5 Location of WAT Adipose tissues in different locations have different physiological and metabolic effects. Generally visceral adipocytes have higher lipolytic activity of catecholamines and less anabolic effect of insulin, which results in greater mobilization of free fatty acids from intra-abdominal depots than subcutaneous adipose tissue (9). Central obesity characterized by increased amounts of intra-abdominal fat or visceral fat is associated with insulin resistance, type 2 diabetes and atherosclerosis (10). By contrast, peripheral obesity with increased subcutaneous fat is associated with improved insulin sensitivity, a lower risk of developing type 2
6 White Adipose Tissue as an Endocrine Organ
diabetes, and dyslipidemia compared to the central obesity with increased visceral adipose tissue (11). Also, surgical removal of visceral fat has been reported to decrease blood insulin and glucose levels in humans (12), whereas removal of subcutaneous fat by liposuction did not result in improvement in any aspect of the metabolic syndrome (13), which suggests some beneficial effect of subcutaneous fat and adverse effects of visceral fat (14).
6.6 Adipokines and Inflammation WAT is a major secretory organ responsible for the release of over fifty adipokines. These adipokines appear to be involved in a wide range of physiological processes; classical cytokines/chemokines (e.g., TNFa, IL-6, IL-1b, MCP-1), growth factors (e.g., transforming growth factor-b; TGF-b), vascular haemostasis (e.g., PAI-1), regulation of blood pressure (e.g., angiotensinogen), lipid metabolism (e.g., RBP4, cholesteryl ester transfer protein), glucose homeostasis (e.g., adiponectin, resistin), angiogenesis (e.g., VEGF), and neuroendocrine control (e.g., leptin) (Table 6.1). The production of inflammation-related adipokines, including TNF-a, IL-6, MCP-1, and leptin, is increased in adipose tissue with obesity, implicating a chronic low-grade inflammation in obesity. In addition, the increased chemokine (MCP-1) production both in hypertrophic adipocytes and resident macrophages recruit additional macrophages. Macrophage recruitment in turn results in a proinflammation state in obese adipose tissue (15). Macropahges produce large amount of cytokines such as TNF-a, and IL-6, and these cytokines increase lipolysis and impair insulin signaling in adipocytes (16). When adipose tissue suffers insulin resistance states, circulating fatty acids and lipid levels go up, which makes other tissue such as liver, muscle, and pancreas accumulate more lipids. This ectopic lipid accumulation further increases whole body insulin resistance together with liver steatosis and muscle lipid accumulation. On the contrary, several adipokines appear to have an anti-inflammatory effect. Adiponectin inhibits phagocytic activity and TNFa production in macrophages, as well as increases human skeletal muscle bioenergetics, which results in antidiabetic effects (4). Recently it has been reported that adipose tissue releases anti-
39 Table 6.1 Biological effect of adipokines Biological effect Adipokines Leptin Adiponectin
Satiety signal and energy expenditure Increases insulin sensitivity and antiinflammatory Resistin Decreases insulin sensitivity Visfatin Insulin-like activity RBP4 Not known but correlated to obesity and insulin resistance Angiotensinogen Regulates arterial blood pressure VEGF Stimulates vascular proliferation, angiogenesis Proinflammatory cytokines TNF-a Increases lipolysis and decreases insulin sensitivity IL-1b Proinflammatory IL-6 Increases lipolysis and decreases insulin sensitivity MCP-1 Chemokine and recruits more monocytes Anti-inflammatory cytokines IL-4 Reduced inflammation and increase tissue repair IL-13 Reduced inflammation and increase tissue repair Acute phage proteins PAI-1 Blocks fibrinolysis, vascular haemostasis Serum amyloid A Recruits immune cells CRP Binds to microbes and assists innate immunity RBP4 retinol-binding protein; VEGF vascular endothelial growth factor; TNF-a tumor necrosis factor-a; IL-1b interleukin-1b; IL-6 interleukin-6; MCP-1 monocyte chemoattractant protein-1; IL-4 interleukin-4; IL-13 interleukin-13; PAI-1 plasminogen activator inhibitor 1; CRP C-reactive protein
inflammatory cytokines such as interleukin-4 and interleukin-13 (17). These cytokines are known to be released by Th2 helper T cells to resolve inflammation and tissue repair. Adipocyte factors could activate macrophages both in proinflammatory (M1) and antiinflammatory (M2) program, and the balance of these programs through PPARd is critical for controlling insulin sensitivity. It is suggested that adipose tissue releases these anti-inflammatory cytokines to control infiltrated macrophage activation and dampen proinflammatory responses. Several human studies showed that anti-inflammatory medication could be beneficial to obesity-induced insulin resistance (18). Thus, identification of adipokines and investigation of their physiological functions will be very important to understand the role of adipose tissue and to protect against obesityinduced metabolic disorders.
40
6.7 Conclusions The incidence of obesity and obesity-related metabolic syndrome is increasing world-wide. WAT plays a central role in controlling body’s metabolic homeostasis and insulin sensitivity as a key endocrine and secretory organ. It is clear that there is extensive cross-talk between white adipocytes and other tissues through paracrine and endocrine functions. Understanding the biology of adipose tissue and the identification of adipokines will provide new insights into normal physiological regulation, as well as the pathogenesis and treatment of obesity, diabetes and disorders of lipid metabolism.
References 1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372(6505):425–432. 2. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001;409(6821):729–733. 3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 1993;259(5091):87–91. 4. Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, Mandarino L, Ravussin E, Smith SR. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 2006;4(1):75–87. 5. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112(12): 1821–1830. 6. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26(3):439–451.
K. Kang 7. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8(7): 731–737. 8. Huang KC, Chen CL, Chuang LM, Ho SR, Tai TY, Yang WS. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 2003; 88(9):4130–4134. 9. Arner P, Hellström L, Wahrenberg H, Brönnegard M. Betaadrenoceptor expression in human fat cells from different regions. J Clin Invest 1990;86(5):1595–1600. 10. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81(3):555–563. 11. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women. Eur Heart J 2003;24(16):1531–1537. 12. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: Omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002;26(2):193–199. 13. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350(25):2549–2557. 14. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008;7(5):410–420. 15. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116(6):1494–1505. 16. Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett 2008;582(1):117–131. 17. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, Lee CH. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab 2008;7(6):485–495. 18. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008;31(2):289–294.
Part Preoperative
II
7
Preoperative Consultation Melvin A. Shiffman
7.1 Introduction Every patient considered for autologous fat transplantation should have a proper history. A physical examination as well as a discussion on the pros and cons of having fat transfer and viable alternative methods of resolving the patient’s problem is also necessary.
7.2 Initial Conference The patient should be able to state the problem that is to be treated, how it occurred, and how long it has been present. Previous attempts to correct the problem should be explored (what was done, how, when, and where) and prior records obtained if at all possible. This is important in case temporary or permanent fillers have been used or if there is possibly excessive scar in the area to be treated. Explore the patient’s past history and family history for diabetes, heart disease, cancer, bleeding problems, and thromboembolism. Obtain a list of all medications the patient is taking including dosage and frequency.
7.3 Physical Examination The specific defect or deficit that the patient is complaining about should be carefully examined and measurements taken if possible. The overlying skin should
M. A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA 92780-2302, USA e-mail:
[email protected]
be examined for scars and hypo or hyperpigmentation. Palpation is performed to determine if there are any deep tissue attachments, induration, and/or masses. If general anesthesia or intravenous sedation is to be used, examination of the heart and lungs should be performed. The fat tissue depth in the areas where fat will be removed for transfer should be determined for adequacy of the amount of fat that will be utilized and, if necessary, frozen and stored. Preoperative photos should be taken for future reference.
7.4 Discussion with the Patient For informed consent, the discussion with the patient should include the procedure contemplated, viable alternatives, and possible (material) risks and complications of each. In one jurisdiction the judge stated that the informed consent is personal to the cosmetic surgery patient. In that instance all possible risks and complications have to be discussed with the patient. Medical records should include when this discussion took place and the possible risks and complications discussed. The surgeon should be involved at some time in this discussion. It may be convenient for staff personnel to perform most of the discussion but the physician should establish some rapport with the patient to show interest and compassion concerning the procedure and its possible complications. Fat transfer may seem like a simple procedure to the physician, but it is important for the patient to understand the need for possible further fat injections because of absorption as well as future loss of fat through the aging process, and possible risks of the procedure. One has to be careful with the patient who is to have injection of fat into the glabella or nasal area. This
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_7, © Springer-Verlag Berlin Heidelberg 2010
43
44
patient must be informed of the possibility of blindness and/or central nervous system injury.
M. A. Shiffman
7.7 Written Instructions Preoperative and postoperative instructions should be given both orally and in writing.
7.5 Laboratory Studies If there is minimal fat to be removed and injected and local or local tumescent anesthesia is used, there is little need for lab studies. However, if the fat transfer is in addition to extensive liposuction or other procedure requiring general anesthesia or deep sedation, there may be need for at least a CBC (complete blood count). Diabetics should have their blood sugar levels evaluated preoperatively and postoperatively as well as when infection or necrosis occurs.
7.8 Postoperative The patient should be seen on the first or second postoperative day to evaluate for possible hematoma or infection as well as to adjust any dressings that have been applied.
7.9 Conclusions 7.6 Radiologic Studies Radiologic studies are not usually necessary. If the patient is to have a general anesthetic and is over the age of 50, chest X-ray may be recommended (as well as an electrocardiogram). If fat is to be injected around the breast, mammogram is usually necessary preoperatively and 6–12 months postoperatively.
The patient should receive enough information about the procedure in order to make a knowledgeable decision as to whether or not to have the procedure. The physician should establish rapport with the patient by being involved in the discussion about the procedure and its possible risks and complications.
Part Techniques for Aesthetic Procedures
III
8
Guidelines for Autologous Fat Transfer, Evaluation, and Interpretation of Results Sorin Eremia
8.1 Introduction The indications for autologous fat grafting (AFG) have gradually changed since the procedure gained popularity in the mid 1980s (1–4). The evaluation of results and critical comparisons with alternative methods has in many respects become more difficult. The initial cosmetic uses of AFG was generally limited to facial furrows – particularly to nasolabial folds, lateral oral commissural folds and glabellar frown lines – to the hands, and to a very limited extent, to the breasts. While the idea of fat grafting for breast augmentation gained a few early adepts, vehement opposition by plastic surgeons and to some extent by the medical establishment has largely rendered this application untenable from a medical legal position. Given the very limited worldwide choice of fillers in the mid-1980s, and even more so in the US, where collagen was the only FDA-approved injectable filler until December 2003, AFG was a clear-cut choice for those patients in need of more than 1–2 mL of collagen and who were willing to accept variability in long-term results and the longer down time associated with AFG. In fact, as AFG injecting needles became smaller and smaller from the 14–16 gauge used early on to the 18–20 gauge more commonly used now, the finesse and precision of the technique vastly improved, and the immediate posttreatment AFG appearance more closely approached results with commercial fillers. However, the unpredictability and variability of the duration of
S. Eremia Cosmetic Surgery Unit, Division of Dermatology, UCLA, Brockton Cosmetic Surgery Center, 4440 Brockton, Suite 200, Riverside, CA 92501, USA e-mail:
[email protected]
the results were probably the biggest obstacles for AFG becoming the gold standard facial filler, particularly in the absence of serious competition. Lack of standardized harvesting, processing, and injection techniques, and lack of sound scientific studies to evaluate the duration of results were additional obstacles. The author (5) designed and carried out one of the first and few studies to objectively compare AFG to Zyplast collagen. The results confirmed the largely accepted opinion in the late 1980s, that AFG was at least equal to, and somewhat superior to, collagen during the first 6–9 months, but where the great majority of patients lost correction by 12–15 months. A followup study of 131 patients who underwent two or more AFG treatments confirmed that for most patients repeated injections of AFG did not achieve longer-term or permanent correction, when measured against baseline and the last treatment (6). These studies, though well designed, should be considered flawed today, because of improved injection techniques now being used. The patients in these two studies were fat grafted with 3–5 mL syringes fitted with 14–16 gauge needles. Due in great part to the work by Coleman (7–9), the switch to 1mL syringes fitted with smaller 18–19 gauge injection cannulas/needles has – confirmed by the author’s own personal experience – resulted in vastly improved duration of results. Other early pioneers such as Ersek (10, 11) noted improved results with improved techniques. While no precise guidelines for AFG have been defined, the author considers the application of certain basic minimum principles of the four components of AFG as a generally accepted “modern” technique. 1. Harvesting This should be as atraumatic as possible, to preserve the maximum amount of viable adipocytes. A low
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_8, © Springer-Verlag Berlin Heidelberg 2010
47
48
pressure aspiration system, usually by syringe, using a blunt harvesting cannula is the generally accepted norm. There is no true consensus as to donor site selection or use of anesthetics. 2. Processing The concept of processing the aspirated fat for reinjection ranges from very basic techniques of washing and concentrating the fat to separate the viable fat strands from any debris, to more complex methods which may include the use of various additives and extensive centrifugation. While there have been multiple studies advocating the benefits of various techniques to maximize the percentage of viable adipocytes to be reinjected, there appears to be some consensus that gentle processing, minimal washing, and the use of short time, low power centrifugation, or at least gravity separation of the fat, result in a relatively high percentage of viable fat cells ready for reinjection (12, 13). 3. Storage Harvesting extra fat for freezing and future reinjection, can render AFG far more competitive with commercial fillers, by eliminating the relatively traumatic, and certainly time consuming steps of harvesting and processing the fat. Significant controversy exists as to the viability and long term effectiveness of frozen fat. Sophisticated methods of freezing the fat, use of special additives, and good thawing technique have been demonstrated in various studies to improve the percentage of viable adipocytes following thawing (14, 15). Crude methods of freezing, storage, and thawing, are likely to result in relatively low percentage of viable adipocytes being reinjected. Nevertheless, the reinjection of nonviable adipocytes will result in short term correction, and in some patients may also induce a certain amount of tissue fibrosis. 4. Injection The use of a 1-mL syringe no greater than an 18 gauge injection needle or cannula, to precisely place small amounts, thin layers or strands of fat, with multiple passes if necessary, in the desired location, should be virtually considered the standard of care. Significant overcorrection should be avoided. Touch-ups, which are needed for many patients, are preferable to difficultto-fix long-lasting overcorrections. Using these types of “modern” techniques, most experienced AFG users report about 40% good long
S. Eremia
term results, which is also the author’s experience over the past 8–10 years. Unfortunately there is a great lack of newer, sound scientific studies that evaluate results of AFG. It is troubling that no side by side studies are being performed to compare AFG to various other available fillers. For areas such as the nasolabial folds this should be relatively simple and safe to do. Though attempts to set current guidelines for use of AFG may be rendered somewhat more difficult by lack of scientific studies to support them, it is nonetheless possible to endeavor to formulate them based on reported general experience. For purposes of guidelines it is best to divide use of AFG into several categories. 1. Correction of superficial furrows such as the nasolabial fold, oral commissural folds, and glabellar frown lines. For correction of these areas AFG are generally placed superficially in the subdermal area, and competes primarily against an increasing array of intradermal injections of temporary or permanent commercial fillers, such as crosslinked collagen and nonanimal hyaluronic acid (HA), Calcium hydroxyl-apatite, poly-l-lactic acid, polymethylmethacrylate beads, silicone, etc. Caution should be exercised with any filler agent for the glabellar area, as tissue necrosis and more rarely blindness have been reported with filler injections; neurotoxin injections or neurolysis provide excellent alternatives. The evaluation and interpretation of results for these areas are relatively straightforward. Results should be analyzed: (a) In the 1–7-day immediate postinjection period to determine swelling, bruising, overcorrection, all of which impact down time and patient acceptance vs. competing alternatives. (b) In the relative short term – 3–6-month period. (c) In the intermediate term – 6–12-month period. (d) In the long term – 12–24-month period and beyond. For short-term evaluation, visual examination and descriptive records supported by photographs should suffice. For longer-term evaluation, optical profilometry would yield the most objective results, complemented by high-quality standardized photographs, which may be sufficient as a stand-alone evaluation standard. MRI has also been used but is somewhat impractical (16).
8 Guidelines for Autologous Fat Transfer, Evaluation, and Interpretation of Results
The guidelines for selecting AFG over available commercial fillers are not easy to set. It is difficult to justify AFG for treatment of relatively shallow nasolabial and commissural folds which can be adequately corrected with less than 1 mL of HA, or other equivalent commercial filler. However for deeper folds, where 2–3 mL of temporary commercial fillers may be needed, or there is serious consideration of use of the more expensive and riskier long term or permanent fillers, AFG should be seriously considered: (a) As a cost-efficient alternative to temporary fillers. (b) As a complement to temporary fillers, combining and layering AFG with intradermal fillers. (c) As a possibly safer, though less predictable, alternative to permanent fillers. The planned use of AFG for larger volume correction in other areas of the face and body, and the availability of state of the art, approved (in states or countries that require it), fat tissue storage capabilities, further improves the economics of AFG selection over commercial fillers. 2. Volume correction of the aging face – larger volume, deeper placement of AFG. The realization of the importance of volume shifting and loss during the ageing process, and its effect on appearance has helped establish AFG as an important technique in modern aesthetic surgery. While commercial injectable fillers for deeper, larger volume augmentation are becoming increasingly available, they have yet to establish the level of safety, and cost effectiveness, that have made them so popular for treatment of superficial furrows. The use of AFG for re-establishing youthful facial contours, through volume restoration, became possible in good part due to the work of Coleman – the premier advocate for use of smaller injection cannulas/needles fitted to 1-mL syringes. Berman (17) should be credited for some pioneering work demonstrating the effectiveness of AFG placed in deeper facial planes to restore desirable contours. Coleman, Berman, and most other advocates of widespread use of fat grafts to increase the volume of the face (temporal forehead, brows, inferior orbital rims, malar areas, perioral areas including lips and chin, etc.), focused more on fat grafting technique, and placing the fat where it seemed to be both needed and accessible, be it supraperiosteal, sub- or perimuscular, or subcutaneous. In 1999 Amar (18, 19) presented a
49
very specific technique (FAMI – fat augmentation by muscle injection) for injecting small quantities of fat only along the facial muscle sheaths. While theoretically elegant, it is difficult to master, and has not gained widespread acceptance. Today, most experienced users of AFG for volume restoration place the fat in various planes – be it periosteal, perimuscular, or within existing deeper fat compartments – based on the perceived needs of the individual patient. Unfortunately, sound scientific studies examining not just differences in techniques, but even something as basic as average duration of results, are sorely lacking. It is clear though, both from the increasing popularity of AFG for contour improvement and volume restoration, confirmed by the author’s own experience, that AFG can yield excellent 6–12-month results, and in some patients, much longer-term results when judiciously placed in deeper planes. The alternatives to AFG for volume restoration include surgical repositioning of ptotic fat compartments, permanent, hard, cheek, chin, and extended jowl implants, larger particle HA’s, subperiosteal placement of hydroxyl-apatite, and poly-l-lactic acid, and BioAlkamid (a non-resorbable Alkyl-amide polymeric material that after injection quickly becomes encapsulated, not yet available in the US). Guidelines for selecting AFG over other alternatives can be only general, and to a great extent subject to physician and patient preferences. The risk profile for AFG compares favorably to surgery, and in terms of infection, it is equal to favorable when compared to hard implants. When compared to injectable fillers, AFG has a cost advantage, especially when larger volumes are needed to treat multiple areas. AFG also has a longevity advantage vs. temporary fillers, in that at least some patients treated with AFG maintain longer-term correction, and AFG has a somewhat lower safety profile compared to HAs and Ca hydroxyl-apatite, and equal to a better safety profile than products like Sculptra or Bio-Alkamid. HAs and hydroxyl-apatite are simpler to use and have less down time. Evaluation and interpretation of results of volume restoration with AFG are a little more difficult, given more reliance on subjective evaluations. Blinded examination of serial, standardized photographs is probably the only practical tool. Patient satisfaction surveys are exceedingly subjective. The combination with other procedures, frequent use of touch up injections, the difficulty of standardizing photographs
50
covering multiple cosmetic regions of the face, are additional obstacles. Imaging studies are available to examine thickness of fat layers and compartments. Both MRI and high resolution ultrasound can distinguish fat from surrounding tissues, but these methods have not proven very useful or practical for following the fate of the grafted fat or the longevity of results. The actual viability of grafted fat remains subject of some controversy, with some of the improvements also attributed to tissue fibrosis. Nevertheless, it is the general consensus that at least some of the grafted fat does survive. This is supported by a multitude of animal studies. In vitro and in vivo animal studies have demonstrated the fact that injected fat cells are viable, and as previously discussed, the percentage of viable fat cells leaving the injection needle can be dependent on the handling of the fat cells up to that point. 3. Volume correction of the ageing hands. Fournier (20), the tireless, initial truly world wide promoter of AFG, was already using fat on the dorsum of the hand, as early as 1984–1985, when the author first became well acquainted with him. Problems with ecchymoses, limited duration of results, and general, if somewhat unsubstantiated fear of potentially very serious infections, limited the popularity of this technique for many years. More recently the technique, which has been modernized to include better preparation of fat, smaller injection syringes and cannulas, and smaller volumes of fat injected, has gained some popularity. Butterwick (21) has been in good part responsible. Her work included scientific studies, examining results with both fresh and frozen/thawed stored fat, and attempted to objectively measure correction and longevity, with albeit somewhat crude, volumetric measurements. The recent usage of both polylactic acid (Sculptra) and hydroxyl-apatite (Radiesse) for the dorsum of the hand provides additional alternatives to AFG. Guidelines for selecting any of these methods over another are still premature, as comparative studies – hopefully side-by-side studies – are needed. Volumetric evaluation of results is possible, though technically not so easy to perform with the level of accuracy needed. Photographic documentation, and patient and blinded evaluator assessment particularly in bilateral comparative studies, or unilateral single filler agent studies, should be performed to determine both level of improvement and longevity.
S. Eremia
4. Correction of localized fat loss. Aggressive liposuction in the early 1980s, with cannulas as large as 8–10 mm, led to a multitude of iatrogenic irregularities and defects, and initial crude attempts were made to correct them by injecting some of the aspirated fat. Surprisingly some of the fat seemed to survive, and over time and with improved AFG techniques, many anecdotal reports of relatively successful treatment of iatrogenic, traumatic, and congenital fat defects have surfaced. AFG has not been very successful in the treatment of most acquired forms of fat atrophy, and has been particularly disappointing in HIV-related lipodystrophy. Given the relatively large volumes of filler needed for most of these cases, fat is a natural first choice – with the exception of HIV-related fat loss – where Sculptra has proven to be particularly effective and should be considered first. One interesting application of AFG is the correction of overly aggressive neck liposuction, which can leave unsightly platysmal muscle bands attached to the dermis that are highly visible. A variation of the FAMI technique is applicable in these cases, where tight adherence of the muscle fibers to the dermis makes it a bit difficult to inject the fat strictly in the subdermal plane. The subsequent addition of neurotoxin injections can yield even better results. Evaluation and interpretation of results for treatment of localized fat loss is relatively straight forward with quality photographs.
8.2 Conclusions Autologous fat has often been referred to as the almost ideal filler. Nevertheless, its use remains relatively limited compared to commercial fillers. It also appears that surgically trained and oriented cosmetic practitioners are far more likely to use fat, and often as a complement to other surgical procedures such as face–neck lifts and blepharoplasty. In sheer numbers, less surgically aggressive dermatologists, and now a wide array of nonsurgically trained “cosmetic practitioners” – not to mention nonphysician “extenders” such as physician assistants and nurse practitioners, and even simple registered nurses – inject the bulk of commercial fillers. Establishment of guidelines of use and criteria for evaluation and interpretation
8 Guidelines for Autologous Fat Transfer, Evaluation, and Interpretation of Results
of both short and longer term results can be very helpful. However, until scientific studies can demonstrate the effectiveness and superiority of AFG as a filler, that is not likely to change. Unfortunately the focus in recent AFG research seems to target the best methods to achieve the highest possible viability of fresh and even more so frozen fat. That is of course very important and those researchers should be commended for innovative methods and well-designed studies. But until well-designed studies demonstrate the effectiveness and safety of AFG, much in the way as it would be necessary to obtain FDA approval for a new filler, it is unlikely that AFG will gain the popularity and stature it likely deserves.
References 1. Kaufman MR, Bradley JP, Dickinson B, Heller JB, Wasson K, O’Hara C, Huang C, Gabbay J, Ghadjar K, Miller TA. Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results. Plast Reconstr Surg 2007;119(1):323–331. 2. Hanke CW. Fat transplantation: indications, techniques, results. Dermatol Surg 2000;26(12):1106. 3. Newman J, Ftaiha Z. The biographical history of fat transplant surgery. Am J Cosm Surg 1987;4:85. 4. Bucky LP, Perec I. The science of autologous fat grafting: views on current and future approaches to neoadipogenesis. Aesthetic Surg J 2008;28:313–321. 5. Gormley DE, Eremia S. Quantitative assessment of augmentation therapy. J Dermatol Surg Oncol 1990;16(12):1147–1151. 6. Eremia S, Newman N. Long-term follow-up after autologous fat grafting: analysis of results from 116 patients followed at least 12 months after receiving the last of a minimum of two treatments. Dermatol Surg 2000;26(12):1150–1158.
51
7. Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg 1997;24(2):347–367. 8. Coleman SR. Structural Fat Grafting. St. Louis, MO, Quality Medical Publishing, 2004. 9. Coleman SR. Structural fat grafts: the ideal filler? Clin Plast Surg 2001;28(1):111–119. 10. Ersek RA. Transplantation of purified autologous fat: a 3 year follow-up is disappointing. Plast Reconstr Surg 1991; 87(2):219–227. 11. Ersek RA, Chang P, Salisbury MA. Lipo layering of autologous fat: an improved technique with promising results. Plast Reconstr Surg 1998;101(3):820–826. 12. Shiffman MA, Mirrafatti S. Fat transfer techniques: the effect of harvest and transfer methods on adipocyte viability and review of the literature. Dermatol Surg 2001;27(9):819–826. 13. Smith P, Adams WP, Jr, Lipschitz AH, Chau B, Sorokin E, Rohrich RJ, Brown SA. Autologous human fat grafting: effect of harvesting and preparation techniques on adipocyte graft survival. Plast Reconstr Surg 2006;117:1836–1844. 14. Matsumoto D, Shigeura T, Sato K, Inoue K, Suga H, Kato H, Aoi N, Murase S, Gonda K, Yoshimura K. Influences of preservation at various temperatures on liposuction aspirates. Plast Reconstr Surg 2007;120(6):1510–1517. 15. Piasecki JH, Gutowski, KA, Lahvis GP, Moreno KI. Purified viable fat suspended in Matrigel improves volume longetivity. Aesthetic Surg J 2008;28:24–32. 16. Horl HW, Feller AM, Biemer E. Technique for liposuction fat reimplantation and long term evaluation by magnetic resonance imaging. Ann Plast Surg 1991;26(3):248–258. 17. Berman M. The aging face: a different perspective on pathology and treatment. Am J Cosm Surg 1998;15:167–172. 18. Amar RE. Adipocyte microinfiltration in the face or tissue reconstruction with fat tissue graft. Ann Chir Plast Esthet 1999;44(6):593–608 (French). 19. Butterwick KJ. Fat autograft muscle injection (FAMI): new technique for facial volume. Dermatol Surg 2005;31(11 Pt 2): 1487–1495. 20. Fournier PF. Fat grafting: my technique. Dermatol Surg 2000;26(12):1117–1128. 21. Butterwick KJ. Lipoaugmentation for the aging hands: a comparison of the longevity and aesthetic results of centrifuged vs. non-centrifuged fat. Dermatol Surg 2002;28(11):1184–1187.
9
Face Rejuvenation with Rice Grain-Size Fat Implants1 Giorgio Fischer
The Plastic Surgeon is undoubtedly the greatest of all contemporary artists. He paints on living canvas and sculpts in human flesh. C.H. Willi
9.1 Introduction Augmentation and restoration of different parts of the body has been the cosmetic surgeons’ primary goal for centuries. Various alloplastic, allogenic, and xenograft materials have been used with this intent. The perfect filler has not been invented yet, but I believe that fat is the best material we can use. No allergic reaction has ever been reported in literature with the use of autologous fat. Facial enhancement for young women or rejuvenation for elder women with rice grain-size fat parcels is, according to me, one of the greatest inventions of the century. Along with the aging process comes the loss of fat which consequently affects the texture of the face skin itself. It is only by cosmetic surgery that we are able to give back vitality and new skin texture to an elderly looking face.
9.2 History After the invention of liposuction together with my father, Arpad, in 1974, I was confronted with the problem of having to correct depressed areas where too
Reprinted with permission of Lippincott Williams and Wilkins.
1
G. Fischer Via della Camiluccia, 643, 00135 Rome, Italy e-mail:
[email protected]
much fat had been taken out. The corrections were made by filling the depressions with adipose tissue taken through a cannula from the patient. The areas were frequently overfilled. More than 50% of the graft was lost. For many years I did not realize the mistake I was making. Today the technique I use differs very much from these first attempts. It is only about 12 years ago that my interest in facial rejuvenation with the use of autologous fat was rekindled. Fournier and I were in London and we came across a book that changed my career. The book was entitled THE FACE and its improvement by aesthetic plastic surgery and was written by Charles H. Willi in 1926 (Fig. 9.3). Over 90 years ago Willi described the use of autologous fat delivered with a syringe for the correction of face lines and the loss of tissue. This technique employed by Willi represents the method that is most similar to our current approach (Fig. 9.1). Around 1985 the author had begun to augment the zygomatic and malar regions with autologous fat and to fill deep nasolabial folds. At that time overfilling the areas was to compensate early graft loss. As a result, more than 50% of the graft was lost. By 1992, with better understanding of grafting tech niques and physiology of adipose tissue, the author began to harvest adipose tissue with small syringes and a sharp needle and the processing technique was abandoned. Since less fat was transferred, there was a great increase in long-term survival and a decrease in early graft loss. The larger the graft, the less chances it has to survive and this is because the implants survive by imbibitions. If the graft is too large, the central part of it goes towards a phenomenon of necrosis. In 1997 the author developed a technique that consisted in the transfer of rice grain-sized fat parcels for total facial rejuvenation. The technique focuses on
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_9, © Springer-Verlag Berlin Heidelberg 2010
53
54
G. Fischer
a
c
d
b
e1
e2
Fig. 9.1 (a) Willi’s cover book. His book has never been cited in any plastic surgeon’s work. (b) Willi’s portrait. (c) Dr. Willi correcting facial lines and loss of tissue. (d) Dr. Willi transferring
fat to face. (e) Dr. Willi’s results with peeling and restoration of fat implantation around the mouth (e1) before; (e2) after
multiple transfers to the subdermal, intradermal, muscular, and fat layers using a microcannula to deposit tiny parcels of adipose tissue. The size of the graft is fundamental to ensure early and reliable neovascularization. This is why any implant whose size
is bigger than that of a rice grain, has less possibility of survival. Different authors describe different techniques of procedure in regard to instrumentation, harvesting processes, processing, and transfer techniques. Data of
9 Face Rejuvenation with Rice Grain-Size Fat Implants
a
b
55
survival rates are inconsistent. The author has observed an 80–90% chance of survival with rice grain-size implant if the face is not overfilled. The procedure has to be repeated at least two times. The procedure is ideal for relatively young patients or older patients associated with other procedures. The implants stimulate new-vessel formation and give the skin an improved color, consistency, and texture. The next step in the evolution of this grafting technique focuses on the lines of gravity and other factors that determine the vector of placement of fat parcels. Fat is placed in an oblique manner, perpendicular to the nasolabial, marionette, orbicularis, and crow-feet folds; previously we used to work parallel to these folds. The great innovation of this technique is the fact that we are now working perpendicular to them. Inserting the grafts in this way strength lines are created that contrast these same folds. Fat is deposited from the chin to the forehead in a herringbone manner; the head of the herringbone at the chin and the tail towards the forehead (Fig. 9.2). Much still has to be learned and proved in this technique but I believe this will be our future.
9.3 Preoperative Evaluation
c
As in any other cosmetic procedure, preoperative evaluation is very important both for the surgeon and for the patient. It is only by observing the patient in his/her normal attitudes that we are able to note the harmonies or disharmonies of a face. We must also try to understand what type of objective the patient wants to achieve. The patient must be informed that she will need at least another procedure, in 3 months’ time. The patient must also be informed that smoking is forbidden in the month prior and following the procedure. Initial consultation is important also because filling might represent only an adjunct procedure. Donor sites must be recognized and marked. Pictures are taken.
9.4 Harvesting Fig. 9.2. Entry site at the angle of the mouth allows transfer of fat. (a) Cheek. (b) Posterior zygomatic area. (c) Anterior zygomatic area
All harvesting procedures are performed using intravenous sedation and modified tumescent anesthesia for harvest. The donor site is selected based on the
56
availability of fat. Preferred areas are the flanks, the lower abdomen, the medial part of the thighs and knees, with the middle plane of fat being harvested from these anatomical sites. The donor site is prepared and draped in the usual sterile fashion as for liposuction. Modified tumescent technique is used for infiltration: lactated Ringer’s solution, xylocaine 10% and adrenaline. Approximately 25% of the normal amount usually administered for liposculpture is used. This quantity allows a more concentrated aspirate. An 18G needle attached to a 1 ml Luer Lock syringe is used. The 1 ml syringe is optimal since a larger one would end up in having too much strength in aspirating fat; what we want instead is lobulated rice grain-sized fat. The cannula used to transfer the fat is attached to the same syringe. The cannula is 1.6 mm wide. This avoids manipulation of fat and contamination of it with air, decreasing the rate of graft death. The harvest needle is directed in a spoke wheel fashion in order to prevent depressions of the skin overlying the donor site. Harvesting should be carried out in a slow and constant manner. It should be a constant and delicate movement. Excessive pressure on the donor site will end up in too much oil in the graft as a result of the rupture of the adipose cells. The syringe is then placed on the server in an upright position.
9.5 Fat Processing Fat can be processed in three ways. It can be centrifuged. Centrifuging will allow the graft to be isolated and separated quickly. The author believes it has a high risk of damaging the fat cells. The fat can also be washed with saline solution. The less we manipulate the fat, the less we risk damaging it. This is why the aspirate is allowed to settle for 5–6 min into two distinct layers. The bottom and more dense layer contains xylocaine and lacated Ringer’s solution, and the top layer will contain only viable fat cells. If the fat is harvested in the correct way, the two layers will not be present and only fat will be present in the syringe. The graft is not manipulated or touched in any way.
G. Fischer
9.6 Fat Transfer Face rejuvenation with my technique should be a sculpture, a contouring of the anatomical variations that can be present in every patient. The face should be studied in each aesthetic unit; not even an inch should remain unstudied. As already mentioned, transfer cannula is attached to the Luer Lock syringe. The entry site for the cannula is anesthetized and a small stab incision is made with a number 11 blade. The entrance incisions are placed on the margin of the hairline in the temple, at the angle of the mouth and under the chin (Fig. 9.2). From these entry sites we are able to transfer fat throughout the entire face. The fat parcels are transferred in a herringbone manner and the microcannula moves in a fanwise direction following the lines of the herringbone. The fat is deposited slowly and the fat lobules are transferred on insertion and withdrawal of the cannula. The cannulas are 1.6 mm wide and 10–13 cm long. The tip of the cannula is blunt, flattened and resembles a duck’s beak. They can be straightened or curved based on the different necessities of the anatomical region. Total face rejuvenation with rice grainsized fat parcels placed in a herringbone manner is able to give thickness to those areas of the face that have defatted with time. I do not use more than seven or eight syringes of fat for each side of the face, and this means that no more than 14 or 16 ml of fat are used for the entire face. Anything more than this will not survive. Only in this way will lobules of fat have the maximum capacity of receiving blood and rapid neovascularization occur. The face can be divided into a third superior, a third medial and a third inferior part. Each of these parts contains critical key points in which fat has to be placed. For what concerns the superior part of the face, the frontal and temporal areas are very important. The slight ptosis of the eyebrows that occurs with time is due to increased skin laxity and loss of fatty layer overlying the galea. Deposits of fat over the forehead will give a lifting effect of the eyebrows. The fat deposits on the forehead act against the force of gravity lifting the forehead and brow in an upward direction. Fat should not de deposited at more than 2 cm distance
9 Face Rejuvenation with Rice Grain-Size Fat Implants
from the superior margin of the eyebrow; otherwise a ptosis of the brow might occur. The eyebrow lift should be finished with filling of the eyeshadows under the eyes. These are a frequent sign of aging but it is often seen in young patients as well. Eye shadows are caused by the orbicularis oculi muscle that shines through the delicate transluscent infraorbital skin. This can be corrected by infiltrating a couple of cc of fat. Fat inserted in this area must be massaged by the patient. The implants must be carried out in a very delicate way. Single deposits are needed otherwise lumps might be visible after the operation. The temporal area is another important key point that should not be forgotten. Frequently with age, this area loses the normal quantity of fat present. The absence of fat here gives the patient a “skeleton look.” The roundness of this area is one of the criteria for a young looking face. Fat transfer in this area is however only for expert surgeons. This is a very delicate area where superficial vessels are very well represented. For what concerns the third inferior of the face, an important area is certainly the nasolabial fold. Today I do not place the grafts in the same way I did in the past. Fat is always deposited perpendicular to the fold. Attention should be paid to the triangle placed under the ala of the nose. This triangle has its apex facing the chin. If this triangle is filled the immediate effect will be that of the disappearing of the nasolabial fold. The perioral area can be thickened with this technique.
57
Insertion of grafts in the chin and along the whole mandibular region enhances and rejuvenates the whole face.
9.7 Postoperative Care No sutures are needed on the temporal and perioral areas. Reston foam is applied on the donor site. Patients remove Reston foam after 2 days. After a further 7 days they come for a first check, and then after 3 months. Pictures are taken on both occasions. After 3 months, the restored area is evaluated further and additional augmentation is performed.
9.8 Discussion Face rejuvenation with rice grain-size fat implants is a versatile procedure. If carried out in the correct manner it has an effective and long-lasting result. The technique avoids excessive and unnecessary manipulation of the graft. Processing of fat is eliminated. Recon touring using autologous rice grain-size fat parcels involves precise layering of the graft in order to ensure a natural result. Overfilling of the face should be avoided.
Fat Transfer in the Asian
10
Samuel M. Lam
10.1 Introduction Rejuvenation of the aging Asian face mandates a unique set of strategies that differs from that of the Occidental face. However, certain commonalities stretch across racial divides. Fat transfer has become the cornerstone for facial rejuvenation in all races and genders for almost all age groups, as volume loss is a principal sign of aging in all categories. Although the principles of fat transfer are universal, the use of fat grafting specifically to modify and enhance an Asian face will be highlighted in this chapter.
10.2 Cultural Issues Although facial enhancement in its broadest sense may be the main objective for the Asian patient seeking facial plastic surgery, at times there may be a layered agenda that combines elements of cultural biases and folkloric beliefs. For instance, some Asians seek dimple fabrication solely for the inspired belief that a dimple will impart greater fertility or prospect for marriage. Similarly, augmentation rhinoplasty may be undertaken for cosmetic improvement or alternatively may be thought to increase the likelihood of one’s future wealth or add to one’s perceived wisdom. Reductive otoplasty may be less common in the Far East as well since large ears can also be favorable signs of wealth and wisdom. While freckles
S. M. Lam Willow Bend Wellness Center, Lam Facial Plastic Surgery Center & Hair Restoration Institute, 6101 Chapel Hill Boulevard, Suite 101, Plano, TX 75093, USA e-mail:
[email protected]
can be thought of as an adorable attribute in some whites, any blemish on untrammeled porcelain skin can be considered both unaesthetic and a marker of moral transgressions. Fortunately, because of this fact and the fear of looking tanned (which is considered unaesthetic), many Asians loathe the sun and protect themselves from the effects of photoaging. In addition, the Asian skin quality is already relatively impervious to photodamage compared with the Caucasian counterpart. Interestingly, these cultural biases that dominate behavior and attitudes in individuals who reside in the Far East can be transmitted even a few generations down to immigrated Asians who have lived in the West for all of their lives. Asians also tend to be much more secretive about cosmetic surgery, as compared with current climate in the West of a gradually relaxing attitude toward plastic surgery. Although HIPAA (Health Insurance Portability and Accountability Act) rules apply universally, the surgeon should be even more circumspect when speaking with family members regarding an Asian patient’s care. Because culturally plastic surgery is not as universally accepted in Asian communities, negative remarks by family members or friends who suspect or know that someone underwent cosmetic enhancement can have devastating psychological ramifications that can then in turn be transferred to the surgeon. Another consideration is the convergence today of standards of beauty. The high arched crease and sculpted eyelid that looks particularly artificial in the Asian patient and was the hallmark of “Westernization” procedures in the 1980s has slowly been replaced with watchful words like “ethnic preservation” and “cultural identity.” Interestingly, the high arched crease and sculpted eyelid that follows browlift and upper blepharoplasty in the aging Caucasian face have also become increasingly suspect in its capacity to rejuvenate and not make an individual’s identity appear unfavorably
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_10, © Springer-Verlag Berlin Heidelberg 2010
59
60
altered. The lower crease height and fuller eyelid contour can be thought of as more universal aspects of beauty that transcend race. The details of the strategy to achieve this aesthetic will be outlined in the following section on Asian eyelid rejuvenation. Despite this trend toward ethnic preservation, many Asians who wed Caucasians tend to desire softening their ethnic features with more aggressive changes to resemble their spouse more closely. Interestingly, many Caucasians are specifically attracted to these Asian or ethnic features in the first place and offer some resistance to that change. Delving into these cultural and psychological issues is paramount when consulting a prospective Asian patient. Certain ethnic differences also prevail between the major Asian races. For instance, Koreans and Vietnamese are in general more predisposed toward cosmetic en hancement and will spend disposable income toward that end. Until recently, Chinese were not very inclined toward spending money on plastic surgery with the exception of the rising demand in modern day China, where it was outlawed until 1979. Asians who have always resided in the West or have lived there since they were very young tend to either adopt Western perceptions or carry the cultural attitudes of their parents, or be somewhere in between these two polar positions. Whatever the case, the surgeon should explore (or at least be aware of) these cultural and psychological beliefs that can inform Asians’ motivation to undergo facial cosmetic enhancement.
10.3 Strategies for the Aging Asian Eyelid The aging Asian eyelid poses unique technical and aesthetic challenges for the Occidental surgeon unfamiliar with anatomy, surgical techniques, and prevailing psychological attitudes. The three major surgical techniques that are important for ideal eyelid rejuvenation in the Asian patient include fat transfer to the brow/ upper eyelid, standard upper blepharoplasty, and supratarsal crease formation or “double eyelid” surgery. When to use which procedure will be the focus of this section. Technical details regarding each operative method lie beyond the scope of this chapter. The key objective besides eyelid rejuvenation in the Asian patient is preservation of supratarsal crease height so
S. M. Lam
a
b
Fig. 10.1 (a) Preoperative Korean patient born with an upper eyelid crease that would have looked worse if raised through traditional blepharoplasty and browlift procedure. (b) Postoperative following periorbital fat transfer to the brow, upper eyelid, and lower eyelid that has maintained if not slightly decreased her eyelid crease height
that results appear natural. In order to understand how to approach the aging Asian eyelid safely, we need to categorize the types of Asian eyelids into the three subgroups: aging Asian eyelids with a natural supratarsal crease, aging Asian eyelids without a supratarsal crease, and aging Asian eyelids with a previously surgically fabricated crease (Fig 10.1–10.3).
10.4 Aging Asian Eyelids with a Natural Supratarsal Crease Perhaps this situation appears rather straightforward. All the surgeon need undertake is a standard upper blepharoplasty and/or browlift and the patient is properly rejuvenated. Unfortunately, a standard blepharoplasty and browlift both serve to elevate the natural crease height oftentimes to an unnatural level. The author believes in the same way that this high-arched crease looks fundamentally unyouthful in a Caucasian and can unfavorably alter a Western individual’s eyelid. However, in the Asian this high crease can in addition look simply unnatural. Accordingly, if the crease height is slightly above the ciliary margin, fat transfer alone is
10 Fat Transfer in the Asian Fig. 10.2 (a) Preoperative Chinese patient with multiple incomplete partial creases that the present text states should be treated as if she has no crease at all. In addition, she has a relatively negative vector eye shape. (b) Postoperative after full facial fat transfer
61
a
a
Fig. 10.3 (a) Preoperative Chinese patient with a more prominent steatoblepharon and a relatively high crease height due to fat involution. She also has a wide, heavy lower face. She would have had a terrible result with any kind of browlift and/or skin removal from the upper eyelid. (b) Postoperative following concurrent transconjunctival blepharoplasty and full facial fat
b
b
transfer including to the inferior orbital rim, brow, and upper eyelid region. By filling fat into the periorbital region, anterior cheek, and anterior chin, the face can ultimately look more dimensional (less flat) and less wide. She also underwent a corset platysmaplasty to improve her neck contour
62
used to perform upper eyelid and brow rejuvenation by restoring the lost convexity of youth and also thereby preserving crease height. In the individual with eyelid crease that rests at or below the ciliary margin, conservative removal of skin alone plus fat transfer can yield the optimal results without altering crease height.
10.5 Aging Asian Eyelids Without a Supratarsal Crease Asian eyelids that have a weak, impartial, or absent supratarsal crease can pose a difficult challenge to the Western surgeon unfamiliar with how to create a supratarsal crease, i.e., perform a “double eyelid” surgery. However, it is not entirely necessary to learn this technique but what is important is performing safe surgery in these kinds of patients. For example, the temptation in an aging Asian eyelid without a discernible crease is to arbitrarily remove skin at a predetermined height. The problem with this maneuver is twofold: a scar can occur that remains visible in the area of skin removal (since there will be no crease to hide it in) and/or the patient who has a naturally narrow palpebral fissure already (that is associated with a monolid appearance) will see little to no improvement in how tired his or her eyes look after simple skin removal. What is worse is if the surgeon interprets the fullness of the eyelid as requiring reduction and decides to remove postseptal fat, an unpredictable scar can develop between the preand postseptal tissues to create an eyelid crease when one was not intended. This eyelid crease can also be variable in its extent making the appearance even worse since it is only a partial crease. It is fundamentally important in an Asian patient without a crease not to simply cut away skin or fat. Accordingly, there are three options for eyelid rejuvenation in individuals without a crease: fat transfer alone to the upper eyelid/brow complex, “double eyelid” crease surgery, or a combination of both. With the absence of a crease, fat transfer can transform what appears to be hanging skin into a more youthful convexity without risking any change in identity that can follow “double eyelid” surgery or arbitrary skin/fat removal with a standard blepharoplasty. In the individual who truly believes that he or she always looked sleepy even in youth, then a “double eyelid” surgery
S. M. Lam
may be required for optimal result. However, creating a supratarsal crease requires special skill on the part of the surgeon, and also eyelid crease creation will fundamentally change the nature of the eyelid in that individual. As one ages, one’s self-image becomes more static in nature, especially in men. Therefore, creating a supratarsal crease at this later age must be carefully weighed with the patient. Furthermore, although the objective for a patient should be to have a very low crease following Asian “double eyelid” surgery that appears natural, the eyelid edema particularly below the crease itself can make the eyelid crease appear unnaturally high and full for an unacceptably long time for the aging Asian patient. It can at times take a full year before a crease height achieves an entirely natural height. For these reasons, it is very important that the surgeon counsel the aging Asian patient considering “double eyelid” surgery later in life who wants to undergo that procedure primarily for purposes of eyelid rejuvenation. The third option mentioned is performing both supratarsal crease formation blepharoplasty and fat transfer for optimal eyelid rejuvenation in those who would benefit from such combined intervention and who would desire to proceed accordingly. In this circumstance, it is important for the patient to undergo the “double eyelid” procedure first since edema from fat transfer can make the ability to read symmetry virtually impossible, which is critical during “double eyelid” surgery. The patient should also be awake enough toward the end of the procedure to open and close his or her eyes to gauge the accuracy of symmetry. Fat transfer can safely proceed after symmetry has been confirmed and the “double eyelid” surgery is completed. One further nuance should be elaborated upon. At times, some Asians appear either to have a very slight crease or a slight crease only on one side. In these circumstances, they should be treated as individuals who have no crease at all.
10.6 Aging Asian Eyelids with a Man-Made Crease The final category of the aging Asian eyelid that merits separate attention is the aging Asian eyelid that has had a previous surgical crease created. If the crease was made
10 Fat Transfer in the Asian
in the past decade or so and undertaken in a conservative fashion, then the patient can be treated like an individual who naturally has a supratarsal crease. However, if the crease is originally “Westernized,” that is, overly sculpted and excised with the objective of a high crease, a different strategy must be enlisted. There are two ways to discern whether this is the case. First, simply looking at the individual will present to the surgeon the appearance of something unmistakably artificial looking to the upper eyelid despite the fact that the crease height is low. The reason for this fact is that the patient most likely underwent an aggressive “Westernization” procedure many years ago and with ongoing brow deflation, the crease height has fallen to a “natural” level but the thick brow skin now overhangs the eyelid skin and creates an unnatural look. Second, the way to confirm this fact is to lift the eyelid skin upward and see how high the original crease was. Generally, the crease was most likely made excessively high like 20 mm or beyond above the ciliary margin. Looking at an individual’s old photographs or asking him or her whether the previous eyelid height was very high can also be helpful. A standard upper blepharoplasty and/or browlift can unmask the unnaturally high crease height of the previous surgery unwittingly. Accordingly, about the only safe and reasonable approach in this individual is fat transfer to create convexity to the deflated eyelid contour without risking unmasking the unnatural crease height from before and thereby exacerbating the situation.
10.7 Strategies for the Aging Asian Face As far as rejuvenation of the aging Asian face, fat transfer can be the cornerstone to a successful outcome for several reasons. First, Asians have a predilection for hypertrophic scarring and hyperpigmentation, so a procedure that in essence removes these risks can be very attractive. Further, many Asians do not suffer from neck problems until an advanced age so a rhytidectomy may not be necessary comparative to the fairer-skinned races. Also, the weaker bone structure and thicker soft-tissue envelope predispose toward a poorer result when it comes to a lower rhytidectomy. The major drawback that can be foreseen in the Asian patient is why fat
63
transfer looks good in the Asian patient who naturally may have more fat and soft-tissue already vis-à-vis their less angular bone structure. This question will be answered by understanding how to shape an Asian face with fat transfer to offset these problems. Most Asian faces appear to be wider and flatter than most Caucasian faces. Accordingly, fat transfer into the buccal region and lower lateral face like lateral mandible may serve to exacerbate the heavy quality of an Asian face rather than improve it. Instead, placement of fat along the prejowl sulcus, anterior chin, and anterior cheek can offset the heavy, wide, and flat qualities of the face in order to create a more artistically balanced face without radically altering identity. In addition, the relative premaxillary and lower chin deficiency that creates a simian appearance can also be balanced by focusing fat transfer to these specific deficient regions. The surgeon should be cautious when deciding to augment the outer malar region, i.e., the area that corresponds with the malar bony eminence, for two reasons. Many Koreans in particular have a very flared outer cheek region that they perceive as unattractive (for which many undergo malar bony reductions). Further, a wider flatter appearance to the face can be worsened by placing fat in the lateral face. For these reasons, in most cases the anterior cheek should be emphasized. In some Asians, the entire cheek complex appears excessively prominent. In this situation, some placement of fat into the buccal region can soften the appearance of the prominent cheek and there by improve overall facial proportion and balance. With all fat grafting endeavors, a level of artistry should be exercised to create a beautiful and balanced result.
10.8 Conclusions Fat transfer is an important method for facial reju venation in almost all races, gender, and age groups. However, specific application of this technique to the Asian face requires a combination of cultural sensitivity and expressed artistry. Understanding the Asian face and its problems may provide some thoughtful guidelines for the Western surgeon unaccustomed to dealing with the Asian patient except on rare or infrequent occasions.
64
References 1. Lam SM, Glasgold MJ, Glasgold RA. Complementary fat grafting. Lippincott Williams & Wilkins, Philadelphia, PA, 2006. 2. McCurdy JA, Jr, Lam SM. Cosmetic surgery of the Asian face (2nd edition). Thieme Medical Publishers, New York, NY, 2005.
S. M. Lam 3. Lam SM. Aesthetic facial surgery for the Asian male. Facial Plastic Surgery 2005;21:317–323. 4. Lam SM. Aesthetic strategies for the aging Asian face. Facial Plastic Clinics of North America 2007;15(3):283–291. 5. Shirakabe Y, Suzuki Y, Lam SM. A new paradigm for the aging Asian face. Aesthetic Plastic Surgery 2003;27:397–402. 6. Shu T, Lam SM. Liposuction and lipotransfer for facial rejuvenation in the Asian patient. International Journal of Cosmetic Surgery and Aesthetic Dermatology 2003;5:165–173.
11
Subcison with Fat Transfer Melvin A. Shiffman
11.1 Introduction
Fig. 11.1 Toledo “pickle fork”
Scars are often tethered because of scarring to the tissues beneath the skin, usually fascia. This may cause a depression that is unsightly. Simply filling the depression with autologous fat or other permanent filler may not raise the skin permanently off the deep scar attachment. At the same time, only subcising will result in reattachment of the skin to the underlying scar. There is a need to subcise and add a filler underneath the region of detachment in order to prevent reattachment. Autologous fat is simple to obtain, inexpensive, and can be permanent.
11.2 Subcision The Toledo “pickle fork” (Fig. 11.1) comes in a variety of sizes and can be used to cut through subcutaneous scar, freeing up the overlying skin. To use the instrument, however, a small skin incision must be made depending on the width of the fork. Coleman devised a small pickle fork at the end of a hollow cannula with an opening just before the fork. This allows the injection of fat immediately after the subcision. The cannula can be used for subcision of the nasolabial fold, marionette lines, and glabellar lines at the time of fat injection. After subcising, the area should be compressed for at least 6 min to prevent bleeding. Blood is the enemy of fat grafting as fat cells can be reabsorbed by blood cells. Sulamanidze et al. (1) devised an instrument for subcision that is comprised of a wire attached to a
Fig. 11.2 Sulamanidze wire
M. A. Shiffman Department of Surgery, Tustin Hospital and Medical Center, 17501 Chatham Drive, Tustin, CA 92780-2302, USA e-mail:
[email protected]
straight needle (Fig. 11.2). Originally the technique was to start on one side of the lesion inserting a needle and then sequentially bringing the needle out of the skin and reinserting in the same hole to proceed to the
Wire
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_11, © Springer-Verlag Berlin Heidelberg 2010
Needle
65
66
M. A. Shiffman
that could not be straightened out. This required cutting the wire at the point of the bend if there was enough intact wire left to complete the procedure or using a new needle and wire. A much simpler method was suggested by Fulton (2) that consisted of using 3-0 or 4-0 Vicryl either attached to the curved needle for small areas of depression or threaded into a Keith needle (Fig. 11.5). The needle is inserted through the skin a centimeter or more away from the depression and pushed through the subcutaneous tissue around one side of the depression. The needle is brought out through the skin on the opposite side of the depression and then turned around and inserted into the exit hole passing through the subcutaneous tissues on the opposite side of the depression from the original insertion. The needle is brought out through the initial skin puncture (Fig. 11.6). Vicryl
a Defect (wrinkles)
Needle Wire
b
Fig. 11.3 Initial technique with use of the wire. (a) Incomplete rectangle. (b) Danger of cutting through the skin when using a sawing motion to cut the scar Wire
Needle
Wrinkle
Fig. 11.5 Vicryl on curved or Keith needle
Fig. 11.4 Final technique with wire is to complete the oval and come out the original puncture site
next point forming an incomplete rectangle (Fig. 11.3). The needle was brought out at a point that was away from the original insertion site. This required care not to cut the skin when pulling the wire back and forth to cut the subcutaneous scar (Fig. 11.3). Ultimately the technique was changed to bring the wire out at the original point of entry and this would prevent cutting of the skin (Fig. 11.4). The major problem was keeping the wire from twisting and forming a bend in the wire
Fig. 11.6 Oval fashion of placing the Vicryl thread ending at the original insertion point
11 Subcison with Fat Transfer
67
has a roughened surface that will cut through scar by using a back and forth motion.
11.3 Autologous Fat Injection The autologous fat can be obtained from the lower abdomen, lateral hips and thighs, or medial knees. The instrument used to harvest the fat is a blunt tipped 2.5-mm cannula for fat to be inserted in the body or 2.0-mm cannula for insertion of fat into the face or neck. The harvested fat is washed with normal saline and excess fluid decanted. Pure fat appears yellow and should not contain any blood products. About twice as much fat as determined for use should be removed and left-over fat frozen for future correction of any residual deficit.
Fat is injected with a 2.5 or 2.0-mm cannula through the original needle openings in each side of the depression. This is not only injected in tunnels into the level of the subcision area but can also be injected into tunnels at other levels of the tissues. Usually it is necessary to overinject about 10% since some fat is lost by absorption.
11.4 Conclusions Depressed scarred areas can be relieved with subcision and insertion of fat as a permanent filler. The total combined subcision and fat transfer technique is easy to learn and the results are satisfying to the patient and the surgeon (Fig. 11.7).
a
b
c
d
e
f
Fig. 11.7 Subcision and fat transfer to depressed scar of neck. (a) Indented scar in the right neck following infection as a child. (b) Marking area for subcision and fat transfer (c) Local anesthesia being injected. (d) Subcision can be performed with an 18-gauge needle. (e) The needle is swept side to side in the subcutaneous tissues under the depressed skin. (f) A Keith needle with 3–0 Vicryl. (g) The needle is inserted subcutaneously and passed along one side of the depression. (h) The needle is brought
out at the opposite end of the area of depression. (i) The suture has been passed around both sides of the depression and brought out of the original entry site. (j) The suture ends are held with slight tension and then with a sawing motion they will cut through the scar and come out at the entry site. (k) Washed fat for transfer. (l) Fat injected into depressed area with a small cannula. (m) Final result with the scar subcised and the depression filled
68
g
M. A. Shiffman
i
k
l
h j m
Fig. 11.7 (continued)
References 1. Sulamanidze, M.A., Shiffman, M.A., Sulamanidze, G.M. Management of Facial Rhytids by Subcutaneous Soft Tissue Dissection. Int J Cosmet Surg Aesthetic Dermatol 2000; 2(4):255. 2. Fulton, J. Personal communication 2005.
Autologous Fat Transplantation for Acne Scars
12
Bernard I. Raskin
12.1 Introduction There exist a bewildering array of injectable fillers which include short and longer duration products, as well as the recent introduction of permanent implantable agents. Lipofilling of acne scars is less frequently considered than other agents such as hyaluronic acids, and in particular subsets of acne scars autologous fat may be the optimal choice (1). Typically acne scars require more than one treatment modality, such as lasers and lipofilling injections (2). Frequently several autologous fat injection sessions are needed. As with many scar revision procedures, results are commonly imperfect and may conflict with patient expectations. Acne scars are complicated problems because the surgeon is dealing with scar tissue, three-dimensional contours affected by light and shadow and the often associated problem of dispigmented skin.
12.2 Volumizers and Fillers Injected contouring agents can be characterized primarily as volumizers, fillers, or both. Volumizers, such as Sculptra®, are introduced to enhance substantial defects of cheek hollows in fat-depleted HIV patients. Hyaluronic acids (Restylane®, Juvederm®, and others) are primarily considered fillers, and are effective for nasolabial folds; other similar deep rhytids are also often beneficial for superficial creases. Radiesse® is an example of a combination volumizer-filler but with its own limitation in
superficial product placement. Autologous fat performs well as both volumizer and filler with relatively few problems. Thus surgeons have excellent choices for injectable agents for correction of gravity-related aging, volume loss, rhytides, and superficial creases. Both volumizers and fillers are important in acne scar rejuvenation. Autologous fat transfer has enjoyed a renaissance in the last several years. As with other surgical approaches, renewed interest has evolved from refined techniques, enhanced instruments, and knowledge gleaned by new research (3, 4). Understanding fat physiology, stem cells and metabolism has benefited an appreciation of the longevity that is possible with fat transfer (5). Micro droplet injection methods and the concept of multiple injection sessions allow more effective contouring of both deeper and superficial defects (6). In particular, the micro droplet approach offers the surgeon an opportunity to address superficial skin problems such as acne scars and relatively shallow rhytids. The use of frozen fat facilitates small repeat injection sessions as may be necessary in acne scar treatment (7). Significant and substantial improvement in many aspects of the aging face is achieved with injectable agents for volumizing and filling. Various products result in satisfied patients and the choices depend on the surgeon’s preference, the patient’s desires, and the cost. A high degree of predictability exists. The various filling and volumizing agents such as fat may help avoid more extensive surgical procedures previously necessary for aging skin.
12.3 Treating Scar Tissue B. I. Raskin Department of Medicine, Division of Dermatology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA e-mail:
[email protected]
Acne scars represent an entirely different, highly challenging frustrating clinical problem. In essence, the issue involves surface and subsurface scar tissue rather
M. A. Shiffman (Ed.), Autologous Fat Transfer DOI: 10.1007/978-3-642-00473-5_12, © Springer-Verlag Berlin Heidelberg 2010
69
70
than normal anatomy. This is further complicated by the three-dimensional face on which light and shadow interact such that shallow and relatively minimal scars may at times appear harsh and objectionable. The scar surface often has overlying dispigmented skin so that the improvement in the scar after treatment may appear clinically suboptimal because of residual color anomalies. However, the same concepts of volumizing and filling apply as with other cosmetic defects. The difference with acne scars is that multiple therapeutic modalities are generally necessary to effect overall improvement, such as laser resurfacing and/or surgical excision. Filling injections into acne scars is but one of several types of treatments that might be required, and filling is not necessarily the most appropriate choice for all depressed scars. Scars may need filling, but underlying volumization may need to be addressed to achieve maximum improvement. Independent of the area of scars, other treatments may be necessary for the remainder of the face as part of the comprehensive improvement needed. Even with multiple modalities available, substantial predictability of results may be ambiguous at best and the number of treatments required is highly variable. Many acne scar patients are among the most highly motivated cosmetic patients seeking assistance with an understanding and appreciation of treatment imperfections. Others require substantial counseling and education. The author advises patients to expect overall a 50% improvement in acne scars - certainly expected results may be better but may also be less. Patient satisfaction is variable and may be less than the actual improvement since patients often anticipate more than realistically possible.
12.4 Physiology of Acne Scars Acne is a disease of the perifollicular sebaceous glands (8). In many individuals this results in the well known whiteheads and blackheads that are essentially dried sebum within the glandular orifice. This type of acne is non inflammatory and does not result in scars. However a bacterial infection within the obstructed orifice results in an inflammatory reaction. This reaction may be minimal causing small elevated acne lesions called papules. A substantial inflammation may develop causing large cysts and deeper nodules. All inflammatory lesions may scar, but whether a scar occurs is highly
B. I. Raskin
variable and appears to depend on ethnicity, sebaceous skin quality, genetic tendency to scar, and unknown factors. The scars that develop may be superficial or deeper in the skin. The scars may be depressed, or hypertrophic and keloidal. The face usually develops depressed scars but the torso regions not uncommonly have elevated scarring, especially in individuals with darker complexion. Depressed scars are of variable morphology and thus treatments depend on the nature of the scar. Determining the approach to any given acne scar, or area of acne scarring depends on multiple variables including patient age, health status, scar location, skin color, and tendency for discoloration. Additionally the characteristics of the individual scar or area of scarring is important, such as whether the scars are ice pick type with significant adjacent cicatrix, or softer superficial scars. Individuals often have several types of depressed scars.
12.5 Evaluating Acne Scars The surgeon needs to first analyze the background skin type. Fitzpatrick color should be established (Type 1 lightest to Type 6 darkest) as part of the initial examination. The nature of the skin quality is important to determine if the skin has a smooth surface or sebaceous oily skin. Thickness should be noted. Sebaceous skin is usually thicker. Smooth skin may be thin and atrophic from previous therapeutic interventions or advancing age. The specific areas of scarring are important to document. Scar discolorations should be identified and pointed out to the patient since scar improvement may be less noticeable when post inflammatory scar pigmentation exists. Other general considerations must address the patient’s age and extent of other cosmetic issues of significance. For instance, a relatively young patient with currently active cystic acne may need acne treatment first rather than cosmetic intervention. Patients with photo aging may require procedures additional to any acne scar treatment. The patient’s verbalization of a complaint about acne scars may not in fact be the true issues requiring treatment. The surgeon must be particularly aware of any gravity-induced issues or age-related tissue loss that may explain why the patient is currently presenting. In the author’s experience patients may initially present
12 Autologous Fat Transplantation for Acne Scars
in their forties or fifties complaining about acne scars. They often state that over time the scars have become more difficult to camouflage with makeup. The scars are visible as a result of facial volume loss, or decreased skin turgor and loss of elasticity. As facial skin begins to droop from aging, the skin becomes irregularly suspended from fibrotic areas of scar, creating an uneven rolling appearance with step like drop offs. Treating just the acne scars in these patients provides only minimal or partial improvement. In fact this group of acne scar patients decidedly benefits from volumizing the underlying tissue loss, and/or tightening the skin. In terms of the volumizing needed, autologous fat transfer can be particularly useful.
12.6 Acne Scar Morphology There is not a well established descriptive or nomenclature system for acne scars, with the exception of the term “ice pick scarring.” Various approaches have been utilized to try and classify acne scars (1, 9), but the author has found that descriptive methods work best. Are the scars discrete (e.g., few scattered scars over an entire cheek) or numerous? What is the depth of the scar? Is the scar size small (a few millimeters) or wider? Is the individual scar well demarcated, or poorly marginated? Does the scar appear almost punched out (also known as crater form or ice pick)? Is the surrounding skin flat, or has there been so much acne activity that the skin has the characteristic of rolling hills and valleys? Is the adjacent tissue hard and scar like or relatively soft and elastic? Since there are typically multiple types of acne scars on any one person, the author has found it beneficial to utilize photos for marking and describing lesions. Checking to see if the scar is distensible is a crucial point. If the surgeon stretches the adjacent skin on opposite sides of the scar and the scar flattens, then the scar is much more amenable to various treatment options. If the scar is bound down and doesn’t flatten or smooth out with stretching, then the scar is substantially more resistant to any therapeutic modality. The term “ice pick scar” is a generally accepted description of a type of acne scar. The description comes from the concept of a sharply demarcated ice pick hole in ice. The dystrophic scar appears like a punched our crater and is usually deeper than it is wide. It is not
71
distensible. This type of scar may be quite small and occur in a cluster of similar small scars on the malar prominence, or may be individual and large. Typically the surrounding tissue is firm and cicatricial. This type of scar is typically resistant to most forms of therapy, including surgical excision because of the extent of surrounding cicatrix. These descriptions are primarily useful on facial scars. The same considerations apply to scars on the torso but treatment for those scars overall is more challenging and results are generally less substantial. Elevated hypertrophic scars are common on the torso but rare on the face.
12.7 Acne Scar Treatment Options As many methods of treatment exist, the overlapping benefit is common. There is no single approach that stands out as most effective. Choices are dictated by the type of scars, age issues, skin color, financial considerations, procedural risk, and upon the patient’s acceptance of any available option. The intent of this chapter is to review autologous fat transfer as one option; however lipofilling may be utilized as part of a comprehensive approach treating both the acne scars and other related cosmetic issues (10). As a dermatologist, the author has considerable experience in various methods including full dermabrasions, CO2 and erbium resurfacing lasers, non ablative laser modalities, fractionated lasers, variable depth peels, multiple filling agents, excisions, grafting, and skin tightening modalities. A consistently beneficial approach in the author’s opinion is surgical subcision (11). In fact subcision is necessary to place any filler under a tight scar. Dermabrasion with a motorized diamond wheel or wire brush was the standard of care prior to lasers and fillers, and is now used more as localized dermasanding (12, 13). The concept became more refined with the accuracy allowed by high energy CO2 and Erbium (14, 15) laser resurfacing, where the surface of the skin was entirely removed to the level of the papillary dermis. This allowed tissue remodeling with the formation of new collagen and generally resulted in a smoother skin surface with reduction of acne scars. While highly effective and still utilized in the proper circumstance, the process was invasive and hypo pigmentation was common. In the author’s opinion, many of the somewhat older
72
patients who benefited did so because the skin tightened substantially primarily with the CO2 laser. The technique had preclusions in the color of the skin. Non ablative (16) lasers were designed to keep the skin surface cool and unaffected while at the same time heating the underlying collagen enough to initiate collagen remodeling. Multiple treatments are required (often about 12 treatments with the 1,450 nanometer Smooth Beam), and significant improvement can occur however more often results are modest but noticeable (17). These lasers may be used in most Fitzpatrick skin types with some limitations (18). Fractionated Lasers are the newest modality, and can be beneficial, with minimal downtime and substantially reduced risk compared to the older high energy CO2 and Erbium systems (19). Depending on the type of system, one or several treatments may be needed. Skin tightening modalities (Thermage® and others) also benefit acne scars, probably from the skin contraction making the scars appear smaller and more superficial. Resurfacing Lasers including CO2 may also be utilized after fat injections (20). Monopolar radiofrequency has no adverse effect on commercial soft tissue fillers, although fat has yet to be specifically studied (21). Peels (22), even very mild no downtime glycolic peels, when repeated multiple times can be useful for mild acne scars. The reason appears to be that even superficial peels stimulate some amount of collagen remodeling, and over time skin smoothing occurs. Microdermabrasion has been suggested to be useful (23). Higher strength trichloroacetic acid (24) can be applied to individual scars and is helpful in combination with injectable fillers. Surgical scar excision, with or without skin or dermal grafting is considered a mainstay of treatment for ice pick or deep atrophic scars, with or without resurfacing techniques (9, 25–27). Surgical Subcision is simple, minimally invasive, performed under local anesthesia and is integral to successful filler treatment of acne scars by establishing a space for injection of the filler or fat (20, 28, 29). Since many acne scars are bound down, injecting fat or other filling substance directly under or into the scar without prior subcision can result in extrusion of the filling substance into the non scar surrounding tissue, and the clinical result is an elevated donut of filler substance around the scar. The author’s preferred subcision technique utilizes variable gauge needles (18–26 gauge) inserted
B. I. Raskin
horizontally or at a slight angle adjacent to the scar. For larger scars or wider area treatment, a filter needle (Nokor, Becton Dickinson, Franklin Lakes, NJ) is excellent when sharp dissection is needed or a blunt cannula can also be effective if the subcision is within the fat (1). The needle is moved back and forth horizontally under the scar in a fanning configuration such that the entire cicatrix binding the scar is released. The subcision is usually performed from at least two insertion points so the tunneling is at 90° from the previous direction and large areas of scars can be treated easily at one session. The depth of the subcision is based on the cicatrix underlying the scar. On superficial scars, the subcision level is within the dermis while on deeper scars, the subcision is sub dermal or within the fat. Subcision at multiple depth levels can be accomplished at the same session on the same scar. Blood should not be removed from the pocket because the blood stimulates new collagen formation thus elevating the depression over time. Subcision repeated monthly may be effective as a monotherapy for some acne scars. Subcision is always performed immediately prior to filler or fat injection. Scar or dispigmentation developing at the needle insertion sites is rare.
12.8 Lipofilling Acne Scars (Figs. 12.1–12.4) Fat is not considered generally effective for individual bound down ice pick scars (30). However once the scar is freed, fat may be satisfactorily injected. For widespread grossly atrophic disease in combination with deeper tissue destruction, fat should be considered as the optimal filling and volumizing agent (1). Fat is an excellent deeper augmenting injectable in acne scars (1). Issues of permanence are gradually being resolved. Fat no longer appears to be as temporary as initially considered (31, 32). Accurate long lasting autologous corrections can result (1, 33, 34). When higher volumes are required, fat injections can considerably save costs for the patient (35). Fat can be combined with other resurfacing techniques (20). Numerous methods exist for harvesting, preparing and injecting which speak of the empirical nature of fat injections. Various factors may contribute to fat cell survival: harvesting method, manipulation of fat, exposure to blood or lidocaine, recipient site, donor site, centrifugation, injection method including syringe and
12 Autologous Fat Transplantation for Acne Scars
Fig. 12.1 The skin is pinched, creating a tunnel, and fat is injected in multiple tissue planes using a micro droplet technique
Fig. 12.2 Acne scars are treated by both volumizing the deeper underlying tissue and injecting superficially directly beneath the scar
needle size and overcorrection. These factors have been reviewed (33, 36, 37) without definitive result although differing opinions exist (3). However, a review of survival rates has demonstrated that good results are obtained independent of the technique employed when small
73
Fig. 12.3 Marking of focal areas injected at a touch-up session utilizing the patient’s frozen fat
volumes are used (37). In histologic studies, the diameter of fat should be less than or equal to 3 mm for effective neovascularization (38). The donor area is selected in consultation with the patient. Hips, outer thighs, and medial knees provide a bloodless dense fat, although the abdomen is also convenient. An optimal donor site has not been documented (39) although it is felt that the take is similar among regions aspirated (40). Fat is harvested under the tumescent technique with blunt-tipped cannula, and manual aspiration with 10-mL syringes is effective (41). The fat is allowed to settle in the upright syringe, and the fluid is decanted. The syringe is then centrifuged for a few minutes, and transferred through a sterile syringe coupling device to 1-mL syringes since small syringes provide more control and less pressure is needed to deliver aliquots. Extra fat may be frozen for later use (3). As with lipofilling of cosmetic defects, the procedure should be considered as a multi treatment program. Small volumes are required even if multiple scars are infused, and as such the use of frozen fat aliquots from a single harvesting will save considerable time with future injection sessions. Any volumization should be performed first. While patients in the teens and early 20s may infrequently require volumizing, most patients that are older do need the enhanced volume. Volumizing smoothes and
74
B. I. Raskin
a
rounds the overall facial contour which reduces shadowing. Thus even when microinjecting fat intralesionally within the scar after subcision, the author still recommends instilling at least a small amount underneath to volumize the area. This helps to stretch or distend some scars making them more superficial in appearance. But the importance of overall facial volumizing is that a rounded facial contour has relatively the same shadowing in most head positions. The next step involves micro lipo injection of the individual scars. Fat will not normalize the contour unless the residual scar attachments are destroyed first. Subcision as described above should be completed initially and the blood from subcision should be left under the skin and not intentionally extruded. Because of the small fat volumes utilized, centrifuged fat will be more concentrated. The fat need not be blood free since blood stimulates new collagen formation in the injection pocket. When a larger infiltration needle or cannula is utilized, a nick is often made in the skin first - this can be accomplished with a Nokor® needle or #11 blade. The incision can be at a distance from the scar, allowing access to a wider area of treatment. When injecting under small scars, the injections should be performed with the surgeon’s choice of the smallest effective needle to allow accurate micro droplet infusion. Injections can be in any tissue plane as determined by the subcision, or within all three (intra dermal, sub dermal and subcutaneous) tissue planes (42). Only micro droplets are usually needed for intra dermal or immediate sub dermal placement. Often infusion is best accomplished as the needle is withdrawn. The endpoint is a slight over correction. Fat should be injected deeply as a three dimensional lattice with 0.1–0.2-mL aliquots. The site is gradually built up to enhance the superficial layers in a lipo layering technique (43). Approximately 50% of transplanted fat should be expected to survive (1). Thus touch up procedures at 3 months may be needed. Overcorrection of about 10% is usually needed. Post operative care usually only requires antibiotic application to the injection sites. Post operative pain is minimal, and oral antibiotics are not required in the author’s experience. Significant edema can be treated with a short course of oral steroids. Residual frozen fat can be utilized up to 12 months later (1).
b
Fig. 12.4 (a) Pretreatment photo of a 50-year-old female with acne scars. There are hollows in the cheek and loss of volume in the malar, periorbital, and perioral regions. (b) Significant overall improvement after a multi modality treatment program with Sculptra, Thermage, and fat. The face has a full rounded quality. Acne scars are considerably reduced. Fullness is present in the periorbital and perioral regions. The skin appears brighter due to increased light reflectance which is common in the author’s opinion after volumizing
12 Autologous Fat Transplantation for Acne Scars
12.9 Longevity Longevity of fat transplants has been extensively studied although consistent results in the literature varies (44–46). Theories include replacement fibrosis, neovascularization of transplanted fat, and differentiation of lipocyte stem cells into mature adipocytes (4, 37, 47– 49). Duration has not been specifically studied in acne scars. However one study of depressed post surgical scars in 30 patients utilizing a subcision technique followed by autologous fat grafting through 4-mm cannula, revealed 27 with very good results at 3 years (50). Two patients required an additional treatment at 6 months due to partial recurrence. A case of greater than 2-year persistence of autologous fat transplantation into a large post radiation thigh defect has been reported, although several sessions were required over 3 years to obtain satisfactory benefit (51). Recent research focuses on lipocyte stem cells rather than mature adipocytes as the driving force in long term clinical benefit for post radiation depressed scars (47). It has been established that adipos